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ABSTRACT 
 
The goal of the research presented in this dissertation is to develop laser-induced 
fluorescence anisotropy (LIFA) detection for detecting and characterizing amyloid beta (Aβ) 
peptide aggregates separated by capillary electrophoresis (CE). Senile plaques composed 
primarily of aggregated Aβ (1-40) and Aβ (1-42) peptides have been found in the brains of 
Alzheimer’s disease patients. These peptides are thought to be responsible for the disease 
pathology. A CE method using UV absorbance detection was developed for the quantification of 
Aβ (1-40) monomer and testing of Aβ monomer preparations for undesired aggregates (Chapter 
2). Analyses of both Aβ (1-40) and Aβ (1-42) monomer and aggregate samples were performed 
by CE-UV (Chapter 3). The CE-UV experiments demonstrated that the CE method can separate 
Aβ monomers from aggregated Aβ.  A lab-constructed CE-LIFA instrument was built to separate 
and detect individual Aβ fibrils using Thioflavin T (ThT) in the separation buffer as a fluorescent 
probe (Chapter 4). Separating and detecting individual Aβ aggregates opens the door to a better 
understanding of amyloid aggregation, which is normally studied with bulk methods, i.e. all 
aggregates measured at once. Individual Aβ aggregates detected by the CE-LIFA instrument 
were shown to exhibit fluorescence anisotropy, but all of the aggregate peaks exhibited similar 
anisotropy values using ThT as a fluorescent probe. Plots of fluorescence anisotropy vs. time did 
not produce peaks as expected. A data treatment method to facilitate visualization of peaks in 
CE-LIFA data was developed (Chapter 5). Thioflavin T spectroscopy in the presence of 
polystyrene spheres was studied to address potential false positives observed in preliminary 
experiments from Chapter 4 using ThT as a fluorescence probe for Aβ aggregate detection 
(Chapter 6). It was found that polystyrene spheres can enhance ThT fluorescence similar to Aβ. 
A CE-LIFA study of Aβ peptides covalently labeled with a fluorophore was performed to 
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overcome the apparent limitations of ThT. Aggregation of two different preparations of Aβ was 
studied as a function of time. Different forms of Aβ were separated and detected using CE-LIFA, 
and peaks resulting from different forms of Aβ exhibited different fluorescence anisotropy 
values. 
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CHAPTER 1 
 
INTRODUCTION 
 
1.1 Amyloid Proteins and Amyloidogenesis 
There are over 20 amyloid-forming proteins that are known to be associated with human 
diseases [1]. Several amyloid proteins and their associated diseases are listed by Rambaran et al., 
Rochet et al. and Ecryod et al. [1-3]. Briefly, some diseases and their associated amyloid proteins 
include Type II diabetes (IAPP, or amylin), Parkinson’s disease (α-synuclein), Huntington’s 
disease (Huntingtin), Creutzfeldt-Jakob disease (prion protein) and Alzheimer’s disease (beta 
amyloid (Aβ)).   
Amyloid proteins misfold and self-assemble under physiological conditions to form 
aggregates. This aggregation process is referred to as amyloidogenesis. Ecroyd et al. have 
suggested that all proteins are capable of undergoing amyloidogenesis, but the amino acid 
sequence of the protein highly dictates a protein’s predisposition to adopt amyloid aggregate 
structures [2]. Amyloid proteins are soluble prior to self-assembly but become more insoluble as 
aggregation progresses, eventually leading to mature, fully-formed fibrils. Not all proteins that 
self-assemble can be characterized as amyloidogenic. Proteins are characterized as “amyloid” by 
the cross β-sheet structure that they form as a result of aggregation. Amyloidogenesis is complex, 
and many transient and metastable intermediate aggregates existing between monomers and 
fibrils. It is believed that the term “amyloid” was derived from “corpus amygdaloideum”, which 
is latin for “amygdale”. Amygdala is the name of neurons located in the brain’s temporal lobe 
that have an effect on memory.  
The nucleation-dependent polymerization pathway is a theory that explains the 
mechanism of amyloid fibril formation [4]. According to this theory, monomers self-assemble in 
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solution to form a nucleus, i.e. “nucleation”. Remaining free monomers in solution add to the 
nucleus and extend its dimensions, i.e. polymerization. The nucleation-dependent polymerization 
reaction follows first-order kinetics, with nucleation being the rate-limiting step followed by the 
thermodynamically favored polymerization step [4,5]. 
Research has shown that the process of monomers aggregating to form fully-formed 
fibrils produces several complex intermediate and transient structures that exist between 
monomers and fibrils [6-8]. Each intermediate aggregate and fully-formed fibril will potentially 
be unique in size, shape and structure. Intermediates can be in the form of oligomers, i.e. 
dimmers, trimers, tetramers, etc., or protofibrils, which are structures intermediate in size 
between oligomers and fully-formed fibrils. Takahashi et al. schematically illustrated the 
aggregation process from monomers to fibrils in a recent article [9]. Aβ species in solution have 
been shown to reach a dynamic equilibrium with a reproducible end point of approximately 1 
µM unpolymerized monomer [10]. Different amyloid proteins do not have similar primary 
sequences or monomer structures, but the aggregates they form have common structural features. 
For example, β-sheet secondary structures and rod-shaped 3D structures that can be up to 
microns in length and roughly 10 nm in diameter. The overall size and shape between aggregates 
formed from the same amyloid protein can vary drastically [11,12]. 
1.2 Amyloid Beta (Aβ) Peptides and Alzheimer’s Disease 
As previously mentioned, amyloid aggregation has been linked to human diseases [1]. 
The research covered in this dissertation focuses on the Amyloid beta (Aβ) peptide. The Aβ 
peptide has been found to be the major protein in the extracellular neuritic plaques of people who 
have Alzheimer’s disease (AD) [13,14]. Alzheimer’s disease is a form of senile dementia named 
after the German Physiologist Alois Alzheimer who originally described the pathology of AD 
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based on analyzing slices of neuronal tissue using microscopy in 1906. Alzheimer’s disease is 
the most common form of dementia [15]. There are no biological markers to diagnose a living 
person with AD, and the greatest risk factor is age [15]. The main symptoms of AD are loss of 
memory and cognitive skills [15]. Diagnoses of AD can be accomplished through eliminating 
other potential sources of AD-like symptoms [15]. It is not clear if genetics plays a role in 
predisposing a person to AD, but genetics does appear to play a role in the timing of the disease 
onset [15]. 
The Aβ peptide is cleaved from the Amyloid precursor protein (APP) by the proteases α, 
β and γ secretases [16]. The APP found in neurons is a type 1 transmembrane glycoprotein that 
contains 695 amino acids and is abundantly expressed in neuronal tissues [17,18]. α secretase 
cleaves APP between amino acids 16 and 17, and produces a nontoxic soluble form of Aβ [16]. β 
secretase first cleaves off the extracellular domain of APP. The remaining transmembrane 
domain APP is then cleaved by γ secretases, which produces the form of Aβ that becomes 
neurotoxic [15,16,18].  
Proteolysis of APP can produce different length Aβ peptides from 39 to 43 amino acids 
in length. The primary sequence of Aβ is shown below as the Aβ (1-43) amino acid isoform. 
Shorter isoforms of Aβ have the same primary sequence minus amino acids from the C-terminus 
of the peptide chain. The molecular weight of Aβ is about 4 kDa, depending on the isoform. 
TA  I V VG G  V M LG  I I AG K  N S G V D E
A  F F V LK  Q H H V E YG  S D H R F EA  D
40353025
20151051
 
The Aβ (1-40) and (1-42) peptides are the most abundant isoforms produced from APP 
cleavage. The cleaved Aβ segments from APP are released into the extracellular matrix and exist 
in human plasma and cerebrospinal fluid even in normal subjects [15,17]. The concentration of 
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Aβ in the cerebrospinal fluid is estimated to be in the low nanomolar range [19]. The secreted 
concentration of Aβ (1-42) is about 5 – 15% of Aβ (1-40) [20]. Interestingly, Aβ (1-42) is the 
most abundant form found in senile plaques of AD patients [21-24]. Aβ (1-42) is more 
neurotoxic relative to Aβ (1-40) [25]. Aβ (1-40) is found in association with blood vessels [21]. 
Under physiological conditions, the Aβ peptide accumulates in the brain, and, through 
aggregation, deposits as amyloid plaques [17]. The accumulation of Aβ plaques can be observed 
decades before the AD symptoms [20]. The amyloid hypothesis describes the accumulation of 
Aβ in the brain, the imbalance of Aβ production and clearance from neuronal tissue and how 
these events could be critical in AD pathology [13]. Aβ is protease-resistant due in part to 
racemization of aspartyl and seryl residues and cyclization of N-terminal glutamyl resides [24]. 
Additionally, racemization from the L-amino acids to D-amino acids could have an impact on 
the aggregation rate of Aβ peptide [26].  
Fully formed Aβ fibrils have been found during autopsies performed on the brains of 
people who were diagnosed with AD. This is likely the reason that researchers initially targeted 
Aβ fibrils to prevent or treat AD. Small molecules and small designer-peptides that can 
potentially dismantle Aβ aggregates or inhibit their formation have been tested [16,27,28]. For 
example, Curcumin (Yang 2005), phenol-related compounds [29] and pixantrone and 
mitoxantrone [30] have been shown to inhibit Aβ aggregation in vitro. An effective disruptor of 
Aβ aggregates for clinical use must be necessarily small in order to cross the blood-brain barrier 
while still being specific enough to bind only neurotoxic Aβ. Small molecular inhibitors satisfy 
the former but can suffer from non-specific binding [28]. Designer-peptide inhibitors have the 
advantage of increased binding specificity, relative to small molecules [28,31]. Peptide-based 
inhibitors can be designed with specific chirality and level of hydrophobicity, both of which can 
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contribute to preventative and disruptive aggregation [28,31]. The central hydrophobic core of 
Aβ, amino acids 16 – 20, is known to play a critical role in Aβ oligomer production and is 
therefore a popular target for developing agonist of aggregation [32,33]. Other than small 
molecules and peptide inhibitors that target the Aβ peptide for prevention or disassembly of the 
aggregation, some researchers have investigated ways to treat AD by more indirect methods. 
One such method is the regulation of the proteolytic secretases that are responsible for cleaving 
APP and producing Aβ [34].  
The previous paragraph discussed ways to treat, manage or prevent AD by dismantling or 
inhibiting Aβ aggregation. Arguably, the biggest challenge in developing methods to treat, 
manage or prevent AD is that there is no clearly defined neurotoxic Aβ aggregate. One 
hypothesis is that AD neurotoxicity is related to Aβ aggregate size, but this does not imply that 
there is a direct relationship between size and neurotoxicity. Large fibrils were initially suspected 
to be the toxic species of AD [32]. More recently, researchers have shown that smaller Aβ 
oligomers are also toxic and could be more toxic than larger Aβ aggregates [13,27,35,36]. One 
method to determine the cytotoxic potency of Aβ peptides is to monitor the cellular 
concentration of 3-(4,5-dimethyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) as a function of 
Aβ peptide exposure [37]. Normal cells reduce MTT and peptide-treated cells do not reduce 
MTT. By monitoring the concentration of MTT using absorbance spectroscopy at 570 nm, 
cytotoxic potency can be ascertained [37]. MTT assays have also been used to test inhibitors of 
aggregation [38]. It is possible that if smaller Aβ aggregates, such as oligomers are more 
neurotoxic relative to larger aggregates, disrupting or dismantling fully-formed aggregates in 
vivo could produce oligomers thus leading to enhanced AD neurotoxicity. 
 
  6 
 
1.3 Preparation of Synthetic Aβ Peptides 
The lack of analytical tools to characterize the plethora of sizes, shapes and structures of 
Aβ, from monomers to fully-formed fibrils, makes designing treatments for AD a major 
challenge. While synthetic Aβ monomer peptides are commercially available as lyophilized 
powders, no analytical standards for aggregates exist that can be used to develop analytical 
methods to characterize and quantify Aβ aggregates. Because no analytical standards of Aβ 
aggregates exist, developing methods to characterize Aβ aggregates relies heavily on the ability 
to reproducibly prepare high quality synthetic Aβ samples [39]. Reproducibility of Aβ samples is 
a major challenge because the final product is extremely sensitive to small preparation variations. 
Chapter 2 demonstrates this clearly. Several Aβ monomer samples were prepared by the same 
scientist using the same method, and some samples were found to contain unwanted Aβ 
aggregates while others were found to contain only Aβ monomers. There are several potential 
sources of Aβ preparation variability [40]. Briefly, some of these include the commercial source 
of the peptide, initial aggregation state and aggregation conditions including solvent polarity, pH, 
ionic strength and incubation temperature [40,41]. Moreover, errors associated with solid phase 
peptide synthesis of Aβ can be a potential source of irreproducible Aβ aggregation [42]. 
Methods have been developed that can provide reproducible Aβ preparations [42-44]. 
The first step in preparing synthetic Aβ samples from the lyophilized monomer is treating the 
lyophilized monomer with a solvent that will disaggregate any preformed aggregates that could 
act as seeds. Seeds are known to accelerate aggregation and increase polydispersity [11,44]. Pre-
formed aggregates could be a result of synthetic impurities or improper storage conditions. An 
effective solvent to dismantle preformed aggregates should break down H-bonding between 
aggregates and be easily removable. Solvent removal can be performed under a stream of 
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oxygen-free and inert gas. Oxygen-free gas is important so that amino acids are not oxidized. 
Trifluoroacetic acid (TFA), hexafluorpisopropanol (HFIP), or a combination of the two, are 
common solvents used to initially treat the lyophilized monomer to dismantle pre-formed 
aggregates. For aggregation studies, incubation temperature is critical because the velocity of 
amyloid formation is highly dependent on temperature [4]. The velocity of amyloid formation at 
25° C is reported to be only 10% of that at 37° C [4]. High ionic strength buffers and pH between 
4 and 7 promote aggregation [40]. 
1.4 Analytical Methods for Studying Aβ Monomers and Aggregates  
An ideal method for studying Aβ aggregation could monitor Aβ monomers, fibrils and all 
aggregates in between with a single technique that would provide size, structure and 
concentration information of each species detected in real time during aggregation. No single 
method is capable of this; however, several methods are routinely used that provide some of this 
information. Quantifying Aβ monomer has been achieved by UV absorbance spectroscopy 
[17,45]. The peptide bonds between the amino acids absorb in the low UV radiation range (~190 
– 254 nm). To accurately quantify Aβ monomer in solution using UV absorbance, a linear 
concentration curve should be developed that has been calibrated to the exact protein 
concentration by amino acid analysis (AAA). The procedure of AAA involves hydrolysis of the 
peptide bonds followed by separation, detection and quantitation of the amino acids. A benefit to 
AAA is that any preexisting aggregates are also broken down to monomers and subsequently 
amino acids. This means that all of the peptide is accounted for, which results in a more accurate 
determination of the peptide concentration. Amino acid analysis can also provide relative amino 
acid composition of a protein to help verify the identity of the protein.  
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It is not clear that UV absorbance spectroscopy can accurately determine the 
concentration of Aβ aggregates. Because aggregates are made up of Aβ monomer subunits, one 
might expect that an aggregate’s absorbance would scale with n monomer units. No literature 
was found to support or dispute this. It is unknown how molar absorptivity scales with 
aggregation. Moreover, unlike monomers, large aggregates will significantly scatter light in 
addition to absorbing it. A UV detector would not differentiate between scattered light and 
absorbed light, so this could obviously lead to unreliable concentration results. Further 
complicating quantification of aggregates by UV absorbance is that, unlike a solution of 
monomers, a solution of aggregates is polydispersed, i.e. each aggregate is potentially unique. 
UV absorbance spectroscopy is a powerful tool, but it can suffer from if the sample is not pure 
since many unwanted analytes can potentially absorb at the same wavelengths being used to 
quantify Aβ monomers. 
Circular dichroism (CD) is a qualitative spectroscopic method that can detect secondary 
structures of proteins. The method relies on the differential absorption of left and right circularly 
polarized radiation. The conversion of Aβ monomers to aggregates in solution is accompanied by 
a conversion of random coil and α-helix structures to β-sheet structures [40]. This conversion can 
therefore be monitored be CD. Circular dichroism is particularly useful in kinetic studies of Aβ 
aggregation and screening inhibitors and disruptors of Aβ aggregates. Because CD is based on an 
absorbance measurement it can suffer from light scattering from larger aggregates similar to UV 
absorbance spectroscopy [44]. 
As mentioned above, light scattering from aggregates is a potential source of interference 
in absorbance-based measurements, but if aggregates are of interest, light scattering (LS) 
detection is a useful tool. Aggregated Aβ has been suggested to be a more reliable target for AD 
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diagnoses compared to soluble Aβ monomers [23]. The power of light scattering detection is that 
the diffusion coefficients, D, of particles in solution undergoing Brownian motion can be 
determined [46,47]. Light scattering detection works well to study Aβ aggregates in solution 
because they behave similarly to particles in solution. Lomakin et al. describe in detail how a 
particle’s diffusion coefficient can be used to determine that particle’s size, i.e. its hydrodynamic 
radius, Rh, using the Stokes-Einstein equation [47]. While the aggregate’s shape has to be 
assumed to relate the D to Rh, no other method was found that can determine an aggregate’s Rh. 
Rh is most accurately related to D when (1) the solution is dilute so that local viscosity does not 
affect D and (2) when the aggregate’s length is not greater than 150 nm [46,47]. Light scattering 
detection may not work well for determining Rh of fully-formed fibrils because they are greater 
than the approximate 150 nm length threshold. The hydrodynamic radius of low molecular 
weight Aβ, however, has been determined to be 1.5 – 2.0 nm based on quasielastic light 
scattering measurements [48]. Furthermore, LS detection is not a useful method for monitoring 
Aβ monomer because monomers do not scatter light. 
Mass spectrometry (MS) is another valuable tool for quantifying Aβ monomer in 
solution. Mass spectrometry can identify different monomeric isoforms of Aβ, e.g. 1-40, 1-42, 1-
43, based on their mass differences. Thompson et al. demonstrated that electrospray ionization 
(ESI) MS could be used to identify different Aβ monomeric forms based on their m/z values 
after being chromatographically separated [49]. Using matrix-assisted laser desorption ionization 
(MALDI) with MS imaging (MSI), Stoeckli et al. were able to map different isoforms of Aβ in 
post-mortem mouse brain tissue, which demonstrates the power of MS analysis [50]. Mass 
spectrometry, however, cannot be used to analyze Aβ aggregates directly because they are too 
large to get into the gas phase [51]. Typically, if aggregates are to be analyzed by MS, the 
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aggregates are first disaggregated to monomers and then analyzed. A report by Teplow and 
coworkers discusses that when monomers build on each other, the m/z remains constant, which 
means that normal MS would not be able to differentiate between a monomer and any higher 
order oligomer [42]. The authors discuss that ion mobility mass spectrometry (IM-MS) can 
differentiate between monomers and higher order oligomers because the technique can resolve 
ions of different masses even if the m/z values are the same [42]. For a recent review on IM-MS, 
see Uetrecht et al. [52]. 
For structural information of aggregates, imaging methods, such as transmission electron 
microscopy (TEM) have been used [39]. Transmission electron microscopy can quantify 
dimensions of a single Aβ aggregate and is commonly used to identify the presence of 
aggregates in a solution of Aβ. Non-imaging techniques, such as solid-state nuclear magnetic 
resonance (SSNMR) and hydrogen-deuterium exchange mass spectrometry (HDXMS), do not 
provide images attainable by imaging techniques. TEM requires that the sample be removed 
from solution, spotted onto a surface and dried prior to analysis. It is likely that the dried 
aggregate is not in the exact confirmation as it was in solution. Also, only aggregates large 
enough to interact with the beam of the electrons from the TEM source will be imaged. 
Monomers and low molecular weight oligomers are too small to be resolved by TEM [53]. 
Atomic force microscopy (AFM) is another imaging technique that has been used to obtain 
structural information of Aβ aggregates, but like TEM, the sample is spotted on a surface and 
dried [54,55]. One advantage of AFM over TEM is that TEM provides 2 dimensional images and 
AFM provides 3 dimensional information. 
Ryu et al. have also demonstrated the use of surface plasmon resonance (SPR) 
spectrometry to study Aβ peptide [56]. Like TEM and AFM, SPR measurements are made with 
  11 
 
the analyte on a surface. The surface in SPR is a dielectric material that resonates with an 
incident beam of radiation at a specific angle, called the SPR angle. As the mass on the surface 
increases due to Aβ accumulation, i.e. aggregation, the SPR angle shifts. The shift in SPR angle 
is therefore indicative of aggregation. A limitation to SPR is that the monomeric Aβ is bound to 
the dielectric surface prior initiating aggregation [56]. While this provides an anchor on which 
aggregation can proceed, it is not known how anchoring the peptide affects polymerization. SPR 
is a non-quantitative method. Moreover, like AFM and TEM, SPR can be used to determine if 
aggregation has occurred. Unlike AFM and TEM; however, SPR is incapable of providing an 
image of the aggregates. 
Solution-based methods that are capable of providing structural information of proteins 
are:  X-ray crystallography, MS and nuclear magnetic resonance (NMR) spectroscopy. 
Unfortunately, Aβ fibrils do not form crystals or ordered repeat structures, which limits the use 
of X-ray crystallography for structural analysis of larger aggregates [57]. Mass spectrometry 
coupled with hydrogen/deuterium exchange (HDX) has been used to probe structural 
information of aggregates [58]. HDX is the process of exchanging amide hydrogens on the 
peptide for deuterons in solution. Structural information can be obtained using HDX based on 
the idea that hydrogens involved in hydrogen bonding and those embedded more deeply in the 
aggregate’s core will exchange for deuterium more slowly relative to hydrogens on the surface of 
an aggregate [51,58]. After the HDX process, the back exchange of deuterium for hydrogens is 
quenched, the aggregates are dismantled and the number of deuterons acquired by an aggregate 
can be measured by MS based on the increase in mass [51,58]. It is critical to perform the MS 
analysis quickly to minimize loss of HDX information due to back exchange of hydrogens for 
deuteriums [58]. Using HDX-LC-MS, Kheterpal et al. were able to demonstrate that about 50% 
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of the amide hydrogens of Aβ are protected from exchange after Aβ has aggregated [59]. 
Another challenge of studying Aβ aggregates is that aggregates become increasing 
insoluble as they get larger. This limits the size of Aβ aggregates that are analyzable by solution-
based NMR because the aggregates precipitate out of solution. Smaller oligomers are more 
soluble relative to larger aggregates. Moreover, oligomers are short lived relative to larger 
aggregates. This means that oligomers are likely to change structure and size before, after or 
during the measurements. NMR is limited to proteins approximately 30 kDa [60], which is 
approximately equal to 6- or 7-mer oligomers. NMR also requires approximately 1 – 10 mM of 
protein, which is a concentration that would certainly promote aggregation and precipitation 
[61]. 
Fluorescence spectroscopy is a very common method for studying and assaying Aβ 
aggregation. For a protein to be intrinsically fluorescent, it must contain aromatic amino acids. 
Tryptophan (abbreviated Trp or W), Tyrosine (abbreviated Tyr or Y) and Phenylalanine 
(abbreviated Phe or F) are the three fluorescent aromatic amino acids of the 22 amino acids. 
Tryptophan is by far the most fluorescent amino acid with a molar absorptivity (ε) of 5600 M-
1cm-1 and a quantum yield (Ф) of 0.20 [61]. This is compared to Tyr (ε = 1400 M-1cm-1 and Ф = 
0.14) and Phe (ε = 200 M-1cm-1 and Ф = 0.04) [61]. Of these aromatic amino acids, Aβ contains 
0 Trp, 1 Tyr and 3 Phe. Aβ does not have strong native fluorescence in part because it lacks Trp 
and only contains 1 Tyr.  
While Aβ does not exhibit strong native fluorescence, researchers have used covalent and 
noncovalent fluorescent labeling techniques to study Aβ. Fluorescently labeled Aβ monomeric 
isoforms are commercially available. One example is carboxyfluorescein (FAM) labeled Aβ, 
which is used in Chapter 7 to fluorescently probe Aβ aggregation. Another labeling technique 
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involves using Aβ aggregate antibodies that are covalently bound to fluorescent dyes. Funke et 
al. used fluorescent labeled antibodies (6E10-Alexafluor-488 and 19H11-Alexafluor-633) to 
fluorescently detect single aggregates by fluorescence correlation spectroscopy [23]. 
Other fluorescence probes for Aβ aggregates are amyloid dyes. The most widely used 
amyloid dyes are Congo Red and Thioflavin T (ThT); although, derivatives of these dyes have 
been used. Thioflavin T is perhaps more widely used compared to Congo Red. Amyloid dyes are 
fluorogenic according to IUPAC’s definition because their fluorescence is enhanced in the 
presence of Aβ aggregates. The research presented in Chapters 2 and 4 of this dissertation 
employed ThT as an amyloid dye to study aggregation of Aβ. Chapter 6 covers research on 
studying the spectral properties of ThT in the presence of polystyrene beads. Because ThT was a 
used in several areas of research for this dissertation, the next section is devoted to covering 
background information of ThT. 
1.4.1 Thioflavin T 
Thioflavin T (ThT) is a water soluble benzothiazole dye that binds to the β-sheet 
architecture formed by amyloid aggregates. Molecules of ThT align parallel to the long axis of 
the Aβ fibrils [62]. Upon binding to Aβ aggregates, ThT undergoes a excitation:emission spectral 
shift from 385:445 nm to 450:482 nm [12,63]. Moreover, ThT fluorescence can increase by 
several orders of magnitude when bound to Aβ fibrils compared to unbound ThT [12]. By 
monitoring the ThT fluorescence near 450:482 nm, the presence of Aβ aggregates can be 
detected. The spectroscopy of ThT in the presence of Aβ has been characterized in detail by 
LeVine and Naiki [63-65]. An EEM of ThT in the presence and absence of Aβ (1-40) aggregates 
is presented in Chapter 6. 
Thioflavin T assays are well-documented and easy to use to determine amyloid 
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aggregation kinetics, especially for Aβ (1-40). For kinetic studies of Aβ aggregation with ThT as 
the fluorescent marker, an initial lag phase is observed where the ThT fluorescence is weak for a 
period of time. This lag phase is presumably during the formation of the Aβ nucleus according to 
the nucleation/polymerization theory. The lag phase is followed by a rapid increase in the ThT 
fluorescence, which eventually plateaus at a maximum ThT fluorescence. Chapter 2 illustrates 
bulk ThT measurements of an aggregating mixture of Aβ (1-40). The rate and extent of Aβ 
aggregation is dependent on the starting Aβ monomer concentration. It is interesting that there 
are cases where the ThT signal, after reaching its maximum value, begins to decrease as a 
function of time. Nilsson et al. have suggested that this is due to the formation of mat-like 
assemblies of Aβ fibrils, which could lack ThT binding sites [39]. 
The structure of ThT is shown below. Researchers have suggested that the free rotation of 
the benzylamine and benzothiole rings around their shared carbon-carbon bond quenches the 
excited state of ThT, which reduces the Ф of free ThT [12].  
 
Figure 1.1.  Structure of Thioflavin T 
It has been suggested that the binding of ThT to the β-sheet of Aβ immobilizes the free 
rotation about this carbon-carbon axis, which enhances the Ф of ThT relative to free ThT [12]. 
This means that the rotation of the ring structure of ThT could be the source of the fluorogenic 
property of ThT. Stsiapura et al. investigated the rotation about the shared carbon-carbon bond of 
the benzylamine and benzothiole rings and how the angle between the rings relates to the 
observed Ф enhancement observed in ThT measurements [66]. At a torsional angle, ψ, of 90° 
and 270°, the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular 
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orbital (LUMO) overlap the least [66]. This means that when the benzylamine and benzothiole 
rings of ThT are perpendicular to each other, ThT is nonfluorescent because there is little to no 
charge transfer from the ground electronic state to the excited state. On the other hand, ψ = 0° or 
180° could provide the most overlap of the HOMO and LUMO, hence, the largest Ф. When the 
two ring structures are in the same plane, the fluorescence is greatest. Stsiapura et al. 
demonstrated that increasing the viscosity of the ThT microenvironment lead to an increase in Ф, 
presumably due to preventing the ThT rings from adopting the perpendicular configuration [66]. 
It was not described by Stsiapura et al. and it is not clear why a viscose solution would prevent 
only the perpendicular configuration and not the parallel configuration.  
Another interesting property of ThT is that it forms micelles [67]. Some data suggest that 
ThT micelles bind to Aβ fibrils rather than free ThT [67]. The critical micelle concentration is 
debatable but has been suggested to be between 4 – 30 µM [67,68]. 
1.4.2 Fluorescence Anisotropy 
Fluorescence anisotropy is a focal point of the research presented in this dissertation. 
Chapter 4 demonstrates a novel use of ThT for fluorescence anisotropy measurements of Aβ 
aggregates. Chapter 5 presents a data treatment method that was developed to extract 
fluorescence anisotropy peaks from separations of Aβ aggregates. In Chapter 7, fluorescence 
anisotropy measurements of FAM-labeled Aβ monomers, intermediate aggregates and fibrils are 
presented. This section will cover background information of fluorescence anisotropy. 
Fluorescence anisotropy (FA) is based on the photoselective excitation of a fluorophore 
using a polarized source. A polarized source means that the electric field vector oscillations have 
a particular orientation, i.e. they are not randomly oriented. Photoselective excitation means that 
only those fluorescent species whose absorption dipoles are oriented with the polarization of the 
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excitation source are excited. The probability of a fluorophore absorbing a photon whose electric 
field vector lies in the z-axis is proportional to the cos2θ, where θ is the angle between the z-axis 
and the absorption dipole of the fluorophore [69]. 
For simplicity, ignoring the fundamental anisotropy, which will be discussed below, the 
fluorescence emission of a fluorescent species, excited by a polarized source, will have the same 
polarization as that of the polarized source. If the emission polarization is altered relative to that 
of the excitation polarization, e.g. through rotational diffusion of the fluorescent species, this can 
be measured as the fluorescence anisotropy.  
The fluorescence anisotropy, then, is a measure of the degree of fluorescence 
depolarization. A major source of fluorescence depolarization is rotational diffusion [69]. 
According to anisotropy theory, slower rotational diffusion rates result in larger fluorescence 
anisotropy values and larger rotation diffusion rates result in smaller fluorescence anisotropy 
values. This relationship is described by the Perrin Equation, which is discussed in Chapter 4 
(Equation 4.2). A fluorescent species’s rotational diffusion rate, hence its fluorescence 
anisotropy, will be affected by its shape and size. For Aβ species, size and shape can change 
drastically as a function of aggregation. 
Fluorescence anisotropy is a calculated value based on measurements of the parallel and 
perpendicular fluorescence intensities relative to the excitation source (see Chapter 4 Equation 
4.1). The fluorescence anisotropy is independent of the total fluorescence emitted by the 
fluorophore because the difference between the parallel and perpendicular intensities is 
normalized to the total fluorescence intensity. It is worth noting that fluorescence anisotropy was 
preceded by fluorescence polarization, which does not normalize the difference between the 
parallel and perpendicular fluorescence intensities to the total fluorescence [69].  
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Each fluorophore has an intrinsic fundamental anisotropy, r0. The fundamental anisotropy 
is the anisotropy in the absence of any depolarization. The fundamental anisotropy is described 
in Equation 1.1, where β is the angle between the absorption and emission dipoles. For collinear 
dipoles, β = 0° and r0 = 0.4. This means that the maximum anisotropy is 0.4. When β > 54.7°, r0 
becomes negative reaching a maximum negative value of -0.2 for β = 90° (Lakowicz 3rd Ed). 
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1.5 Methods for Separating Various Forms of Aβ Peptides 
Section 1.4 highlighted some of the more common analytical approaches for studying Aβ 
with a focus on fluorescence and fluorescence anisotropy. It is clear that no one method can 
detect, quantify and characterize the range of Aβ species between monomers and fibrils. Many 
detection methods for studying Aβ rely on bulk-based measurements, i.e. the results are 
population averages. The difficulty with bulk-based measurements is that the larger species tend 
to dominate the signal. As mentioned, there is growing consensus that smaller Aβ aggregated 
species may be more cytotoxic compared to very large fibrillar aggregates. There is an obvious 
need for detecting and characterizing smaller aggregates independent of monomers and fibrils. 
To accomplish this, separation methods are needed to effectively characterize Aβ monomers and 
aggregates.  
Several liquid-based separation methods have been used to study Aβ. Separation methods 
like high performance liquid chromatography (HPLC) and size-exclusion chromatography (SEC) 
use columns that are packed with small particles that serve as a stationary phase. Stationary 
phases have the potential to disrupt amyloid aggregates due to shear force as the aggregates are 
forced through the stationary phase at high pressures. The mechanism of separation is based how 
much time the analytes spend in the mobile phase versus the stationary phase. Analytes that 
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spend more time in the mobile phase pass through the column faster than those that spend more 
time in the stationary phase. For HPLC, the affinity of an analyte for the stationary phase versus 
the mobile phase determines how much time the analyte will spend on the column. For SEC, the 
analyte does not interact chemically with the stationary phase like HPLC. Instead, the stationary 
phase particles are porous, and the analytes that can physically fit into the particles’ pores have 
more volume of solvent to pass through compared to an analyte that is too large to fit into the 
pore volume. Size exclusion chromatography thus separates analytes based on size. For amyloid 
aggregates, it is assumed that shape also affects how the aggregate passes through an SEC 
column. HPLC is typically only used to separate monomers of various isoforms of Aβ [49]. 
Researchers have successfully separated Aβ oligomers from monomers using SEC [70].   
Gel-based separations are another approach used for Aβ separations. Klafki et al. 
optimized an SDS-PAGE separation method to separate synthetic Aβ (17-40), Aβ (1-40) and Aβ 
(1-42) monomers [71]. Gel electrophoresis has also been used successfully for separating smaller 
oligomeric forms of Aβ [25,72]. Gel-based separations certainly offer the advantage of simplicity 
over HPLC and SEC while still achieving separations of monomer and oligomers. A 
disadvantage of gels is that large fibrillar aggregates may not be able to traverse the gel because 
they are too large to enter the pore-sizes of the gel material. This means that fibrillar aggregates 
may not be easily analyzable by gel-based separation methods. Hartley et al. were able to use 
SDS-PAGE with western blotting employing the Aβ antibody R1282 to analyze monomers, 
protofibrils and fibrils, but the fibrils showed little to no movement through the gel [53]. Agarose 
gels can provide large intrinsic pore sizes relative to sodium dodecyl sulfate gels and may be 
more suitable for analyzing larger fibrils [73]. 
While HPLC, SEC and gels are popular separation platforms for amyloid studies, 
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stationary phases have the potential to disrupt amyloid aggregates on-column. Alternative to 
stationary phase-based separations, field-flow fractionation (FFF) and capillary electrophoresis 
offer stationary-free separations. The analytes are separated based on their diffusion coefficient 
and hydrodynamic size [74]. Field-flow fractionation can separate macromolecular complexes 
ranging from 1 nm to 100 µm [74]. Rambaldi et al. demonstrated the use of FFF with UV/Vis 
absorbance detection and multiangle light scattering (MALS) detection for the size 
characterization of soluble and insoluble Aβ (1-42) aggregates [75]. While FFF has not gained 
significant attention for Aβ separations, Silveira et al. demonstrated the utility of FFF to separate 
aggregates of another aggregate-forming peptide, PrP-res [74].  
1.5.1 Capillary Electrophoresis (CE) 
Open tubular capillary electrophoresis, also known as capillary zone electrophoresis 
(CZE), has been shown to be a powerful separation method to study Aβ monomers and 
aggregates [76,77]. Capillary electrophoresis was extensively used in this research, and CE 
theory and applications will be discussed in this section. Some features of CE that are 
advantageous for Aβ studies are (1) no stationary phase that can potentially disrupt aggregates on 
column, (2) small volumes (nL) of sample can be analyzed, (3) the ability to separate individual 
particle-like structures and (4) many types of on-column detection methods are possible. 
Moreover, commercial CE instruments are available. Additionally, laboratory-constructed CE 
instruments are simple in design and can be easily constructed. For the work presented in this 
dissertation, a commercial CE instrument and a laboratory-constructed CE instrument were used. 
Figure 1.2 illustrates the basic components of a CE instrument. 
Capillary dimensions, i.e. length, inner diameter (i.d.) and outer diameter (o.d.), will vary 
depending on the application. For the work in this dissertation, typical dimensions were 
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approximately 60 cm in length with i.d. and o.d. of 50 µm and 360 µm, respectively. The silanol 
groups of the fused silica capillary are ionizable, and at pH values above 3, they become 
negatively charged. When the capillary is filled with buffer, the negatively charged silanol 
surface attracts positively charged ions from the buffer, and an ionic double layer is formed at 
capillary wall. Under an applied voltage, cations in the double layer migrate to the cathode. 
Because these cations are hydrated, they pull bulk solvent toward the cathode. This phenomenon 
is called electroosmotic flow (EOF), which will be discussed below. 
 
Figure 1.2.  Schematic diagram of a capillary electrophoresis instrument.  
The EOF is extremely important in CE separations because it is the pumping mechanism 
of CE [78]. Having control of the EOF is equivalent to having control of the pump in HPLC. 
Two main factors to consider with EOF are direction and velocity. The direction of the EOF will 
depend on whether electrophoresis is performed in negative or positive polarity. For example, in 
the Figure 1.2, applying a positive voltage (positive polarity) causes the electrode on right to 
become negatively charged, i.e. the cathode. As a result, the EOF would flow from left to right. 
The direction of the EOF can be reversed by applying a negative polarity, which would cause the 
electrode on the left to become the cathode, and the EOF would flow from right to left.  
The velocity of the EOF should be fast enough to drag all analytes past the detector, even 
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anions. The general order of elution in normal CE is cations, neutrals and anions. The EOF 
velocity can be controlled based on the buffer ionic strength and pH.  Buffer cations are attracted 
to the negatively charged silanol groups of the capillary surface, which forms an electric double 
layer at the capillary surface. The double layer thickness (δ), is dependent on the molar 
concentration of the buffer (c), dielectric constant of the eluent (εr), the permittivity of a vacuum 
(ε0), the universal gas constant (R), temperature (T) and the Faraday constant (F) according to 
Equation 1.2 [78]. The formation of the double layer produces a potential called the zeta 
potential, ζ. The ζ is highest at the capillary surface and falls off exponentially moving away 
from the surface toward the center of the capillary [79]. Equation 1.3 relates the ζ to the δ, where 
σ is the surface charge density [78]. Equation 1.4 shows the Smoluchowski equation, which 
relates the linear velocity of the EOF, ueo, to ζ, where E is the electric field and η is the solvent 
viscosity [78]. 
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Increasing the ionic strength of the buffer, i.e. c, results in a decreased δ (see Equation 
1.2). This results in a decrease in ζ (see Equation 1.3), which results in a decrease ueo (see 
Equation 1.4). For high pH values, more silanol groups on the capillary surface are ionized, 
which increases the surface charge density, σ. This results in an increase in the ζ (see Equation 
1.3) and an increase in ueo.   
Ionic strength also plays a considerable role in Joule heating, which increases peak 
broadening [78]. This has a negative impact on peak resolution. Joule heating is generated from 
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the resistance of the current flowing through the ions of the buffer. Joule heating can be reduced 
by reducing the ionic strength of the buffer and/or reducing the applied voltage. Thermostatting 
the capillary and/or using a capillary with higher surface to volume ratios, i.e. capillaries with 
smaller inner diameters, are other ways to effectively remove heat from the capillary. Joule 
heating has the potential to alter Aβ and is known to have an effect on the spectroscopy of ThT 
[66]; therefore, measures were taken in this work to reduce Joule heating by using low ionic 
strength buffers (10 mM Tris), small i.d. capillaries (50 µm) and capillary thermostatting when 
available. 
To perform a CE separation, analytes are injected into a buffer filled capillary by 
positioning the inlet end of the capillary into the sample vial, and a voltage is applied across the 
capillary for a short time. This type of injection is called electrokinetic injection. The injection 
time and voltage applied depend on the application. Hydrodynamic injection and gravity 
injections are other injection techniques that use pressure and gravity, respectively, instead of 
voltage to transfer the analytes into the capillary. After the analytes have been injected into the 
inlet of the capillary, the inlet is positioned into the inlet buffer reservoir. A voltage is then 
applied across the capillary via a high voltage power supply, which induces the EOF.  
During electrophoresis, analytes separate according to their electrophoretic mobilities. 
Chapter 2 describes equations that govern electrophoretic mobility (Equations 2.1 and 2.2). For 
protein separations, the net charge on the protein will be a function of the solution pH. The 
isoelectric point, pI, is the pH at which the net charge on the protein is zero. For example, 
monomeric Aβ (1-40) has a pI of 5.1, therefore, in buffers of pH < 5.1, Aβ has a net positive 
charge and in buffers of pH > 5.1, Aβ has a net negative charge.  
For CE separations, analytes migrate at different rates based on their electrophoretic 
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mobilities. For example, using a positive polarity, cations will pass the detector at a faster rate 
than anions. This is unlike liquid chromatography, where analytes pass the detector at a constant 
velocity dictated by the mobile-phase flow rate. This point is discussed here because in Chapter 
2, the CE-UV peak areas are divided by the corresponding migration times of the peaks [80]. 
This was done to normalize the peaks’ areas for varying migration rates. Slower migration rates 
produce wider peaks, and faster migration rates produce narrower peaks for analyte zones of the 
same physical dimensions migrating at different rates. This is not to be confused with band 
broadening. Band broadening is the longitudinal diffusion of a zone of analyte and should not 
have a major impact on peak area. In other words, as a zone broadens, the peak gets wider and 
the peak height reduces, so the peak area is not changed. 
Another benefit of CE for Aβ separations is that CE can separate particles based on size 
without the need for a stationary phase. This is ideal for Aβ fibrils, which will migrate similarly 
to particles in solution. Chapter 4 demonstrates the separation and detection of individual Aβ 
aggregates by CE and discusses how peak widths of aggregates are defined and how it differs 
from how peak widths of monomers are defined. The electrophoretic migration of particles is 
covered in great detail by Radko and coworkers [81]; however, because of the complexity of 
particle separations by CE and the similarities of particles to Aβ fibrils, in terms of size, a brief 
discussion explaining how particles separate by CE will be covered next.   
A particle in an electrolyte solution will develop an electric double layer that forms due 
to the electrostatic interaction of counterions in the buffer with charges on the particle’s surface. 
The thickness of a particle’s double layer, κ-1 is a function of the ionic strength of the solution, I 
(κ ~ I1/2) [81].  In CE experiments, when a voltage is applied, a particle’s motion is dependent on 
the magnitude of the charge of the particle, the magnitude of the charge of the counterions in the 
  24 
 
double layer (which moves opposite to that of the particle) and the viscous drag of the double 
layer [81]. Adding to the complexity of translational motion of a particle in CE is the effect of 
double layer distortion, which is called the relaxation effect. The relaxation effect describes how 
when a particle is displaced in solution, its double layer lags behind, which has been shown to 
decrease particle mobility [81].  
Spherical particles of the same size with very narrow size distributions have been shown 
to have slightly different electrophoretic mobilities, referred to as electrophoretic heterogeneity 
[82]. Electrophoretic heterogeneity could be a result of ζ heterogeneity [81]. As discussed above, 
ζ is the potential that arises due to the formation of an electric double layer. Recall that peak 
widths of particles passing a detection zone are defined by their electrophoretic mobilities. This 
means that electrophoretic heterogeneity can result in various peak widths for particles of the 
same size due to differences in the particles’ ζ potentials. Another factor to consider is that non-
spherical particles, such as Aβ fibrils, can be oriented in an electric field, which can affect their 
electrophoretic mobilities [81].  
1.6 Goals of This Research 
Amyloid beta (Aβ) proteins have been linked to Alzheimer’s disease (AD). Some of the 
challenges studying Aβ are discussed above. To reiterate a few of these challenges, (1) 
aggregating mixtures of Aβ are heterogeneous with various Aβ species ranging in size from 
monomers to micron-sized aggregates, (2) detection methods that work well for smaller Aβ 
species tend to not work well for larger Aβ species and vice versa and (3) most detection 
methods are based on bulk measurements that do not provide information regarding individual 
Aβ aggregates. The overall goal of this research is to develop analytical methods for studying 
and characterizing Aβ species from monomers to fully-formed fibrils. 
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Chapter 2. A CE-UV method is developed to analyze Aβ (1-40) peptide samples. 
Chapter 2 demonstrates that CE-UV can be used to quantify monomeric Aβ (1-40) and can 
separate monomeric and aggregated Aβ (1-40). The CE conditions established in Chapter 2 lay 
the foundation for the CE conditions in later chapters were fluorescence detection is used. 
Chapter 3. One of the goals in Chapter 3 was to confirm that the additional non-
monomeric peaks observed in the electropherograms from Chapter 2 were due to aggregated Aβ. 
Samples of Aβ (1-40) monomers, fibril and seed and Aβ (1-42) monomers and fibrils were 
prepared for this study. These samples were carefully prepared at nearly equal monomeric-
equivalent concentrations to minimize difference between the electrophoretic profiles that could 
be a result from differences in Aβ concentration. The results of Chapter 3 confirmed that the two 
main electrophoretic peaks observed in Chapter 2 were due to monomer and aggregate. Chapter 
3 also demonstrates some additional sharp electrophoretic UV peaks in samples that were 
prepared to contained fibrils. These peaks were thought to be due to individual Aβ fibrils and 
were further investigated in Chapter 4. 
Chapter 4. In Chapters 2 and 3, the UV detector on the commercial-based instrument 
was not fast enough to detect individual Aβ aggregates. For detecting and characterizing 
individual aggregates, a CE instrument with laser-induced fluorescence anisotropy (LIFA) 
detection was constructed. The CE-LIFA instrument is shown in Chapter 4 to separate and detect 
individual aggregates from Aβ (1-40) and Aβ (1-42) samples. The dye thioflavin T was used in 
the separation buffer to fluorescently label the Aβ aggregates online during the separation. The 
fluorescence part of the method was validated based on bulk measurements of the same samples 
using a microplate reader. The anisotropy of the individual aggregates was calculated in an 
attempt to differentiate one individual aggregate from another, but no clear anisotropy 
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differences between individual aggregates were observed.  
Chapter 5. In Chapter 4, the anisotropy values calculated from the individual Aβ 
fluorescence peaks were indistinguishable from the anisotropy calculated from the background 
ThT fluorescence. A data treatment method was developed to extract anisotropy peaks from the 
anisotropy background. The method is mathematically described using data from experiments in 
Chapter 4. The benefits and limitations of the method are discussed in the chapter. 
Chapter 6. Thioflavin T is a powerful tool for detecting amyloid aggregates. It is widely 
used in the literature and was used in this dissertation for Aβ detection. While ThT is branded as 
an amyloid specific dye, preliminary CE-LIF data using ThT in the electrophoresis buffer to 
label and detect Aβ aggregates suggested that ThT was binding to non-amyloid species and 
producing false-positives. This observation initiated a spectroscopic investigation of ThT in the 
presence of non-amyloid particles, polystyrene spheres. Chapter 6 confirms that polystyrene 
spheres can enhance ThT spectroscopy similar to that of Aβ. Several concentrations and sizes of 
polystyrene spheres are analyzed to demonstrate the enhancement. 
Chapter 7. In Chapter 7, we investigated if Aβ monomers, intermediate aggregates and 
fibrils could be differentiated based on their fluorescence anisotropy values using a FAM-
labelled Aβ instead of ThT as in Chapter 4. By using a covalently labeled fluorescent Aβ 
monomer to perform the study, all forms of Aβ could be detected independent of size. Unlike 
other Aβ analysis by CE in this dissertation, the Aβ samples were analyzed at different time 
points during the aggregation process. The main reason for this was to attempt to detect any 
transient intermediate Aβ species. Additionally, Arctic Aβ was mixed with normal Aβ, which 
has been shown to stabilize oligomeric/protofibril structures [83].  
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CHAPTER 2 
ANALYSIS OF MONOMERIC Aβ (1-40) PEPTIDE BY CAPILLARY 
ELECTROPHORESIS
*
 
 
2.1 Introduction 
 Protein aggregation to form amyloid fibrils is closely linked to many diseases 
including Parkinson’s disease, type II diabetes, Huntington’s disease, prion diseases and 
Alzheimer’s disease [1,84-86]. Peptides that are seemingly unrelated in terms of size and 
sequence aggregate to form structures that are very similar in size and shape – amyloid 
fibrils. A major component of senile plaques found in the brains of patients suffering from 
Alzheimer’s disease is the β-amyloid (Aβ) peptide, and this peptide is thought to be 
responsible for the disease pathology [1,84,86]. The amyloid core of these plaques contains 
interwoven fibrils that are composed of 40 and 42 amino acid residue peptides denoted as Aβ 
(1-40) and Aβ (1-42), respectively. Figure 2.1 shows a transmission electron microscopy 
(TEM) image of Aβ (1-40) fibrils produced in vitro for this work. These fibrils typically are 
10 – 12 nm in diameter and can be 102 – 103 nm long. 
 
Figure 2.1.  TEM of Aβ (1-40) fibrils. The monomer equivalent concentration of this sample 
was 31 µM. Scale bar is 1 µm. Data for this sample are also presented in Figures 2.2b and 
2.4b. 
                                                 
* Reproduced by permission of The Royal Society of Chemistry 
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 Due to the link between Aβ aggregation and Alzheimer’s disease, the aggregation 
mechanism and kinetics of Aβ aggregation are the focus of intense study [86,87]. In vitro 
studies of Aβ fibril formation have demonstrated that this process occurs via a complex 
multi-step nucleated polymerization mechanism [4,41,86,88]. Preparing consistent 
monomeric Aβ samples, free from aggregates and at known concentrations, is critical for 
kinetic and mechanistic studies of Aβ aggregation, and it is a significant technical challenge. 
Complex protocols are used in an attempt to prepare Aβ monomer solutions free of 
aggregates that might influence both aggregation kinetics and the aggregation mechanism 
[40,42-44]. Studies have shown that sample preparation significantly influences aggregation 
kinetics and the aggregate structures formed [40-42,44,89,90].  
 In this work, we present a capillary electrophoresis (CE) method with UV absorbance 
detection for characterizing Aβ preparations and quantifying Aβ monomer. Capillary 
electrophoresis has been used to separate and detect Aβ peptides and aggregates, and most of 
this work has been qualitative [77,91-93]. Alper et al. showed a calibration curve for Aβ (1-
40) monomer based on CE-UV peak areas in the Supplementary Material of a recent 
publication [17]. Our initial goal for this work was to develop an alternative method to HPLC 
for quantifying Aβ monomer solutions prior to using them for aggregation studies [17,43,44]. 
During the development of this method, Aβ peaks in addition to the major monomeric Aβ 
peak were observed. We investigated differences in aggregation kinetics relative to the 
presence and absence of these additional aggregate peaks in monomer preparations. 
2.2 Experimental 
2.2.1 Chemicals 
Tris (hydroxymethyl) aminomethane hydrochloride (Tris-HCl), sodium phosphate 
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monobasic, trifluoroacetic acid (TFA), thioflavin T (ThT) and hexafluoroisopropanol (HFIP) 
were purchased from Sigma (St. Louis, MO). Sodium hydroxide was purchased from Fisher 
(Pittsburgh, PA). All solutions were prepared in 18 MΩ water obtained from a Modulab water 
purification system (United States Filter Corp.; Palm Desert, CA). Chemically synthesized Aβ 
(1-40) peptide was purchased from Biosource International, Inc (Camarillo, CA). 
2.2.2 Aβ Monomer and Fibril Preparation 
 Monomer samples were prepared as described previously [43]. Briefly, Aβ peptide 
was treated with TFA/HFIP to remove any pre-existing aggregates. The solvent was 
evaporated off, and the peptides were dissolved stepwise in equal volumes of 2.0 mM NaOH 
and 2× phosphate buffered saline (PBS) at pH 7.4, containing 0.1% sodium azide. The PBS 
was prepared with sodium chloride. Alternate to the PBS preparation, a fraction of the 
sample was dissolved in 10.00 mM Tris buffer at pH 7.8. Centrifugation (~50,000 g) for a 
minimum of 10 hr at 4 °C was carried out to remove any aggregates. The supernatant 
monomer concentration was determined using CE as described below, and the quantification 
of the peptide monomer was confirmed by amino acid analysis. Fibril samples were prepared 
by incubating the Aβ samples in 1× PBS without agitation at 37 °C for approximately 7 days. 
Thioflavin T fluorescence was used to monitor fibril growth. 
2.2.3 Capillary Electrophoresis 
 All CE separations were performed using a Beckmann Coulter P/ACETM MDQ CE 
system. The instrument was equipped with a photodiode array (PDA) detector. Fused-silica 
capillaries (50 µm i.d., 353 µm o.d.; 60 cm total length, 50 cm to detector) were used 
(Polymicro Technologies, Phoenix, AZ). A new capillary was pretreated by flushing with 1.0 
M NaOH for 30 min followed by rinsing with water for 20 min and the separation buffer 
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(10.00 mM Tris buffer, pH 7.8). Between runs, the capillary was flushed with water (20 psi, 
2.0 min) and separation buffer (20 psi, 2.0 min). Hydrodynamic injections were used (1.0 psi, 
5.0 s), and the applied separation potential was 30.0 kV (500 V/cm) for 6 min. The 
instrument was thermostatted at 20.0 °C. Data were acquired using 32 Karat™ Software 
Version 5.0 from Beckman Coulter at a scan rate of 4 Hz. Quantification was based on 
integrated peak areas corrected for the migration time for each individual CE run as 
discussed by Hjerten et al [94]. 
 The electropherograms were plotted as as a function of electrophoretic mobility rather 
than migration time due to variablility in migration times between runs. This is commonly 
observed in CE separations of peptides and biological samples due to changes in 
electroosmotic flow (EOF) caused by adsorption of sample components to the capillary 
surface. For the CE experiments presented in this work, the RSD for migration times 
(intraday) ranged from 1-5 % although it was below 2% for all but one day. The changes in 
EOF can be corrected by using a neutral marker peak to measure the average EOF rate [95]. 
In these experiments, there was a reproducible neutral system peak in the electropherograms 
at about 150 s. This peak was confirmed to be neutral by adding mesityl oxide to the sample, 
which co-migrated with this peak. The electrophoretic mobilities, µep, of the peaks were 
calculated by subtracting the electroosmotic mobility, µeo, from the apparent mobilities, µapp, 
of the peaks (Equation 2.1). Equation 2.2 shows how µeo can be calculated based on 
experimental data where Ld is the length of capillary from the inlet to the detection window 
(cm), Lt is the total length of the capillary (cm), V is the applied voltage (V) across the 
capillary, tm is the migration time of the analyte peak (s) and teo is the migration time of the 
neutral marker peak (s). 
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2.2.4 Thioflavin T Fluorescence 
 The aggregation progress, or fibril formation, of Aβ samples was monitored using 
ThT fluorescence. The change in fluorescence is linear with an increase in protein 
concentration of the amyloid fibrils [57]. Samples were incubated at 37 °C in PBS, and 
representative aliquots were taken daily to measure the ThT fluorescence. Each aliquot was 
transferred to a well of a 96-well plate, containing 200 µL PBS and 2 µL of 1.5 mM ThT 
([ThT]final = 15 µM). The sample volumes were adjusted to give a final peptide mass of 1.00 
– 1.25 µg per well. Fluorescence excitation was at 450 nm, and the emission was measured at 
482 nm using a BMG Lab Technologies FLUOstar 430 microplate reader (Offenburg, 
Germany). 
2.2.5 Amino Acid Analysis 
 A Dionex Direct Amino Acid Analysis System (Sunnyvale, CA) was used to perform 
the amino acid analysis (AAA) with an internal standard correction to determine the Aβ 
monomeric concentration of each sample. The technique involved hydrolyzing the peptide, 
separating the amino acids on an anion-exchange column by a stepwise salt and pH gradient, 
detecting the amino acids by integrated pulsed amperometric detection and calculating the 
amino acids’ peak areas, which allow the determination of each amino acid’s concentration 
and the original peptide concentration. The concentration of each Aβ sample determined by 
AAA was used as the starting concentration of the stock solution to quantify the Aβ 
monomer by CE-UV. 
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2.2.6 Transmission Electron Microscopy 
 Transmission electron microscopy images of the aggregated Aβ samples were 
obtained with a JEOL 100CX  (Tokyo, Japan). TEM analyses are routinely performed by 
spotting the sample on a carbon coated mesh grid, allowing the sample to rest for several 
minutes, wicking the excess solvent from the grid, applying 2% uranyl acetate to the grid, 
wicking off excess solvent and imaging. 
2.3 Results and Discussion 
2.3.1 Separations of Aβ Monomer Samples 
 The initial goal of this research was to develop a method based on capillary 
electrophoresis with UV absorbance detection for quantifying Aβ peptide in preparations of 
monomeric peptide for studies of Aβ fibril formation. This analysis is commonly carried out 
by HPLC [17,43,44,89]. Determining the initial concentration of Aβ peptide in a preparation 
at the start of an experiment is critical in order to obtain reproducible kinetic data or even 
reproducible aggregate structures [40-42,44,90]. Some loss of peptide during preparation to 
remove aggregates before the start of an experiment is inevitable and will vary substantially 
between different experiments or different experimentalists. While satisfactory quantification 
of Aβ peptide can be obtained by HPLC, CE offers several potential advantages. Very rapid 
separations consuming only a few nL of sample per injection are possible with CE. 
Laboratory-constructed CE instruments with UV detectors are common, inexpensive and 
simple to operate, and more sophisticated commercial instruments with autosamplers are 
available. 
 Figure 2.2 presents a typical electropherogram of monomeric Aβ peptide with UV 
absorbance detection at 200 nm. The monomer peak, M, has an electrophoretic mobility of -
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1.20 × 10-4 cm2V-1s-1 (migration time of 183 s) in this separation. Just after the main 
monomer peak there are two small peaks that are consistently present in sequential 
separations of the same sample and for different Aβ monomer preparations. It is suspected 
that these peaks are produced by impurities from Aβ synthesis [42,96]. If these peaks were 
due to Aβ aggregates or impurities from sample preparation, more variability in magnitude 
would be expected between different preparations. 
 
 
 
 
Figure 2.2.  Electropherograms of (a) Aβ monomer, M, and (b) Aβ monomer, M, with aggregate, 
A. The injections were 5.0 s long at 1.0 psi, and the separation potential was 30.0 kV (500 V/cm). 
The Aβ peptide monomeric-equivalent concentrations for (a) and (b) were determined by AAA 
to be 26 and 31 µM, respectively. The Aβ preparation used in (b) is the same as that used in 
Figure 2.1. The same electropherograms plotted vs time are presented in Appendix A Figure A.1. 
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2.3.2 Quantification of Aβ Monomer 
 Peptide samples are difficult to prepare at accurate concentrations due to the difficulty 
of removing water, salts and other impurities from the peptides so that standard solutions can 
be generated. Quantitative sample preparation is  particularly challenging for Aβ peptide due 
to the extensive procedures used to prepare a monomer solution initially free of aggregates. 
Amino acid analysis was used to quantify the Aβ monomeric peptide in each stock solution 
prepared for this work as described in the Experimental section. Analysis with this technique 
provides the absolute concentration of the peptide as prepared in the sample solution without 
using a standard of the same peptide at known concetration. After the monomeric equivalent 
concentrations were determined by AAA, CE-UV was performed on the same stock 
solutions. The Aβ stock solutions were then serially diluted to generate calibration plots 
using CE peak areas. 
 Two plots of peak areas measured by CE with UV absorbance detection vs. Aβ 
monomer concentration (based on AAA analysis and serial dilution) are shown in Figure 2.3. 
A linear response is obtained for the range of concentrations studied. Table 2.1 presents 
linear regression data for calibration curves measured using four different preparations of Aβ 
monomer (including the two shown in Figure 2.3). The lowest concentration of Aβ monomer 
injected was 5 µM, resulting in a peak with a S/N of 28. For Aβ monomer, the estimated 
detection limit (S/N = 3) is 0.5 µM, and the estimated limit of quantitation (S/N = 10) is 1.8 
µM. The calculated sample injection volume is 8.8 nL, and the mass LOD and LOQ are 19.1 
pg and 68.6 pg, respectively. The LOD for a method used to quantify Aβ in our laboratory 
based on HPLC with UV absorbance detection is 0.2 µM (5 ng) (unpublished results). It is 
not unexpected that the plots for the 4 samples are not perfectly superimposable. One source 
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of error is AAA since each of the fours Aβ monomer samples were prepared seperately, and 
their concentrations were determined by AAA separately [97]. Another source of error is CE, 
since different capillaries were used for analysis of different preparations. Any difference in 
capillary inner diameter (nominally 50 µm) will lead to a different pathlength for absorbance 
detection. 
 
Figure 2.3.  Calibration curves for two Aβ monomer preparations. The starting concentration 
of Aβ monomer for each preparation was determined by AAA to be 35 µM (open circles/plot 
(A)) and 26 µM (closed circles/plot (B)). Serial dilutions were performed to generate the 
standards at lower concentrations. All samples were run in triplicate and the error bars are 
presented in the figure. Linear regression data for these plots are presented in Table 2.1. The 
Aβ preparation used to generate plot (B) is the same as that used in Figure 2.2a. 
 
Table 2.1. Concentrations of Aβ monomer and linear regression values from peak areas 
measured for serial dilutions of 4 Aβ preparations. 
Sample ID 
Starting Monomer 
Concentration by 
AAA (µM) 
Linear Regression 
Slope  
(mAU min µM-1) 
Y-intercept 
(mAU min) 
R2 
(A)a 35 0.476 0.69 0.97 
(B)b 26 0.386 -0.47 1.00 
(C) 18 0.302 0.69 0.93 
(D) 11 0.271 -0.48 0.89 
a,b
 Data shown in Figure 2.3 (A) and (B) 
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2.3.3 Aggregate Peaks and Fibril Formation 
 Figure 2.2b shows an electropherogram that contains an additional peak with an 
electrophoretic mobility of -2.43 × 10-4 cm2V-1s-1 (migration time = 247 s). This peak was 
present in the electropherograms for some, but not all of the Aβ monomer samples prepared 
for this study. One hypothesis is that this peak is due to an aggregated form of Aβ present in 
those preparations. Unpublished studies in our laboratory showed that Aβ samples containing 
fibrils or protofibrils result in electropherograms with additional peaks at more negative 
electrophoretic mobilities compared to monomer peaks. Other studies in the literature also 
indicate that Aβ aggregates migrate with more negative electrophoretic mobilities (relative to 
monomer peaks) although those published studies were carried out in different buffers at 
different pH’s [91].  
 Aggregation studies were carried out using both Aβ monomer samples that contained 
the putative aggregate peak and samples for which this peak was absent. Fibril formation for 
these two different types of monomer samples was monitored using Thioflavin T (ThT) 
fluroescence with excitation at 450 nm and detection of emission at 482 nm. Thioflavin T 
fluorescence is routinely used to follow the progression of Aβ aggregation 
[4,41,57,63,89,90]. Thioflavin T fluorescence increases in intensity and shifts spectrally 
when it selectively binds to amyloid fibrils [4,57,63].  
 Figure 2.4 presents representative plots of ThT fluorescence from these aggregation 
studies. The plot in Figure 2.4a is typical for Aβ aggregation from monomer to form fibrils. 
The fluorescence is relatively low and constant through about Day 5, and then it increases 
rapidly to a higher values at Day 6 and 7. This lag phase followed by rapid aggregation is 
typical of Aβ aggregation [41,44,86,89]. The lag phase is reduced for peptides that aggregate 
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more rapidly to form amyloid fibrils [41,89].  
 Figure 2.4b shows a representative plot of ThT fluorescence for aggregation studies 
using a sample with the additional peak present in the CE separation at -2.43 × 10-4 cm2V-1s-
1. The ThT fluorescence is relatively high at the initial measurement and remains relatively 
constant throughout the aggregation study. This indicates that the fibril formation was 
extremely rapid, and a lag phase was not apparent. 
 We hypothesize that the presence of aggregates as indicated by the peak with an 
electrophoretic mobility of -2.43 × 10-4 cm2V-1s-1 is the cause of the abnormally rapid 
aggregation kinetics shown in Figure 2.4b (no lag phase). We studied the aggregation by ThT 
fluorescence of six Aβ preparations. Of the six preparations, four contained preexisting 
aggregates, and the ThT data indicated no lag phase or sustained ThT fluorescence increase 
over 6-7 days. The other two preparations did not contain aggregates, and they demonstrated 
typical lag phases and subsequent increases in ThT fluorescence over time as expected. 
These results are consistent with the hypothesis that monomer preparations that contain 
preexisting aggregates eliminate the lag phase indicated by ThT fluorescence, and CE with 
UV absorbance detection is capable of detecting these aggregates in monomer preparations. 
 We do not believe that the presence of these putative aggregate peaks indicates a 
limitation of the sample preparation method used in this work [43]. This basic CE method 
has been used previously in our laboratory to analyze Aβ monomer samples prepared by 
scientists with more experience using this preparation technique, and the aggregate peaks 
were never observed (unpublished data). The scientist who prepared Aβ monomer samples 
for this publication was eventually able to routinely prepare monomer samples without the 
aggregate peak. It is not known what improvements in technique led to the elimination of the 
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aggregate peaks in CE, but based on our experience this method can be used to routinely 
prepare aggregate free monomer preparations. 
 
 
 
Figure 2.4.  Plots of ThT fluorescence of (a) Aβ monomer (26 µM) and (b) Aβ monomer with 
aggregate (31 µM) vs. time.  [ThT] = 15 µM.  The Aβ preparation used for (a) is the same as that 
used for Figure 2.2a (no peak at -2.43 × 10-4 cm2V-1s-1 . The Aβ preparation used for (b) is the 
same as that used for Figures 2.1 and 2.2b (has a peak at -2.43 × 10-4 cm2V-1s-1). 
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2.4 Conclusions 
These results demonstrate that CE with UV absorbance detection is an effective 
technique for characterizing and quantifying Aβ peptide monomer preparations for studies of 
amyloid fibril formation. Compared to HPLC methods, CE offers rapid analysis times and 
reduced sample consumption. Importantly, this study shows that aggregate peaks in CE analysis 
of Aβ monomer preparations can be used to indicate whether a preparation will exhibit normal or 
accelerated aggregation kinetics. 
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CHAPTER 3 
ANALYSIS OF Aβ (1-40) AND Aβ (1-42) MONOMER AND FIBRILS BY CAPILLARY 
ELECTROPHORESIS
†
 
 
3.1  Introduction 
  Amyloid beta (Aβ) peptides have been identified as the primary peptide component of the 
neuritic plaques of Alzheimer’s disease (AD) patients [13,15,21]. This has led to the hypothesis 
that Aβ peptide aggregates are the cause of the development and progression of AD. 
Biologically, monomeric Aβ is formed through the enzymatic cleavage of the transmembrane 
amyloid precursor protein (APP) [98]. Different length Aβ peptide monomers can be formed 
from APP through additional enzyme processing [98]. The characteristic plaques of AD patients 
are composed of both Aβ (1-40) and Aβ (1-42), but Aβ (1-42) is the dominant species [70]. 
Under physiological conditions, soluble Aβ monomers that have been released into the 
extracellular fluid can self-assemble to form Aβ aggregates, reaching 10 – 12 nm in diameter and 
102 – 103 µm in length for mature Aβ fibrils. The toxicity of Aβ is thought to be related to 
aggregate size and structure, and the most toxic species may be an intermediate species between 
monomer and fibrils [15,36,53,99]. 
  Both Aβ (1-40) and Aβ (1-42) peptides have been the focus of intense research because 
of their relevance to AD and their potential as therapeutic targets for AD treatment. The 
characterization of Aβ aggregation is complex and challenging, even when synthetic peptides of 
only one length (e.g. Aβ (1-40) or Aβ (1-42)) are studied. Preparations of aggregated, synthetic 
Aβ peptides result in heterogeneous mixtures containing numerous aggregated structures and 
unaggregated monomer. In order to understand the aggregation process and determine which Aβ 
aggregate species are toxic, it is necessary to characterize and quantify the different aggregate 
                                                 
† Reproduced by permission of Journal of Chromatography B  
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species present in a sample. Few analytical techniques are capable of analyzing Aβ monomer and 
aggregates with a single experiment. Thioflavin T (ThT) fluorescence, transmission electron 
microscopy (TEM) and light scattering, for example, are powerful tools for analyzing large Aβ 
aggregates but are not well suited for studying small oligomeric structures and monomer [44]. 
Separation techniques such as HPLC, size-exclusion chromatography and gel electrophoresis 
have been applied to Aβ analysis [44,70]; however, these methods are able to separate Aβ 
structures only over a limited size range. Their stationary phases have the potential to disrupt 
aggregates during the separation [100]. An ideal separation method for Aβ analysis would 
provide rapid and gentle separations of structures ranging in size from monomeric Aβ to mature 
Aβ fibrils. 
  Capillary electrophoresis (CE) has been used to analyze species ranging in size from 
small cations like Na+ and K+ to whole cells [101-103]. Capillary electrophoresis with UV 
absorbance detection (CE-UV) is emerging as a valuable tool for studying Aβ peptides 
[17,30,45,77,91,93]. In 1993, Sweeney et al. first applied CE-UV to analyze Aβ peptides [77]. 
Over a decade later, Verpillot et al. produced similar CE-UV results and additionally analyzed 
Aβ (1-40) peptide from cerebrospinal fluid of an AD patient [93]. De Lorenzi and coworkers 
analyzed Aβ (1-40) and Aβ (1-42) peptides by CE-UV after performing ultracentrifugation using 
different molecular weight cut-off filters to determine the sizes of aggregates producing peaks 
attributed to Aβ aggregates [91]. The antifibrillogenic effectiveness of small molecules on Aβ (1-
42) peptides by CE-UV was also studied using a similar approach [30]. Picou et al. recently 
reported a CE-UV method to characterize and quantify Aβ (1-40) monomer samples and predict 
whether an Aβ preparation will exhibit normal or accelerated aggregation kinetics [45]. While 
previous papers have shown that CE-UV has the potential to serve as a powerful tool for 
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studying Aβ aggregation, such studies are challenging. Small changes in sample preparation can 
result in large variations in aggregation kinetics and aggregate structures [45,70,90]. In this 
paper, stringent preparation procedures were used to prepare high quality Aβ monomer and 
aggregated samples at low concentrations (≤ 25 µM). The Aβ concentrations were determined 
independently by HPLC with UV absorbance detection (calibration based on amino acid analysis 
(AAA)), and the aggregated samples were characterized by TEM. This study assesses the 
potential of CE-UV to distinguish the aggregate types present in different Aβ samples. 
3.2 Experimental 
3.2.1 Chemicals 
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification 
system (United States Filter Corp.; Palm Desert, CA) unless otherwise noted. 
Tris(hydroxymethyl)aminomethane (Tris) and methanol (99.8%) were purchased from Fisher 
Scientific (Fair Lawn, NJ). Tris buffer was prepared at 10.00 mM, and the pH was adjusted to 
7.79 with 1.0 M HCl and filtered through a 0.2 µm filter (Whatman; Hillsboro, OR). This Tris 
buffer was used for all experiments as the electrophoresis buffer unless otherwise noted. Mesityl 
oxide (MO) was purchased from Alfa Aesar (Ward Hill, MA), and solutions of MO were 
prepared in Tris buffer at a concentration of 0.2 % (v/v) MO. Formic acid was obtained from 
Acros Organics; (Geel, Belgium). α-Cyano-4-hydroxycinnamic acid (CHCA) was prepared in 
acetonitrile/H2O (50:50, v/v) containing 1.0 % trifluoroacetic acid (TFA) with a final 
concentration of 10 mg/mL. 
3.2.2 Aβ Peptide Sample Preparation 
  Aβ (1-40) was purchased from the W.M Keck Foundation Biotechnology Research 
Laboratory (Yale University; New Haven CT), and Aβ (1-42) peptides were purchased from 
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rPeptide (Bogart, GA). The Aβ (1-42) sequence is shown below, and the Aβ (1-40) sequence is 
identical except the two amino acids at the C terminus, isoleucine (I) and alanine (A), are not 
present. 
Aβ (1-42) 
A  I V VG G  V M LG  I I AG K  N S G V D E
A  F F V LK  Q H H V E YG  S D H R F EA  D
40353025
20151051
 
 
  Five sample types were prepared for this work: Aβ (1-40) monomer, Aβ (1-40) mature 
fibrils, Aβ (1-40) seed prepared by ultrasonicating mature fibrils, Aβ (1-42) monomer and Aβ (1-
42) mature fibrils. The samples were prepared as described previously by O’Nuallian et al. and 
Picou et al. [44,45]. Briefly, Aβ peptides were treated with TFA/hexafluoroisopropanol (HFIP) 
to remove any preexisting aggregates. For Aβ monomer samples, the solvent was evaporated off, 
and the peptides were dissolved in 10.00 mM Tris at pH 7.79. For Aβ (1-40) aggregate samples, 
the TFA/HFIP was evaporated off, and the peptides were dissolved stepwise in equal volumes of 
2.0 mM NaOH and 2× phosphate buffered saline (PBS) containing 22.8 mM phosphate, 274 mM 
NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. The samples were centrifuged at 50,000 g for a 
minimum of 10 hr at 4 °C. The supernatant was incubated at 37 °C for 7 d. Fibril formation was 
monitored using HPLC-UV and ThT fluorescence as described previously [44]. The seed sample 
was prepared by ultrasonicating a mature fibril sample for 30 s with a Branson Digital Sonifier 
Microtip (Model 450) and then placed on ice for 1 min. The ultrasonication process was repeated 
5×. Prior to CE analysis, the fibril and seed samples were buffer exchanged from PBS to 
electrophoresis buffer, 10.00 mM Tris at pH 7.79 as described previously [59]. 
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The Aβ (1-42) monomer and fibril samples were prepared using the same procedure with 
the following exceptions: (1) the Aβ (1-42) monomer sample was centrifuged for 30 min at 
20,000 g and 4 °C instead of 10 hr at 50,000 g and 4 °C, and (2) the Aβ (1-42) fibril sample was 
incubated for 2 days to form mature fibrils. These method changes were due to the faster 
aggregation kinetics for Aβ (1-42) peptide compared to Aβ (1-40) peptide. 
3.2.3 Characterization and Quantification of Aβ Samples 
  The Aβ concentration for each sample was determined with a Shimadzu HPLC-UV 
instrument with detection at 215 nm. The concentration of Aβ standards for calibration was 
determined independently by AAA, as described previously [10]. For aggregate-free samples, the 
monomer concentration was determined using peak areas and the standard curve for Aβ. For 
aggregate-containing samples, the Aβ monomer-equivalent concentration was determined by (1) 
disassembling the aggregates to form monomers by treatment with 70% formic acid and (2) 
determining the resulting monomer concentration by HPLC-UV. The monomer-equivalent 
concentrations of the samples used in this work are reported in Table 3.1. Mature fibrils and seed 
were characterized by TEM and ThT fluorescence assays [4].  
 
Table 3.1. Monomeric-equivalent concentrations determined by HPLC-UV 
Peptide Type Sample ID 
Monomeric Equivalent 
Concentrations by HPLC-UV 
(µM) 
(1-40) 
Monomer 20 
Fibril 25 
Seed 20 
(1-42) 
Monomer 22 
Fibril 22 
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3.2.4 Aβ Analysis by MALDI-MS 
Mass spectrometry experiments were performed on an Applied Biosystems Voyager DE-
PROTM MALDI-TOF MS, equipped with a 20 Hz repetition rate nitrogen laser (337 nm). The 
instrument was controlled by Voyager Version 5.0 Software with Data ExplorerTM and was 
operated in linear mode. The CHCA matrix was prepared as described in Section 3.2.1. The CE 
separation buffer for these experiments was 10 mM Tris-HCl at pH 8.0, and a Beckman Coulter 
CE-MDQ was used for CE experiments. Fractions were collected from 30 consecutive CE 
separations and combined with an equal volume of matrix. This sample was spotted on a 100 
well stainless steel MALDI sample plate for MS analysis. The laser power was adjusted for each 
sample spot with 200 shots acquired per spectrum. 
3.2.5 Aβ Analysis by CE-UV 
  Capillary electrophoresis with UV absorbance detection was performed with a Beckman 
Coulter P/ACE MDQ CE system equipped with a diode array detector (DAD) (Brea, CA) [45]. 
All electropherograms were plotted at 190 nm. The instrument and data collection were 
controlled with Beckman Coulter 32 KaratTM Software Version 5.0. Fused-silica capillaries were 
purchased from Polymicro Technologies (Phoenix, AZ). The capillary (ID = 50 µm, OD = 366 
µm) was cut to 63.0 cm total length with a window created 53.0 cm from the inlet end using a 
window maker (MicroSolv Technology Corp.; Eatontown, NJ). The capillary was conditioned by 
flushing with 1.0 M NaOH (20.0 psi for 1.0 h), 18 MΩ water (20.0 psi for 1.0 h) and Tris buffer 
(20.0 psi for 30 min). 
  All samples were dissolved or buffer exchanged (see Section 3.2.2.) into electrophoresis 
buffer prior to CE in order to eliminate conductivity and composition differences between the 
sample buffer and electrophoresis buffer. The Tris electrophoresis buffer has a low ionic strength 
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compared to PBS, and the high conductivity of PBS results in a high electrophoretic current and 
poor results due to excessive Joule heating. Samples (50 µL) were placed in 200 µL thermowell 
polypropylene vials (Corning Incorporated; Corning, NY). Prior to each run, the sample was 
removed from the MDQ and vortexed briefly to resuspend any aggregates that settled to the 
bottom of the sample vial. For each run, MO was injected for 2.0 s at 0.3 psi prior to the Aβ 
sample injection. The Aβ sample was then injected for 5.0 s at 0.5 psi. The calculated Aβ 
injection volume was 4.2 nL. Because MO migrated faster than all forms of Aβ, injection of MO 
first minimized potential on-column interaction between MO and Aβ. The capillary was 
thermostatted at 20 °C. The applied separation voltage was 25.0 kV (397 V/cm), and the current 
was 5.0 µA. The detection scan rate was 32 Hz (maximum allowed), and the run time was 10 
min. 
  All electropherograms were plotted as a function of electrophoretic mobility, µep, instead 
of migration time to correct for any electroosmotic flow (EOF) variations, which is a common 
problem for CE [45,95].  
3.3 Results and Discussion 
  The goal of the studies presented here was to determine if CE-UV could be used to 
separate and characterize monomeric and aggregated samples of Aβ (1-40) and Aβ (1-42) 
peptides for carefully prepared and well-characterized samples. In this study, samples of Aβ (1-
40) monomer, mature fibrils and seed (ultrasonicated fibrils) and Aβ (1-42) monomer and fibrils 
were analyzed using CE-UV. The equivalent monomer concentrations of all samples, as 
measured by HPLC-UV, were kept at low concentrations between 20 and 25 µM Aβ, to 
minimize structural differences resulting from Aβ concentration differences [104]. Each sample 
was quantified independently by HPLC-UV and characterized by TEM. Mass spectrometry was 
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used to confirm that selected peaks in the electropherograms were due to Aβ peptide. 
3.3.1 Aβ (1-40) Monomer, Fibril and Seed Analysis by CE-UV 
  A representative electropherogram with UV absorbance detection (plotted at 190 nm) of 
an Aβ (1-40) monomer sample is presented in Figure 3.1a. Monomeric Aβ (1-40) was dissolved 
directly in electrophoresis buffer (10.00 mM Tris at pH 7.79) and analyzed by CE-UV. The CE 
conditions are summarized in Table 3.2. All electropherograms are plotted as absorbance vs. 
electrophoretic mobility, where the neutral marker (NM) has µep = 0 cm2/Vs. The principal peak 
at a mobility of -1.082 × 10-4 cm2/Vs in Figure 3.1a is Aβ (1-40) monomer (M). The 
electrophoretic mobility of the main monomer peak is consistent with that from our previous 
studies (-1.2 × 10-4 cm2/Vs) [45]. Figure 3.1a does not indicate the presence of aggregates, which 
is expected for unaggregated samples. Furthermore, the electrophoretic peak pattern of the Aβ 
(1-40) monomer sample is similar to that observed by Sabella et al. for Aβ (1-40) at a higher Aβ 
concentration (100 µM) dissolved in 20 mM phosphate at pH 7.4 and electrophoretically 
separated using 80 mM phosphate buffer at pH 7.4 [91]. The small peaks near the principal 
monomer peak are thought to be minor impurities from the peptide synthesis [45]; however, 
other researchers have hypothesized that peaks with similar mobilities could be due to different 
oligomerization states of Aβ monomers ranging from 3000 to 50000 Da [91]. Attempts to 
identify these minor peaks by dilution-based experiments provided inconclusive results (data not 
shown). 
  In related experiments, Aβ (1-40) monomer was analyzed by MALDI-TOF MS to 
confirm the identity of the main monomer peak based on its measured molecular mass. Figure 
3.2 shows a mass spectrum for the Aβ (1-40) monomer peak. Fractions at the migration time of 
the monomer peak were collected from 30 CE runs (see Figure 3.2 inset) and spotted on a 
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MALDI target for MS analysis. The main MS peak corresponds to the molecular ion, [M+H]+, of 
the Aβ (1-40) monomer (m/z of 4330.5 Da), and this supports the identification of the main peak 
in Figure 3.1a as Aβ (1-40) monomer. The weak MALDI MS signal is not surprising since the 
sample volume injected for each CE run was only a few nanoliters. 
  An electropherogram of the Aβ (1-40) fibril sample is presented in Figure 3.1b. This 
sample was prepared to contain mature fibrils by allowing an aliquot of Aβ (1-40) monomer to 
aggregate for 7 days. Incubation for 7 – 10 d is common to produce mature fibrils [44,45,105]. 
Figure 3.1b shows two main peaks at -1.071 × 10-4 cm2/Vs and -2.39 × 10-4 cm2/Vs in addition to 
the neutral marker peak. The peak at -1.071 × 10-4 cm2/Vs is identified as monomer based on its 
electrophoretic mobility. Detecting a small monomer peak is not surprising since 0.7 – 1.0 µM 
residual monomer remains unaggregated at equilibrium with fibrils [10]. While the monomer 
equivalent concentrations of the Aβ (1-40) monomer and fibril samples are similar (20 and 25 
µM, respectively, Table 3.1), the monomer peak area in Figure 3.1b is reduced relative to that in 
Figure 3.1a, 2.2 mAU·s and 15.2 mAU·s, respectively. This is expected because Aβ monomer is 
aggregating to form fibrils, which migrate at different times relative to monomer. The monomer 
concentration in the Aβ (1-40) fibril sample is estimated to be 3.5 µM based on its peak area (2.2 
mAU·s). This is four to five-fold greater than the residual monomer concentration reported by 
O’Nuallian, et al. by HPLC [10]. 
Table 3.2.  Summary of Capillary Electrophoresis Conditions 
Capillary Dimensions (LT, LD, i.d.) 63.0 cm, 53 cm, 50 µm 
Separation Buffer (concentration, pH) 10.00 mM, 7.79 
Aβ Injections (tinj, pressure) 5 s, 0.5 psi 
Applied Electric Field 397 V/cm 
Electrophoretic Current 5.0 µA 
Electroosmotic Flow Velocity (n = 5)* 0.25 ± 0.01 cm/s 
Thermostated Capillary Temperature 20 °C 
*The EOF is averaged from the 5 electropherograms shown in Figures 3.1 and 3.3.  
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Figure 3.1.  Electropherograms of Aβ (1-40) samples. Absorbance plotted at 190 nm. (a) Aβ (1-
40) monomer, (b) Aβ (1-40) fibril and (c) Aβ (1-40) seed. The neutral marker, NM, has an 
electrophoretic mobility of 0 cm2/Vs. A monomer peak, M, was detected in all Aβ (1-40) 
samples at µep = -1.077  (± 0.006) × 10-4 cm2/Vs (n = 9). An aggregate peak, A, was detected in 
the fibril and seed samples at µep = -2.37 (± 0.02) × 10-4 cm2/Vs (n = 6). The TEM insets confirm 
the presence of aggregates observed in the electropherograms (scale bar = 1 µm). 
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Figure 3.2.  MALDI-TOF mass spectrum of collected CE fractions of Aβ (1-40) monomer, M. 
The Aβ was mixed 1:1 (v/v) with α-cyano-4-cinnamic acid matrix prior to MS. MS data were 
collected in linear mode. Inset: CE-UV (λ = 200 nm) electropherogram of Aβ (1-40) monomer 
sample in 10.0 mM Tris-HCl at pH 8.00. The main electrophoretic peak at µep = -1.2 × 10-4 
cm2/Vs is monomer, M. Fractions were pooled from 30 consecutive CE runs to obtain the mass 
spectrum.  
  The broad peak (FWHM = 18.70 s) at -2.39 × 10-4 cm2/Vs in Figure 3.1b is attributed to 
Aβ (1-40) aggregates (A). In previous work, we analyzed several Aβ (1-40) monomer 
preparations by CE-UV absorbance [45]. In that work, some preparations produced only a 
monomer peak in the CE-UV electropherogram; however, other samples contained an additional 
broad peak at -2.4 × 10-4 cm2/Vs. These samples also exhibited accelerated aggregation kinetics 
based on ThT fluorescence studies, suggesting that the additional peak was due to Aβ (1-40) 
aggregates [45]. Analyses of the Aβ (1-40) aggregate peak by CE-UV and MALDI-TOF MS 
confirmed that the electrophoretic peak at µep = -2.4 × 10-4 cm2/Vs in mature fibril preparations 
produced a MS peak at m/z of 4330 Da (data not shown), similar to that shown in Figure 3.2. 
This confirms that the CE peak at -2.4 × 10-4 cm2/Vs contained Aβ (1-40) peptide. The presence 
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of full-length, mature fibrils in the sample studied in Figure 3.1b was verified by TEM (Inset, 
Figure 3.1b). 
An interesting observation in Figure 3.1b is the detection of several sharp peaks (FWHM 
~0.25 s) with electrophoretic mobilities between those of the monomer and aggregate peaks. 
These peaks were consistently observed for injections of the Aβ (1-40) fibril sample, but they 
were not observed for injections of the Aβ (1-40) monomer sample (Figure 3.1a). The exact 
electrophoretic mobilities of these peaks and the number of peaks were quite variable for 
consecutive injections of the Aβ (1-40) fibril sample compared to the mobility and appearance of 
the monomer peak and peak A. We hypothesize that these peaks are due to individually detected, 
large Aβ aggregates. They are similar in appearance to the sharp peaks detected in previous 
reports for Aβ (1-43) and Aβ (1-42) analyses by CE-UV [30,77,91]. If these sharp peaks are due 
to individually detected aggregates, then the peak widths will be defined by the migration rate of 
the aggregate through the detection zone [82]. The optical aperture used in the capillary cartridge 
defines the detection zone for this work, which is 0.08 cm. The calculated migration rate of the 
sharp peak in Figure 3.1b at -1.7 × 10-4 cm2/Vs is 0.179 cm/s, which was determined by dividing 
the length of the capillary to the detection window (53.0 cm) by the peak’s migration time 
(295.50 s). The predicted peak width, calculated by dividing the detection zone length by the 
migration rate of the peak, is 0.5 s. This value is consistent with the measured baseline peak 
width of 0.45 s. To put this into context, the FWHM and baseline width for the monomer peak in 
Figure 3.1b are 2.25 s and 3.81 s, respectively. For the work in this paper, the instrument’s 
maximum data sampling scan rate was 32 Hz, which means that the 0.45 s peak was represented 
by about 14 points. Therefore, a scan rate much less than 32 Hz would be insufficient to 
accurately represent peaks from individual aggregates migrating at the rate described above, 
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based on a minimum of 10 points to define a peak [82,106]. 
The results in Figure 3.1a and 3.1b clearly show that the electrophoretic mobility of Aβ 
peptide changes as it aggregates from monomer to mature fibrils. Both the broad aggregate peak 
and the sharp peaks have more negative electrophoretic mobilities (i.e. slower migration times) 
relative to that of the monomer peak. Ideally, the relative sizes of aggregates could be 
determined by their relative electrophoretic mobilities. Based on the relative migration of the 
monomer peak and peak A, one might expect that Aβ monomer would be detected first (smaller 
negative electrophoretic mobility), followed by the broad aggregate peak labeled A (intermediate 
negative electrophoretic mobility) and finally the sharp peaks due to mature fibrils (largest 
negative electrophoretic mobility). However, the sharp peaks migrate between monomer and 
peak A. For molecules, it is known that electrophoretic mobility is proportional to the ratio of an 
analyte’s charge, z, to hydrodynamic radius, Rh, but it is not known how the ratio z/Rh scales as 
Aβ aggregates. Additionally, the electrophoretic mobilities of larger Aβ aggregates will depend 
on more than just their size. Aggregate shape, counter ion double layer and surface zeta potential 
have been shown to be important for electrophoresis of polystyrene spheres of dimensions 
similar to mature Aβ fibrils [107]. Because standards for Aβ aggregates do not exist, interpreting 
separations of Aβ aggregates based on CE and other techniques (e.g. size-exclusion 
chromatography and field flow fractionation) is quite challenging [42,75]. 
  Seeds are aggregated amyloid peptides that can be added to an unaggregated peptide 
solution, e.g. a solution of Aβ monomer, to accelerate aggregation to form amyloid fibrils [108]. 
Seeds reduce the lag phase of Aβ aggregation in a concentration-dependent manner [10,89,108]. 
An Aβ seed sample was prepared by ultrasonicating mature fibrils as described in the Section 
3.2.2. Ultrasonication breaks apart mature fibrils into smaller pieces. The TEM inset of Figure 
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3.1c confirms the presence of aggregates after ultrasonication. The Aβ (1-40) seed sample was 
analyzed by CE-UV, and the electropherogram is shown in Figure 3.1c. The electrophoretic 
profile of the Aβ (1-40) seed closely resembles that of Aβ (1-40) fibril (Figure 3.1b) with two 
peaks at -1.072 × 10-4 cm2/Vs and -2.34 × 10-4 cm2/Vs for monomer and aggregates, 
respectively. The monomer and aggregate peak areas from the Aβ fibril and seed samples are 
similar, which is consistent with the samples having similar equivalent monomer concentrations 
of 25 µM and 20 µM, respectively. For the Aβ (1-40) fibril sample (Figure 3.1b), the average 
monomer and peak A areas are 2.3 ± 0.1 mAU·s (n = 3) and 20.6 ± 0.5 mAU·s (n = 3), 
respectively. The sum of the sharp peak areas in Figure 3.1b is 0.6 mAU·s for six peaks. For the 
Aβ (1-40) seed sample (Figure 3.1c), the average monomer and peak A areas are 1.7 ± 0.1 
mAU·s (n = 3) and 18.9 ± 0.7 mAU·s (n = 3), respectively.  
 Although the electropherograms for Aβ (1-40) fibril and seed are quite similar in most 
respects, it is interesting to note that the seed sample produced fewer sharp peaks between the 
mobilities of the monomer and aggregate peaks relative to fibril samples. We hypothesized that 
the sharp peaks observed in the electropherogram for the Aβ (1-40) fibril sample are due to 
individually detected mature fibrils. If ultrasonication broke up the mature Aβ fibrils producing 
the sharp peaks, fewer sharp peaks would be observed. 
3.3.2 Aβ (1-42) Peptide Analysis by CE-UV Absorbance 
  Figure 3.3 presents electropherograms for Aβ (1-42) samples. Like Aβ (1-40), Aβ (1-42) 
is present in neuritic plaques associated with AD, but it is thought to be more neurotoxic 
compared to Aβ (1-40). It is well known that Aβ (1-42) peptide aggregates much faster than Aβ 
(1-40) peptide. The Aβ (1-42) monomer sample (Figure 3.3a) was prepared as described in the 
experimental section. The sample was analyzed by CE-UV within 6 hr of its initial preparation, 
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and during that time, the sample was on ice or refrigerated at 4 °C to minimize aggregation 
before analysis. A large Aβ (1-42) monomer peak at -1.072 × 10-4 cm2/Vs and a small aggregate 
peak at -2.29 × 10-4 cm2/Vs were observed in the electropherogram (Figure 3.3a). The TEM in 
Figure 3.3a (inset) confirmed that aggregates were present in the Aβ (1-42) monomer sample 
despite careful sample preparation and low peptide concentration (22 µM). 
  Other reports of Aβ (1-42) monomer analysis using CE-UV have shown the presence of 
aggregate peaks but not a monomer peak in contrast to the data shown in Figure 3.3a [30,91]. 
Several factors may explain these differences: sample concentration, peptide source, sample 
preparation and handling and buffers. De Lorenzi and coworkers used 100 µM Aβ (1-42), about 
5 times the concentration used in this work. Their sample was prepared in 20 mM phosphate 
buffer at pH 7.4, and 80 mM phosphate buffer at pH 7.4 was used as the electrophoresis buffer. 
In the work presented here, the sample and electrophoresis buffers were 10.00 mM tris at pH 
7.79. Consistent with the electropherogram for Aβ (1-42) monomer in Figure 3.3a, De Lorenzi 
and coworkers did report a broad peak at a more negative electrophoretic mobility (longer 
migration time) compared to the peaks they attributed to small (< 50000 Da) Aβ oligomers. The 
electropherogram in Figure 3.3a indicates that it is possible to prepare and analyze a sample of 
Aβ (1-42) that contains primarily monomer as indicated by the peak at -1.072 × 10-4 cm2/Vs, in 
contrast to the work of De Lorenzi et al. 
  The electrophoretic mobility of the Aβ (1-42) monomer peak in Figure 3.3a is almost 
identical to that for the Aβ (1-40) sample presented in Figure 3.1, suggesting that the two 
additional amino acids in the Aβ (1-42) peptide did not result in a significant mobility shift. The 
CE method described in this work was not optimized to separate Aβ (1-40) monomer from Aβ 
(1-42) monomer. Rather, it was designed to separate monomeric Aβ from aggregated Aβ, and it 
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is successful for both Aβ (1-40) and Aβ (1-42) peptides. Other reports have demonstrated that 
CE is capable of separating a mixture of different length Aβ peptides, including Aβ (1-40) and 
Aβ (1-42) [77,93]. 
 
Figure 3.3 
Figure 3.3.  Electropherograms of Aβ (1-42) samples. Absorbance plotted at 190 nm. (a) Aβ (1-
42) monomer sample produced a monomer peak, M at µep = -1.074 (± 0.003) × 10-4 cm2/Vs (n = 
3) and an aggregate peak at µep = -2.294 (± 0.002) × 10-4 cm2/Vs (n = 3). (b) Aβ (1-42) fibril 
sample produced many peaks in the mobility range of aggregates. The neutral marker, NM, has 
an electrophoretic mobility of 0 cm2/Vs. The TEM insets confirm the presence of aggregates 
observed in the electropherograms (scale bar = 1 µm). 
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  Figure 3.3b shows an electropherogram for an Aβ (1-42) mature fibril sample. To 
produce fibrillar Aβ (1-42), this sample was incubated at 37 °C for 2 days in PBS. After 
incubation, the sample was buffer exchanged to 10.00 mM tris at pH 7.79 as described in Section 
3.2.2. Unlike all of the other electropherograms in this work, there is no monomer peak apparent 
near -1.1 × 10-4 cm2/Vs. The equilibrium concentration of Aβ (1-42) monomer has been reported 
as approximately four to five-fold less than Aβ (1-40), which may be below the detection limit 
for Aβ (1-42) monomer using this method [109]. The TEM for the fibril sample (inset in Figure 
3.3b) indicates the presence of fibrils. Unlike the Aβ (1-40) fibril and seed samples, no broad 
peak is detected at an electrophoretic mobility near -2.4 × 10-4 cm2/Vs. Instead, there are 17 
peaks between -1.4 × 10-4 and -2.9 × 10-4 cm2/Vs (253–314 s). These peaks all have a FWHM of 
~ 0.30 s. Based on these peaks’ electrophoretic mobilities and appearance; it is believed that they 
are due to mature Aβ (1-42) fibrils. Other researchers have reported detecting sharp peaks when 
analyzing Aβ (1-42) peptide [30]. Colombo et al. analyzed 100 µM Aβ (1-42) peptide in 20 mM 
phosphate buffer at pH 7.4. In that work, after 24 hr of incubation at room temperature, two main 
oligomer peaks and a few sharp peaks attributed to micro-precipitation and fibril deposition were 
observed [30]. No other reports examining Aβ (1-42) by CE-UV have shown a separation similar 
to that in Figure 3.3b. As discussed in Section 3.3.1 for Aβ (1-40) fibril samples, the length of 
the detection zone and data sampling rate are critical when detecting peaks due to individual 
fibrils passing through the detector. 
3.4 Conclusions 
  In this chapter, five distinct monomeric and aggregated samples of Aβ (1-40) and Aβ (1-
42) peptides were analyzed by CE with UV absorbance detection. The results showed that the 
CE-UV method can separate monomeric and aggregated forms of Aβ based on differences in 
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electrophoretic mobilities. Samples that contained Aβ aggregates, confirmed by TEM, produced 
a single broad peak, several sharp peaks or both in CE-UV separations. The broad peak is 
attributed to smaller oligomeric Aβ aggregates, and the sharp peaks are due to larger mature 
fibrils. Detecting these sharp fibril peaks requires fast data sampling, and faster data collection 
combined with a narrower detection window should improve the detection of the individual 
fibrils. Capillary electrophoresis with UV detection is a powerful tool to examine the contents of 
aggregating Aβ samples containing aggregates ranging from monomers to fibrils, and the method 
and results described here help lay the foundation for future amyloid analysis by CE. 
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CHAPTER 4 
SEPARATION AND DETECTION OF INDIVIDUAL Aβ AGGREGATES BY 
CAPILLARY ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE 
DETECTION 
 
4.1 Introduction 
Senile plaques composed of neurofibrillary tangles and polymorphic amyloid beta (Aβ) 
fibrils are hypothesized to be responsible for the neurological degeneration associated with 
Alzheimer’s disease (AD) [36,110]. Aggressive research efforts have focused on developing 
methods to prevent the formation of or cause the dissociation of amyloid fibrils [9,110]. 
Effective development of such treatments requires a thorough understanding of the formation 
and composition of Aβ plaques. Amyloid β peptides (1-40) and (1-42) readily form amyloid 
fibrils in vitro. The aggregation reaction from soluble monomeric peptide to insoluble fibrils is a 
complex, multistep process including heterogeneous populations of dynamic polymorphic 
intermediates [110]. These intermediates have been implicated to be cytotoxic; however, the 
identity and structure of the cytotoxic species are unknown. These multiple potential therapeutic 
targets make developing a treatment for AD extremely challenging. 
An ideal technique to analyze Aβ peptide aggregation would provide concentration and 
structural information as a function of time for the entire reaction landscape from monomer to 
fully-formed fibrils, where all forms of Aβ would be distinguishable. Current analytical 
techniques are far from this ideal. A variety of techniques has been employed to study static Aβ 
structures, mainly monomers or fully-formed fibrils. These include imaging techniques such as 
transmission electron microscopy (TEM), atomic force microscopy and total internal reflection 
fluorescence microscopy [54,111]. In addition, spectroscopic and spectrometric techniques such 
as circular dichroism, ThT and Congo red fluorescence, fluorescence correlation spectroscopy, 
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light scattering techniques, surface plasmon resonance, nuclear magnetic resonance and mass 
spectrometry have been applied to study Aβ structures [4,23,46,51,56,63,112]. 
Detecting and distinguishing monomeric Aβ peptides, intermediate oligomeric 
aggregates and fully-formed fibrils within a sample mixture using one technique is an important 
challenge that has not been met. Most of the aforementioned techniques can detect larger peptide 
aggregates, or fibrils, but are incapable of simultaneously detecting smaller aggregated peptide 
structures. Imaging techniques, for example, have a size threshold, below which the peptide is 
not detectable. This size threshold also exists for light scattering detection. Thioflavin T (ThT) 
fluorescence measurements allow the detection of peptide aggregates that have folded into a β-
sheet conformation, which is more pronounced as a function of increasing aggregate size. The 
signal measured by bulk fluorescence is also dominated by larger Aβ aggregates, which mask the 
signal produced from smaller aggregates. Larger aggregates also dominate bulk light scattering 
measurements. Although there is no one technique to monitor all forms of Aβ, all of the current 
techniques are very informative and important within their limitations. 
Characterizing the structural pathway from monomeric peptides to fibrillar aggregates 
involves measuring and characterizing the intermediate oligomeric structures between monomers 
and fibrils for which little information is available. Separations of Aβ aggregates based on size 
have been performed using several techniques, including ultracentrifugation, sedimentation 
velocity analysis, gel electrophoresis, size-exclusion chromatography (SEC) and capillary 
electrophoresis (CE) [22,26,53,70,71,77,91,92,113-115]. Capillary electrophoresis was first 
applied to the analysis of Aβ monomer in 1993 by Sweeney et al. [77]. Since this early paper, 
only a few reports regarding the application of CE to Aβ analysis have been published 
[26,45,91,92,113,116-118]. Capillary electrophoresis offers fast separations with higher peak 
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capacities and lower mass detection limits relative to other separation methods applied to study 
Aβ aggregation. Speed is especially important since some aggregate species will presumably 
disaggregate when they are physically separated from an aggregating mixture. Another 
advantage of CE relative to gel electrophoresis and SEC is that it does not require a gel or 
stationary phase that can disrupt or otherwise alter aggregates due to shear and adsorption. 
Clodfelter et al. demonstrated that CE is a more gentle technique relative to SEC for separating 
protein aggregates for another aggregate-forming peptide (C8GLIP) [100]. 
Laser-induced fluorescence (LIF) is a common on-column detection technique for CE, 
and CE-LIF has been used to study Aβ peptides [113]. Laser-induced fluorescence anisotropy 
(LIFA) is a less common detection method for CE, which has been applied to study protein-
protein and protein-nucleic acid interactions [119-122]. Fluorescence anisotropy (FA) is a 
fluorescence phenomenon that is dependent on the size of the fluorescent entity being 
investigated. Sabaté et al. demonstrated the use of bulk ThT anisotropy to monitor aggregation 
kinetics of the fungal prion protein HET-s(218-289) [68]. Allsop et al. demonstrated that bulk 
time-resolved fluorescence anisotropy can be used for monitoring early stages of Aβ aggregation 
using a fluorescein-labeled Aβ peptide [123]. Capillary electrophoresis with LIFA detection has 
the potential to be developed into a powerful tool for studying Aβ aggregation. Capillary 
electrophoresis is capable of resolving different Aβ aggregate species, and LIFA could provide a 
sensitive on-line detection method that also could provide information about the sizes of the 
separated species. To the best of our knowledge, there are no reports of the application of CE-
LIFA to study aggregation of amyloid forming peptides. 
The goal of this work was to separate and detect individual Aβ aggregates labeled with 
ThT using capillary electrophoresis with laser-induced fluorescence detection. Furthermore, the 
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potential of laser-induced fluorescence anisotropy to characterize individual Aβ aggregates 
labeled with ThT was explored. 
4.2 Experimental 
4.2.1 Chemicals  
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification 
system (United States Filter Corp.; Palm Desert, CA) unless otherwise noted. Tris 
(hydroxymethyl) aminomethane (Tris) and methanol (99.8%) were purchased from Fisher 
Scientific (Fair Lawn, NJ). Tris buffer was prepared at 10.00 mM, and the pH was adjusted to 
7.79 with HCl. This Tris buffer was used for all experiments unless otherwise noted. The buffer 
was filtered through a 0.02 µm filter (Whatman; Hillsboro, OR). Mesityl oxide (MO) was 
purchased from Alfa Aesar (Ward Hill, MA), and working solutions of MO were prepared in 
Tris buffer at a concentration of 0.2% (v/v). Coumarin 334 was purchased from Acros Organics 
(Morris Plains, NJ), and a stock solution was prepared at 1.00 µM in methanol. Working 
solutions of coumarin 334 were prepared at 50 nM in Tris buffer. Thioflavin T was purchased 
from Sigma (St. Louis, MO). A stock solution of 289 µM ThT solution was prepared in Tris 
buffer, and working solutions of ThT were prepared at 15.0 µM in Tris buffer. 
4.2.2 Aβ Peptide Sample Preparation and Characterization 
Aβ (1-40) peptide was purchased from the W.M. Keck Foundation Biotechnology 
Research Laboratory (Yale University, New Haven, CT), and Aβ (1-42) peptide was purchased 
from rPeptide (Bogart, GA). Four Aβ sample preparations were studied in this work:  Aβ (1-40) 
monomer, Aβ (1-40) fibril, Aβ (1-42) monomer and Aβ (1-42) fibril. All Aβ samples were 
prepared as previously described [44,45,118]. Aβ peptides were treated with trifluoroacetic acid 
(TFA)/hexafluoroisopropanol (HFIP) to remove any preexisting aggregates. For Aβ monomer 
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samples, the solvent was evaporated off, and the peptide was dissolved in 10.00 mM Tris at pH 
7.79. For the Aβ (1-40) fibril sample, the TFA/HFIP was evaporated off, and the peptides were 
dissolved stepwise in equal volumes of 2.0 mM NaOH and 2× phosphate buffered saline (PBS) 
containing 22.8 mM phosphate, 274 mM NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. The 
samples were centrifuged at 50,000 g for a minimum of 10 h at 4 °C. The supernatant was 
incubated at 37 °C for 7 d. The Aβ (1-42) monomer and fibril samples were prepared using the 
same procedure with the following exceptions:  the Aβ (1-42) monomer sample was centrifuged 
for 30 min at 20,000 g and 4 °C, and the Aβ (1-42) fibril sample was incubated for 2 d to form 
mature fibrils. These changes were due to the faster aggregation kinetics of Aβ (1-42) peptide 
compared to that of the Aβ (1-40) peptide. 
Fibril growth was monitored using ThT fluorescence and transmission electron 
microscopy as described previously [4,118]. Depletion of Aβ monomer during fibril formation 
was monitored using a Shimadzu HPLC-UV instrument with detection at 215 nm as described 
previously [44,45,118]. Samples were characterized by CE-UV. The CE-UV analysis was 
performed using a Beckman Coulter P/ACE MDQ equipped with a diode array detector, and the 
absorbance was monitored at 190 nm as previously described [118]. The capillary (ID = 50 µm, 
OD = 366 µm) used for CE-UV was cut to 63.0 cm total length with a window created 53.0 cm 
from the inlet end using The Window MakerTM (MicroSolv Technology Corp.; Eatontown, NJ). 
The Aβ samples were vortexed prior to every injection to resuspend any aggregates that settled 
to the bottom of the sample vial. 
Prior to CE analysis, fibril samples were buffer exchanged from PBS to 10.00 mM Tris 
electrophoresis buffer at pH 7.79 [51]. This step eliminated conductivity and composition 
differences between the sample buffer (PBS, higher conductivity) and electrophoresis buffer 
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(Tris, lower conductivity). The higher conductivity of PBS would result in high electrophoretic 
current and poor results due to excessive Joule heating if it were used for electrophoresis. The 
monomer-equivalent concentrations of all samples were determined by HPLC-UV as previously 
described [44] and were:  Aβ (1-40) monomer, 15.7 µM;  Aβ (1-40) fibril, 5.1 µM;  Aβ (1-42) 
monomer, 19.9 µM;  Aβ (1-42) fibril, 29.5 µM. For CE analysis, the total sample volume was 
50.0 µL, and it was placed in a 200 µL thermowell polypropylene tube (Corning Incorporated; 
Corning, NY). 
4.2.3 Capillary Electrophoresis with Laser-Induced Fluorescence Anisotropy Detection 
The Aβ samples were characterized first by CE-UV and then analyzed with the CE-LIFA 
system on the same day. The samples were not transferred to different vials when switching from 
the CE-UV instrument to the CE-LIFA instrument. A laboratory-constructed instrument was 
used for all CE-LIFA experiments. The CE part of the instrument was similar to an instrument 
described previously [124]. 
Capillary electrophoresis was performed in an open-tubular capillary (ID = 50 µm, OD 
366 µm) cut to 60.0 cm total length. A detection window was created at 23.0 cm from the inlet 
end. A new capillary was initially conditioned with a manual syringe pump using the following 
sequence:  400 µL of 1.00 M NaOH, 400 µL of 18 MΩ water and 2 × 400 µL of Tris buffer. The 
total rinse time was approximately 60 min. The capillary was rinsed twice between sample types 
with 400 µL of Tris electrophoresis buffer using a manual syringe pump. The fluorescent neutral 
marker (coumarin 334) was injected for 1.0 s at 25.0 kV prior to the Aβ sample injection for 5.0 
s at 25.0 kV. This injection order minimized potential interactions between Aβ and the neutral 
marker because all forms of Aβ detected migrated slower than the neutral marker. The Aβ 
samples were vortexed prior to every injection. The electrophoretic potential was applied using a 
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Spellman CZE1000R high-voltage power supply (Hauppauge, NY) at 25.0 kV (417 V/cm). The 
electrophoretic current was 5-6 µA. This system was not temperature controlled, unlike the 
commercial CE-UV system. 
Figure 4.1 presents a schematic of the detection system for the CE-LIFA instrument. The 
light source was a 445 nm diode laser (Model No. LDCU12/7532, Power Technology, Inc; 
Alexander, AR). The laser produced a continuous beam of polarized radiation, and the measured 
power was 30.0 mW. The beam was attenuated with a neutral density filter to 3.0 mW and 
focused onto the capillary window with a plano-convex lens (focal length = 25.4 mm). The 
fluorescence emission was collected with a 20× microscope objective lens (Numerical Aperture 
= 0.4) at 90° relative to the excitation beam. The emission was directed through a 441.6 ± 10 nm 
notch filter (MK Photonics, Inc; Albuquerque, NM) to remove Rayleigh scattered light from the 
laser and a 490 ± 10 nm bandpass filter (Omega Optical; Brattleboro, VT) to selectively detect 
amyloid-bound ThT fluorescence. After being spectrally filtered, the emission was spatially 
filtered with a 1000 µm pinhole. The emission was then separated into its parallel and 
perpendicular polarized components (relative to the excitation source) with a broadband 
polarizing cube beamsplitter (10FC16PB.3, Newport Corporation; Irvine, CA). Both emission 
components were detected simultaneously and equidistant from the capillary by two identical 
photomultiplier tubes (PMT) (H9306-04, Hamamatsu; Bridgewater, NJ). The PMT collecting 
parallel emission (PMT║) was at 1000 V, while the PMT collecting perpendicular emissions 
(PMT┴) was at 935 V. The outputs of the PMTs were filtered by 500 Hz low pass RC filters and 
collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz. The CE-
LIFA data collection was controlled by a program written with LabView Version 5.0, and the 
data were analyzed using Origin Pro 7.5, Synaptosoft Minianalysis Programs version 6.0.7 and 
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Microsoft Excel 2007. 
Equation 4.1 was used to calculate the fluorescence anisotropy, r, where I║, and I┴, are 
the measured parallel and perpendicular fluorescence intensities relative to the polarization of the 
excitation source. The factor G corrects the anisotropy for the differences in sensitivities of the 
two PMTs. For this work, G was empirically adjusted to 1 by optimizing the potentials applied to 
both PMTs so that the responses and sensitivities were equal for a small fluorescent molecule, 
Lucifer Yellow (Molecular Probes; Eugene, OR), from 250 nM to 1 µM (data not shown). 
r =
.∥ − 0.1.∥ 2 20.1 																																																																																			(4.1) 
 
Figure 4.1. Schematic of the fluorescence anisotropy detection system for CE. Components are 
(a) polarized laser (445 nm), (b) neutral density filter, (c) focusing lens, (d) capillary, (e) 
microscope objective lens (20×), (f) 440 ± 10 nm notch filter, (g) 490 ± 10 nm bandpass filter, 
(h) 1000 µm pinhole, (i) polarizing beam splitter cube, (j) PMT║, (k) PMT┴. 
 
4.2.4 Microplate Reader Fluorescence 
The same samples analyzed by CE-UV and CE-LIF were also analyzed by bulk ThT 
fluorescence using a BMG Lab Technologies FLUOStar 430 microplate reader (Offenbur, 
Germany). The instrument and data acquisition were controlled by FLUOstar Software Version 
3.02-0. Forty microliters of each sample were transferred from the 200 µL polypropylene tubes 
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used for CE to separate wells of 96-well Corning, Inc. 3650 black nontransparent microplates. 
Consistent with the CE experiments, ThT was added at 15 µM to each sample well. The 
excitation was set to 440 ± 12 nm with a bandpass filter, and the emission was collected at 485 ± 
12 with a bandpass filter. 
4.3 Results and Discussion 
The primary goal of this work was to separate and detect individual Aβ peptide 
aggregates by CE-LIF using thioflavin T as an amyloid-selective fluorescent label. Thioflavin T 
(ThT) is a common fluorescence probe used to study Aβ aggregation because it is selective for 
amyloid aggregates, and its excitation/emission maxima shift from 330/440 nm to 440/490 nm 
when it noncovalently binds to amyloid aggregates [4,12,63]. Thioflavin T was added to the 
electrophoresis running buffer to bind to the Aβ aggregates on-column [113]. This approach 
eliminates the potential for ThT to alter the Aβ aggregates’ sizes and shapes during the 
aggregation process while still being used as an effective fluorescent label for their on-column 
detection. At the excitation and emission wavelengths used in this work, fluorescence 
interference from unbound ThT is minimal [63]. The concentration of ThT (15 µM) was chosen 
based on earlier publications which used 10 and 20 µM ThT for Aβ aggregate detection [45,63]. 
This is above the critical micelle concentration of free ThT reported by Khurana et al. (3.8 ± 0.5 
µM) [67]. 
The work presented here is distinct from the earlier study by Kato et al. [113] because the 
instrument used here was designed to detect peaks resulting from individual aggregated Aβ 
species, which required the use of sufficiently fast data sampling and electronic filters [82,106]. 
In addition, the ThT fluorescence measured after CE separation was validated by measuring bulk 
ThT fluorescence for the same samples. 
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4.3.1 Detection of Individual Aggregates by CE-LIF 
The detection system was designed as a two channel (polarization) fluorescence detector 
in order to evaluate the potential of fluorescence anisotropy to size-characterize individual 
aggregates (see Experimental for details); however, for the purpose of separating and detecting 
individual ThT-labeled Aβ aggregates by CE-LIF, two channel fluorescence detection is not 
required. Data from one fluorescence channel has been plotted in Figures 4.3-4.6 for clarity. The 
two channel data will be discussed in Section 4.3.3. 
Four different Aβ sample types were prepared and used for this work:  Aβ (1-40) 
monomer, Aβ (1-40) fibril, Aβ (1-42) monomer and Aβ (1-42) fibril. The two fibril samples 
were prepared to contain large mature fibrils that would bind to ThT to produce fluorescence 
peaks. The Aβ (1-40) monomer and Aβ (1-42) monomer samples were prepared to be free of 
aggregates and serve as negative controls. A TEM of each sample type is shown in Figure 4.2. 
The Aβ fibril samples (Figures 4.2B and 4.2D) show clear evidence of fibrillar aggregates and 
were expected to bind ThT and produce fluorescence peaks. The Aβ monomer samples did not 
show fibrillar aggregates by TEM (Figures 4.2A and 4.2C). These samples were not expected to 
produce fluorescence peaks with ThT. Amyloid monomers, unlike amyloid fibrils, do not cause 
the ThT enhancement [4,12,63]. 
Figures 4.3A and 4.3B show electropherograms with LIF detection for the Aβ (1-40) 
monomer sample without and with ThT in the running buffer, respectively. As expected, no 
peaks were observed in the absence of ThT (Figure 4.3A). In contrast, with ThT a few small, 
sharp peaks were present (Figure 4.3B). The migration times of these peaks appear to be random 
for consecutive injections, and approximately the same numbers of peaks were observed in 
electropherograms of the electrophoresis buffer with thioflavin T for which no Aβ was injected 
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(data not shown). These peaks are hypothesized to be a result of unfiltered particulate matter 
(non Aβ particles) in the running buffer that can enhance ThT fluorescence similar to amyloid 
fibrils. We are currently investigating ThT fluorescence in the presence of synthetic 
nanoparticles due to their potential to produce false positives in amyloid fibril assays. The Aβ (1-
40) monomer sample also was analyzed by a CE-UV method previously developed by Picou et 
al. [45]. A representative CE-UV electropherogram of the Aβ (1-40) monomer sample is 
available in Appendix A Figure A.2. This experiment confirmed that the Aβ (1-40) monomer 
sample does contain Aβ monomer, and it does not indicate that Aβ aggregates are present. 
          
Figure 4.2. TEM images of (A) Aβ (1-40) monomer; (B) Aβ (1-40) fibril; (C) Aβ (1-42) 
monomer; (D) Aβ (1-42) fibril. Samples were buffer exchanged into 10.00 mM Tris buffer at pH 
7.79 prior to imaging (scale bar = 500 nm). 
 
The large, relatively broad peaks at approximately 60 s in Figures 4.3A and 4.3B are the 
fluorescent dye, coumarin 334, which was used as a neutral marker to determine the 
electroosmotic flow. The coumarin 334 and Aβ samples were injected consecutively 
(electrokinetic injection) from separate vials to minimize potential interaction of the neutral 
marker and Aβ. For these experimental conditions, Aβ has a negative electrophoretic mobility. 
The coumarin 334 and Aβ sample buffers did not contain ThT. As a result, when they were 
injected into a capillary filled with ThT, a vacancy zone was created, which caused the 
fluorescence to decrease as observed at 47 s in Figure 4.3B. No ThT vacancy zone is present in 
Figure 4.3A because ThT was not included in the running buffer. The vacancy peak in Figure 
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4.3B gives an indication of the magnitude of the background fluorescence due to unbound ThT 
and is consistent with reports of ThT background fluorescence in the literature [4,12,63]. 
 
Figure 4.3. Electropherograms with LIF detection for Aβ (1-40) monomer without (A) and with 
(B) 15 µM ThT in the electrophoresis buffer (10.00 mM Tris at pH 7.79). The peak at 59 s in 
each electropherogram is the neutral marker (NM), coumarin 334. Coumarin 334 was injected 
for 1.0 s at 25.0 kV prior to the Aβ sample injection for 5.0 s at 25.0 kV. The separation potential 
was 25.0 kV (417 V/cm). The dip in the baseline at 47 s in (B) is due to a ThT vacancy zone. 
 
Figures 4.4A and 4.4B show representative electropherograms with LIF detection for the 
Aβ (1-40) fibril sample without and with ThT in the running buffer, respectively. The Aβ (1-40) 
fibril sample was prepared by allowing Aβ (1-40) monomer to aggregate for 7 d to produce 
mature Aβ (1-40) fibrils. Many sharp peaks are observed near 110 s in both Figures 4.4A and 
4.4B. Table 4.1 shows that the electropherograms for the Aβ (1-40) fibril sample with ThT in the 
separation buffer contain approximately 100 of these peaks compared to 10 peaks for the Aβ (1-
40) monomer sample (Figure 4.3B). The peaks in Figures 4.4A and 4.4B are hypothesized to be 
due to individual Aβ (1-40) aggregates passing through the LIF detection zone. The inset of 
Figure 4.4B is an expanded view showing two individual aggregate peaks in the Aβ (1-40) fibril 
sample, illustrating their narrow peak widths. 
It is extremely challenging to show definitively that these sharp peaks are due to 
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individual amyloid fibrils. The fundamental limitation is the lack of an analytical standard or 
surrogate standard for Aβ fibrils. Our laboratory has extensive experience with single particle 
detection [82,125] and Aβ fibril preparation and analysis [45,51,118]. The peak widths observed 
are consistent with peaks due to single polymer particles of comparable size observed with a 
similar CE detector [82]. The expected FWHM of an aggregate passing through a focused laser 
beam can be estimated by dividing the calculated diameter of the focused laser spot by the 
measured migration rate of the aggregate [82]. In this case, the calculated diameter of the 
focused laser beam is 5.7 µm, and the migration rate for species detected at 105.03 s is 0.22 cm/s, 
which gives a theoretical FWHM for a single aggregate peak of 3 ms. In the inset in Figure 4.4B, 
the peak at 105.03 s has a measured FWHM of 11 ms, and the peak widths for peaks attributed to 
individual aggregates ranged from 3–15 ms. The width for the peak in Figure 4.4B is greater than 
the predicted FWHM of 3 ms, but this is expected due to refraction of the excitation beam at the 
curved capillary surfaces, which causes the actual spot size to be significantly larger than the 
calculated spot size [82]. An actual spot size of 24.2 µm would produce the observed peak width 
of 11 ms. The measured FWHM for coumarin 334 is 1.2 s, which is typical for a CE peak due to 
large numbers of identical fluorescent molecules.  
The presence of large Aβ aggregates in the Aβ (1-40) fibril sample was confirmed by 
CE-UV, TEM and bulk ThT fluorescence measurements. In the CE-UV electropherogram 
(Figure 4.4C), the broad peak at 313 s and the sharp peaks from 300-400 s are typical for Aβ 
samples containing mature fibrils [118]. Bulk ThT fluorescence was higher for the Aβ (1-40) 
fibril sample compared to the Aβ (1-40) monomer sample (Table 4.2), which is consistent with 
the presence of large Aβ aggregates in the fibril sample [4,12,63]. Finally, the TEM of this 
sample (Figure 4.2B) shows that mature Aβ fibrils were present in this sample. 
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Table 4.1. Number of CE peaks detected with and without ThT. All data are presented as 
averages with standard deviations from 3 experiments. All peaks with S/N > 3 were included. 
Sample 
Peaks Detected 
with ThT without ThT 
Aβ (1-40) Monomer 10 ± 3 1 ± 1 
Aβ (1-40) Fibril 99 ± 23 13 ± 4 
Aβ (1-42) Monomer 176 ± 27 5 ± 2 
Aβ (1-42) Fibril 300 ± 46 300 ± 30 
 
 
Table 4.2. Comparison of the total signal measured for each sample by CE and bulk 
fluorescence with a plate reader. All data are presented as averages with standard deviations 
from 3 trials. Data are normalized to the values for the Aβ (1-42) fibril sample. The CE values 
were calculated by summing the integration of the peaks detected in the electropherogram. 
Sample 
Capillary Electrophoresis (CE) Plate Reader 
with ThT (RFU) without ThT 
(RFU) 
with ThT (RFU) without ThT 
(RFU) 
Aβ (1-40) 
Monomer 
0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 
Aβ (1-40) Fibril 3.8 ± 0.1 0.9 ± 0.5 8.8 ± 0.1 2.1 ± 0.1 
Aβ (1-42) 
Monomer 
5.9 ± 0.6 0.2 ± 0.0 3.2 ± 0.1 0.2 ± 0.0 
Aβ (1-42) Fibril 100.0 ± 26.3 12.3 ± 3.0 100.0 ± 0.5 18.9 ± 0.1 
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Figure 4.4. Electropherograms with LIF detection of Aβ (1-40) fibril without (A) and with (B) 
15 µM ThT in the electrophoresis buffer. The experimental conditions for (A) and (B) are the 
same as in Figure 3. The inset in (B) is an expanded view (0.2 s) of Aβ (1-40) aggregate peaks. 
The same sample analyzed by CE with UV absorbance (190 nm) is shown in (C). In (C), the NM 
was injected for 2.0 s at 0.3 psi followed by the Aβ injection for 5.0 s at 0.5 psi. The separation 
potential in (C) was 25.0 kV (397 V/cm). The peaks at 200 s and 243 s are due to the neutral 
marker (NM) and Aβ monomer (M), respectively. 
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The peaks in Figure 4.4A (Aβ (1-40) fibril without ThT) are hypothesized to be due to 
scattered light from individual aggregates and are not unexpected. We have previously shown 
that polystyrene spheres as small as 110 nm diameter can be detected individually by light 
scattering after CE separation [82], and Aβ fibril samples produce similar peaks in instruments 
designed to detect scattered light with CE (unpublished results). The peaks in Figure 4.4A were 
detected despite the use of a 440 nm notch filter and a 490 nm bandpass filter to minimize 
detection of scattered light and isolate ThT fluorescence. The peaks in Figure 4.4A suggest that 
aggregates in the mature Aβ (1-40) fibril sample produced a non-negligible light scattering signal 
in the absence of ThT that will contribute to the apparent fluorescence signal in the presence of 
ThT. Comparing Figure 4.4A and 4.4B, it is clear that most of the observed signal in Figure 4.4B 
is due to enhanced ThT fluorescence. The data in Table 4.2 for microplate fluorescence 
measurements of this sample (without ThT) also produce a higher signal than microplate 
measurements of Aβ monomer samples both with and without ThT added. 
It is important to recognize that the migration times and electrophoretic mobilities for the 
aggregate peaks in the three electropherograms in Figure 4.4 cannot be directly compared. The 
differences between the migration times of the aggregate peaks in the CE-LIF and CE-UV 
electropherograms are mainly due to the difference in capillary length from the inlet to the 
detection window, LD, for the two instruments (23.0 cm, Figure 4.4A and 4.4B; 53.0 cm, Figure 
4.4C). This will not affect electrophoretic mobilities of the Aβ aggregate peaks, but ThT added 
to the running buffer in Figure 4.4B can potentially alter the electrophoretic mobilities of Aβ 
aggregates compared to Figure 4.4A and 4.4C. Finally, the laboratory-constructed CE-LIF 
instrument used for Figure 4.4A and 4.4B was not thermostatted, but the commercial CE 
instrument used for Figure 4.4C does control the capillary temperature. Even though the 
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separation buffers used for all separations were identical, changes in capillary temperature will 
affect the electrophoretic mobilities of the Aβ species. 
Aβ (1-42) peptide samples also were prepared and investigated by CE-LIF. Preparing an 
Aβ (1-42) monomer sample to be completely aggregate-free is extremely challenging owing to 
the fast aggregation kinetics of Aβ (1-42) peptide relative to that of the Aβ (1-40) peptide [70]. 
Figures 4.5A and 4.5B show representative electropherograms of the Aβ (1-42) monomer sample 
without and with ThT in the running buffer, respectively. Figure 4.5A shows that other than the 
coumarin 334 peak at 58 s, few peaks (<10) are detected in the Aβ (1-42) monomer sample when 
no ThT is included in the running buffer (Table 4.1). In contrast, Figure 4.5B shows an 
electropherogram of the same Aβ (1-42) monomer sample injected with 15 µM ThT in the 
electrophoresis buffer, and over 150 peaks were detected (Table 4.1). These peaks have FHWMs 
ranging from 3–15 ms like those attributed to individual aggregates for the Aβ (1-40) fibril 
sample. Characterization of this sample by CE-UV also indicated that the sample contained 
aggregates based on the presence of the broad peak at 343 s (Figure 4.5C) [45,118]. The large 
UV peak at 259 s also demonstrates that this sample contains unaggregated Aβ (1-42) monomer 
[118]. 
In the presence of ThT, the Aβ (1-42) monomer sample produced a broad peak (FWHM 
= 9 s) at 98 s that is separated from most of the peaks attributed to individual aggregates (Figure 
4.5B). The Aβ (1-40) fibril sample (with ThT) also produced a broad peak that co-migrated with 
most of the peaks attributed to individual aggregates (Figure 4.4B). These broad peaks in Figures 
4.4B and 4.5B could be due to oligomeric structures, which are too small to produce large 
distinct peaks for individual aggregates but are large enough to bind ThT and enhance its 
fluorescence. Biancalana et al. discuss minimal β-sheet requirements for binding and 
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fluorescence enhancement of ThT using a peptide self-assembly mimic [12], but it is not certain 
exactly what size Aβ aggregates meet the minimum β-sheet requirements. 
 
 
 
Figure 4.5. Electropherograms with LIF detection of Aβ (1-42) monomer analyzed without (A) 
and with (B) 15 µM ThT in the electrophoresis buffer. (C) shows the same sample analyzed by 
CE-UV at 190 nm. The peaks at 213 s and 259 s are due to neutral marker (NM) and Aβ 
monomer (M), respectively. The experimental conditions for (A–C) are the same as in Figure 
4.4(A–C). 
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A sample containing Aβ (1-42) fibrils also was prepared and analyzed by CE-LIF (Figure 
4.6) and CE-UV. The CE-UV electropherogram (Appendix A Figure A.3), bulk ThT 
fluorescence (Table 4.2) and TEM data (Figure 4.2D) from the Aβ (1-42) fibril sample clearly 
indicate that large aggregates were present in this sample. Unlike the Aβ (1-40) fibril sample 
studied in this work (Figure 4.4), the CE-UV data of the Aβ (1-42) fibril sample showed no signs 
of Aβ monomer (Appendix A Figure A.3). The absence of a monomer peak in the Aβ (1-42) 
fibril is presumably due to the fast aggregation kinetics and the smaller monomer equilibrium 
concentration of the Aβ (1-42) peptide relative to that of the Aβ (1-40) peptide [70]. 
Figures 4.6A and 4.6B are electropherograms of the Aβ (1-42) fibril sample without and 
with ThT in the running buffer, respectively. Figure 4.6A shows that the Aβ (1-42) fibril sample 
produced many sharp peaks in the absence of ThT that are believed to be due to scattered light 
from individual aggregates, similar to the scattering observed in the Aβ (1-40) fibril sample 
(Figure 4.4A). Table 4.1 shows that an average of 300 peaks were detected for the Aβ (1-42) 
fibril sample in the absence of ThT, and the peaks were much larger than those observed for Aβ 
(1-40) fibrils. This is consistent with the microplate measurements for the samples without ThT 
(Table 4.2). The large peak heights for the Aβ (1-42) fibrils relative to the Aβ (1-40) fibrils, 
without ThT, suggest that the Aβ (1-42) fibrils are larger. 
Adding ThT to the running buffer resulted in an increase in the intensity of the peaks 
detected for the Aβ (1-42) fibril sample. Most of the peaks were off scale initially, and a neutral 
density (ND) filter (10.7% transmission) was used to attenuate the emission for the 
electropherogram shown in Figure 4.6B. The inset of Figure 4.6B highlights a few of the Aβ (1-
42) aggregate peaks, which shows that the most peaks are well-resolved from each other. The 
average values for total peaks presented in Table 4.1 are the same for the Aβ (1-42) fibril sample 
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with or without ThT, but the peaks are much larger with ThT in the running buffer. The total 
signal from the Aβ (1-42) fibril sample does increase by a factor of 8 when analyzed in the 
presence of ThT (Table 4.2). 
 
 
Figure 4.6.  Electropherograms with LIF detection of Aβ (1-42) fibrils analyzed without (A) and 
with (B) ThT in the electrophoresis buffer. A neutral density filter was used in (B) to attenuate 
the emission (10.7% transmission), and the y-axis in (B) was adjusted to account for this. The 
inset in (B) shows a 0.2 s segment of the electropherogram showing several of the Aβ (1-42) 
aggregate peaks. The experimental conditions for (A) and (B) are the same as in Figure 4.3. 
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4.3.2 Validating CE-LIF Results by Bulk Measurements 
Bulk ThT fluorescence measurements are widely used for studying amyloid aggregation 
[4,10,12,45,63,70]. While the studies presented in Section 4.3.1 and by Kato et al. [113] show 
that ThT can be used as a label for LIF detection of Aβ aggregates with CE, it is not known if the 
fluorescence detected as peaks by CE is equivalent to the increase in bulk ThT experiments 
commonly used to indicate increased Aβ aggregation and to study Aβ aggregation kinetics. To 
validate the CE results, the total fluorescence detected in electropherograms (summed area of all 
peaks) has been compared to bulk fluorescence measurements obtained with a microplate 
fluorometer using the same Aβ samples. 
The data for these experiments are presented in Table 4.2. All microplate fluorometer 
data were normalized to the fluorescence for the Aβ (1-42) fibril sample with ThT, and all of the 
CE-LIF data were normalized to the total fluorescence for the Aβ (1-42) fibril sample with ThT 
for CE experiments. The data presented in Table 4.2 demonstrate that the results from the two 
methods are equivalent. Both methods show almost no signal for Aβ (1-40) monomer both with 
and without ThT added. Relative to Aβ (1-40) monomer, both techniques indicate a significant 
increase in signal for the Aβ (1-40) fibril sample without the addition of ThT, suggesting that 
signal due to scattered light for CE experiments (Figure 4.4A) is also detected by the microplate 
reader. Upon binding to ThT, the fluorescence signal for Aβ (1-40) fibrils increased by a factor 
of 4.2 using both techniques. Similarly, both Aβ (1-42) monomer and Aβ (1-42) fibrils show 
similar signal intensities using both techniques in the presence and absence of ThT. 
Overall, the data in Table 4.2 show that the CE-LIF data are consistent with standard bulk 
fluorescence measurements. The advantage of the CE-LIF technique is that it separates the 
aggregates in the sample, providing a profile of mobility and intensity data for the Aβ aggregate 
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population. 
4.3.3 Fluorescence Anisotropy of Individual Aβ Aggregates 
The results presented in Sections 4.3.1 and 4.3.2 demonstrate that this CE-LIF method 
can separate Aβ aggregates, providing information about their numbers, electrophoretic 
mobilities and fluorescence intensity with ThT labeling. While this approach provides a wealth 
of information about the Aβ aggregate population compared to bulk measurements of ThT 
fluorescence, it does not allow us to determine the size and shape of an individual aggregate 
based on CE-LIF peaks. For particles of the size scale of Aβ fibrils, electrophoretic mobility is 
not a simple function of aggregate size and shape [81,82]. Standards or suitable surrogate 
standards representative of amyloid fibrils to determine these relationships do not exist. The 
relationship between aggregate size, shape and structure and ThT fluorescence also is not well 
understood. This section investigates the potential of characterizing individual aggregates by 
fluorescence anisotropy with ThT fluorescence. 
Fluorescence anisotropy (FA) is a technique capable of providing size-related 
information about fluorescent analytes. Equation (4.2) shows how fluorescence anisotropy is 
related to the rotational diffusion coefficient, D, through the Perrin equation, where r0 is the 
fundamental anisotropy and τ is the fluorescence lifetime. The fundamental anisotropy is 
dependent on the angle between the absorption and emission transition dipoles of the fluorophore 
[69]. It was hypothesized that the differences in size and structure of Aβ aggregates detected by 
CE would result in differences in fluorescence anisotropy, according to Equation (4.2). 
 = 	 1 2 645																																																																																	(4.2) 
For this work, the fluorescence anisotropy detector used two PMTs that simultaneously 
collected perpendicular and parallel emission relative to the polarization of the excitation source 
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(Figure 4.1). A pair of data points was collected at each time point, and the emission intensities 
were used as described in Equation (4.1) to calculate the fluorescence anisotropy, r, as described 
in Section 4.2.3. 
Figures 4.7A–C show three representative 100 ms time segments of the parallel and 
perpendicular fluorescence signals from the electropherograms of the Aβ (1-42) monomer 
sample. This sample was chosen to test the potential of fluorescence anisotropy to characterize 
Aβ aggregates because it produced on-scale peaks in the presence of ThT and no significant 
signal in the absence of ThT, i.e. minimal scattering signals. These are important attributes for 
this assessment because peak intensities, which are used in the calculation of fluorescence 
anisotropy (See Equation 4.1), cannot be determined from off-scale peaks. Moreover, it is known 
that scattered light from a polarized source is highly polarized and could have a significant 
impact on the fluorescence anisotropy results [69]. 
In Figure 4.7A–C, the parallel channel data are plotted as solid lines, and the 
perpendicular channel data are plotted as dashed lines. Note that the parallel channel data in 
Figure 4.7A–C are from the same electropherogram shown in Figure 4.5B. It is clear from 
Figures 4.7A–C that the signal detected in the parallel channel is higher than that detected in the 
perpendicular channel, indicating fluorescence anisotropy. Coumarin 334, which was used as a 
neutral marker to measure the electroosmotic flow for these studies, was also used to as a control 
to assess the performance of the fluorescence anisotropy detection system. The fluorescence 
anisotropy of coumarin 334 is expected to be near zero because it has a low MW (283.32 g/mol) 
[69]. The fluorescence anisotropy of coumarin 334 that was injected with the Aβ (1-42) 
monomer sample in Figure 4.7 was calculated to be 0.007 (coumarin 334 data not shown). This 
verifies that the detection system was performing properly. 
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Figure 4.7.  Electropherograms of Aβ (1-42) monomer for LIFA detection. Figures A–C are 
three 0.1 s segments of the electropherogram shown in Figure 4.5B. The parallel and 
perpendicular fluorescence emissions are shown as solid and dashed lines, respectively. Figures 
D–F show fluorescence anisotropy electropherograms corresponding to A–C, respectively. The 
anisotropy data in D–F were calculated using Equation 4.1. 
 
Figures 4.7D–F show fluorescence anisotropy vs. time calculated from the LIF data in 
Figures 4.7A–C. Figures 4.7D–F show that individual aggregate peaks have non-zero 
anisotropies, but these anisotropy values are indistinguishable from the anisotropy calculated 
from the background signal, i.e. no fluorescence anisotropy peaks were observed in Figures 
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4.7D-F. It was hypothesized that plots of fluorescence anisotropy vs. time for an Aβ aggregate 
sample would result in distinguishable fluorescence anisotropy peaks and that the intensity of 
these peaks might provide information about the relative sizes of the aggregates. Protein-protein 
affinity interaction studies by CE-LIFA included plots of fluorescence anisotropy vs. time with 
distinct peaks [121]. Sabate and Saupe reported an increase in ThT fluorescence anisotropy due 
to aggregation of a fungal prion protein (HET-s(218-289) [68]. A study by Khurana et al. 
reported anisotropy values near 0.3 for ThT without any protein aggregates present in the 
solution [67]. While ThT clearly produced enahanced fluorescence for Aβ aggregates in this 
study, fluorescence anisotropy did not appear to increase significantly relative to background 
levels. In order to effectively use CE with fluorescence anisotropy detection to characterize 
individual aggregates, the fluorescence anisotropy of Aβ aggregates must be distinct from that of 
the background anisotropy.  
4.4 Conclusions 
This work shows that CE with LIF detection can be used to analyze samples of 
aggregated Aβ (1-40) and Aβ (1-42) using ThT, a dye that fluoresces upon binding to the 
amyloid fibrils, in the running buffer. This study distinguishes itself from an earlier study [113] 
by demonstrating the ability to separate and detect individual aggregates and by validating the 
CE-LIF data using direct comparison with bulk thioflavin T fluorescence measurements, which 
are widely used to study aggregation kinetics of amyloidogenic peptides. Compared to bulk ThT 
fluorescence measurements, CE-LIF provides a profile of the aggregate population based on 
electrophoretic mobilities, fluorescence intensities and numbers of individual aggregate peaks. 
The studies presented here focus on analysis of Aβ aggregates, but they should be applicable to 
studies of other amyloidogenic peptides. 
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Initial studies of CE-LIFA to characterize individual Aβ aggregates yielded encouraging 
results, but significant improvements must be made to effectively apply this to study Aβ 
aggregation. 
 
 
 
 
  
  85 
 
CHAPTER 5 
 
A DATA TREATMENT METHOD FOR DETECTING FLUORESCENCE 
ANISOTROPY PEAKS IN CAPILLARY ELECTROPHEROGRAMS 
 
5.1 Introduction  
Fluorescence anisotropy (FA) is a measure of the degree of emission depolarization of a 
fluorescent molecule after being excited with a polarized excitation source [69]. A major cause 
of emission depolarization is molecular rotational diffusion during the excited state lifetime of 
the fluorophore. In general, molecules with smaller rotational diffusion rates, i.e. slower rotation 
in solution, exhibit larger fluorescence anisotropy. Similarly, molecules that have large rotational 
diffusion rates exhibit smaller fluorescence anisotropy. 
Laser-induced fluorescence anisotropy (LIFA) has been demonstrated as an on-column 
detection technique for capillary electrophoresis (CE) for studies of biomolecular interactions, 
e.g. protein-protein or oligonucleotide-protein interactions [119-122,126,127]. Chapter 4 
demonstrates the separation and detection of individual Aβ peptide aggregates by CE-LIF using 
ThT in the running buffer as the fluorescent probe. It was hypothesized that fluorescence 
anisotropy differences between aggregates could indicate relative size differences between 
separated aggregates (see Chapter 4). Plots of fluorescence anisotropy vs. time showed that 
fluorescence anisotropy due to aggregates and the ThT background [67] were indistinguishable; 
i.e. no fluorescence anisotropy peaks were observed although there were obvious peaks in plots 
of fluorescence vs. time. In order to evaluate if CE-LIFA can be used to differentiate individually 
detected Aβ aggregates, it is important that the fluorescence anisotropy of the aggregates be 
easily distinguishable from the background anisotropy. 
 A close examination of the few CE-LIFA papers available indicated that most papers did 
not include plots of fluorescence anisotropy vs. time [119,121,122,126]. This hinted that other 
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researchers using fluorescence anisotropy for separation detection may have faced the same 
issues that we encountered when plotting fluorescence anisotropy vs. time, i.e. clear fluorescent 
peaks, low background fluorescence, high fluorescence anisotropy background and no observed 
fluorescence anisotropy peaks. We then set out to understand why our anisotropy plots did not 
produce peaks like some examples in the literature [120,127] and how we could better visualize 
the peaks in plots of fluorescence anisotropy vs. time that are evident in the raw fluorescence 
data. 
A simple data treatment method is described here that enables differentiation of 
anisotropies due to fluorescent peaks (peptide aggregates here) and background signals. This 
data treatment method effectively extracts anisotropy peaks from fluorescence anisotropy 
electropherograms that were originally embedded in the background fluorescence anisotropy 
noise. This method allows simple visualization of anisotropy peaks vs. time. 
5.2 Experimental 
5.2.1 Chemicals and Peptide Samples 
The chemicals, solutions and sample preparations used in this study have been described 
in detail in Chapter 4. Tris (hydroxymethyl) aminomethane (Tris) was purchased from Fisher 
Scientific (Fair Lawn, NJ). Thioflavin T (ThT) was purchased from Sigma (St. Louis, MO). 
The electropherograms presented in this work were performed using 10.00 mM Tris 
buffer at pH 7.79. Thioflavin T (15 µM) was included in the running buffer to detect Aβ (1-42) 
aggregates [113]. The Aβ (1-42) peptide sample was prepared as previously described [45,118]. 
The monomer-equivalent concentration of the Aβ (1-42) was measured to be 5.1 µM by HPLC-
UV [44]. Analysis of the sample by TEM, CE-UV and CE-LIF confirmed that the sample 
contained Aβ (1-42) aggregates (see Chapter 4). 
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5.2.2 Capillary Electrophoresis 
Capillary electrophoresis was performed in a fused-silica capillary (ID = 50 µm, OD 366 
µm; Polymicro Technologies, Phoenix, AZ) cut to 60.0 cm total length with a window created at 
23.0 cm from the inlet. The electrophoretic potential was applied across the capillary using a 
Spellman CZE1000R high-voltage power supply (Hauppauge, NY) at 25.0 kV (417 V/cm), 
which produced an electrophoretic current of 5-6 µA. Sample injections were performed for 5 s 
at 25.0 kV. Prior to each injection, the sample was vortexed to suspend any aggregates that could 
have settled to the bottom of the sample vial. 
5.2.3 Laser-Induced Fluorescence Anisotropy Detection System 
The fluorescence anisotropy detection system used here has been described in detail 
previously (see Chapter 4 Figure 4.1). This detector is based on the design reported by Whelan et 
al. [120] and has been modified for the detection of narrow peaks (3-15 ms) due to individual 
aggregates. The beamsplitter cube (10FC16PB.3, Newport Corporation; Irvine, CA) separates 
the fluorescence emission into parallel and perpendicular components relative to the polarization 
of the 445 nm diode laser excitation source (Model No. LDCU12/7532, Power Technology, Inc;  
Alexander, AR). Both emission components were spectrally filtered by a 490 nm bandpass filter 
and 440 nm notch filter. Then the emissions were detected simultaneously and equidistant from 
the capillary by two identical photomultiplier tubes (PMT) (H9306-04, Hamamatsu; 
Bridgewater, NJ). The outputs of the PMTs were filtered by 500 Hz low pass RC filters  and 
collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz. The CE-
LIFA data collection was controlled by a program written in LabView 5.0, and the data were 
analyzed using Origin Pro 7.5 and Microsoft Excel 2007. 
Equation 5.1 was used to calculate the fluorescence anisotropy, r, where I║, and I┴, are 
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the measured parallel and perpendicular fluorescence intensities relative to the polarization of the 
excitation source. The factor G corrects the anisotropy for the differences in sensitivities of the 
two PMTs. For this work, G was empirically adjusted to 1 by optimizing the potentials applied to 
both PMTs so that the responses and sensitivities were equal for a small fluorescent molecule, 
Lucifer Yellow (Molecular Probes, Eugene, OR) over range of concentrations (data not shown). 
The applied potentials for PMT║ and PMT┴ were 1000 and 935 V, respectively. 
r = I∥ − GI1I∥ 2 2GI1 																																																							(5.1) 
5.3 Results and Discussion 
The aggregation of Aβ peptides has been linked to Alzheimer’s disease. The data presented 
here are from a capillary electrophoretic separation of a mixture of Aβ (1-42) peptide aggregates. 
The peptides are non-covalently labeled with the amyloid dye, Thioflavin T (ThT). The peaks in 
the electropherograms presented here are due to individual Aβ (1-42) aggregates. 
Figure 5.1 presents parts of three electropherograms for a sample containing Aβ (1-42) 
aggregates. The individual parallel and perpendicular fluorescence signals are plotted in the 
lower part of the figure (left y-axis), and the fluorescence anisotropy calculated from these 
signals (Equation 5.1) is plotted in the top part of the figure (right y-axis). The fluorescence peak 
in Figure 5.1 is due to an individual Aβ (1-42) aggregate with ThT noncovalently bound to it 
(refer to Chapter 4 for more details). The binding of ThT to Aβ causes an excitation and emission 
spectral shift and enhancement at the wavelengths being using for excitation and detection (440 
and 490 nm) [12,63]. Figure 5.1 shows only 1 of the 178 aggregate peaks that were detected for 
this injection of Aβ (1-42) aggregates. Figure 5.1 shows that the anisotropies of the fluorescence 
due to Aβ aggregates and due to background fluorescence of ThT [67] are indistinguishable, i.e. 
no fluorescence anisotropy peaks are apparent in the plot of fluorescence anisotropy vs. time 
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although fluorescence peaks for I║, and I┴ and their different heights are obvious. The slight 
difference in the background fluorescence signals for ThT is also apparent in Figure 5.1. 
 
Figure 5.1.  Bottom two plots are electropherograms with LIF detection showing an individual 
Aβ (1-42) aggregate peak at 120.65 s (left axis). The dashed plot and dark solid plot are the 
parallel and perpendicular fluorescence emissions, respectively. The lighter solid plot is the 
fluorescence anisotropy, r, calculated from the parallel and perpendicular emissions using 
Equation 5.1 (right axis).  
 
Based on reports in the literature, we expected that fluorescence peaks resulting from the 
Aβ (1-42) aggregates would produce distinguishable peaks in a plot of fluorescence anisotropy 
vs. time [120]. Whelan et al. demonstrated the use of CE-LIFA for affinity assays to monitor the 
fluorescence anisotropy of Gαi1 protein complex formation with BODIPY-GTPγS (BGTPγS) 
[120]. In that work, the fluorescent probe, BODIPY, was included in the electrophoresis buffer, 
similar to ThT in this paper [120]. As shown in Figure 4 of Whelan et al. [120], the parallel and 
perpendicular fluorescence signals of the Gαi1/GTPγS complex were approximately 40 and 25 
RFU above background signals of 35 RFU for both the parallel and perpendicular channels 
[120]. A fluorescence anisotropy peak was clearly observed in plots of fluorescence anisotropy 
vs. time for the Gαi1/GTPγS complex with an intensity of approximately 0.08 above a 
background fluorescence anisotropy of approximately 0.00 [120]. 
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An important difference between the data reported by Whelan et al. and that presented 
here is the heights of the analyte peaks relative to the fluorescence background signal. In Figure 
5.1 of this manuscript for example, the ratios of the Aβ aggregate peak heights to the intensity of 
the background signals for the parallel and perpendicular channels are 11.2 and 10.3, 
respectively. The equivalent ratios observed by Whelan et al. for the Gαi1/GTPγS complex were 
about 1.1 and 0.7 [120]. 
It was hypothesized that uniformly adding an artificial background signal to the data for 
both fluorescence channels, I║, and I┴, prior to calculating the anisotropy might enable 
differentiation of the anisotropies of the aggregate peaks and background, resulting in the 
visualization of anisotropy peaks. This would greatly facilitate visualizing and interpreting 
differences between fluorescence anisotropy of Aβ aggregates and that of the background. 
Adding an artificial signal to all fluorescence data points would have the same effect on the data 
as if ThT were producing a high fluorescence background signal similar to the BODIPY 
background signal observed in the work of Whelan et al. [120]. 
Figure 5.2A shows plots of the original fluorescence data (bottom two traces) and the 
fluorescence data after adding an artificial signal, z, of 0.5 to the original data (top two traces). In 
Figure 2, the ratio of the fluorescence intensity of the Aβ aggregate peak at 121.8 s to that of the 
background for the parallel and perpendicular channels are 7.0 and 8.4, respectively. The added 
value of 0.5 RFU produced a ratio of Aβ peak height:background signal of 1.1 and 0.7, which are 
the same ratios of analyte signal:background signal observed by Whelan et al. [120]. 
Figure 5.2B shows the fluorescence anisotropy before and after the addition of the 0.5 
RFU background signal. In Figure 5.2B, the upper trace is the anisotropy calculated from the 
original fluorescence data, and the lower trace is the anisotropy calculated from the modified 
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fluorescence data. As hypothesized, the addition of the artificial background signal results in a 
relative enhancement of the anisotropy of the aggregate peaks relative to the background 
anisotropy. It is clear that the fluorescence anisotropy peaks correspond in time to the 
fluorescence peaks in Figure 5.2A. 
 
 
Figure 5.2.  (A) Electropherograms with LIF detection showing peaks due to two individual Aβ 
(1-42) aggregates at 121.84 s and 122.02 s. The dashed plot and solid plot are the parallel and 
perpendicular fluorescence emissions, respectively. The bottom two plots are LIF emissions 
without any addition of z, and the top two traces are the LIF emissions after the additions of z = 
0.5. (B) Anisotropy calculated from (A) using Equation 5.1. The lighter solid plot was calculated 
from the unadjusted parallel and perpendicular LIF emissions (lower two traces in (A)). The 
lower darker solid plot was calculated from the parallel and perpendicular LIF emissions after 
the addition of z = 0.5 (upper two traces in (A)). 
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This result can be explained mathematically starting with the Equation 5.1, where r is the 
original anisotropy, i.e. the anisotropy before the fluorescence signals are artificially adjusted. 
Equation 5.1 is used to calculate the anisotropy data plotted in the upper trace of Figure 5.2B. 
Recalling that this method adds a constant artificial signal, z, to all the fluorescence data, the 
modified anisotropy, rm, can be described by Equation 5.2, which can be reduced to Equation 
5.3. Equation 5.3 can be used to calculate the modified anisotropy data, which is plotted vs. time 
in the lower plot in Figure 5.2B. Subtracting Equation 5.3 from Equation 5.1 gives Equation 5.4, 
which is useful for considering the differences observed between the two plots in Figure 5.2B. 
r9 = (I∥ 2 z) − (I1 2 z)(I∥ 2 z) 2 2(I1 2 z)																																									(5.2) 
																																						r9 = I∥ − I1I∥ 2 2I1 2 3z																																																						(5.3) 
 
																																						r − r9 = ; I∥ − I1I∥ 2 2I1< − ; I∥ − I1I∥ 2 2I1 2 3z<																			(5.4) 
 
Only the second term on the right side of Equation 5.4 is dependent on z. For lower 
fluorescence intensities, the z term is more important, and greater differences will result between 
the original and modified anisotropies. Conversely, adding z to higher fluorescence intensities, 
e.g. like those produced by aggregates, has less of an impact on the second term of Equation 5.4, 
which translates to smaller differences between the original and modified anisotropies. 
In general, the anisotropy of the background fluorescence is reduced to a greater extent 
relative to the anisotropy of the Aβ aggregate peaks. After addition of an artificial background 
signal, our data resembles the data obtained by Whelan et al., and peaks become apparent in a 
plot of anisotropy vs. time as shown in Figure 5.2B. The natural background fluorescence in our 
data is due to the fluorescence of unbound ThT, and this fluorescence does have a fluorescence 
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anisotropy value of about 0.2 at the ThT concentrations used in this work. If the background 
fluorescence did not exhibit fluorescence anisotropy, the plot of fluorescence anisotropy vs. time 
would be similar to the upper plot in Figure 5.2B, except it would be centered at 0.0 instead of 
0.2. The high noise in the plot of fluorescence anisotropy vs. time would still largely mask the 
fluorescence anisotropy peaks observed after data modification (bottom plot in Figure 5.2B) 
[67]. The modified fluorescence anisotropy values are not equal to the true (original) anisotropy 
values. Our goal here was to develop a data treatment method that allows better visualize 
fluorescence anisotropy peaks in a plot of fluorescence anisotropy vs. time. Once the peaks of 
interest have been identified with the help of this method, the true anisotropy values can be 
easily calculated using Equation 5.1 for data points at the migration times of interest. 
       
Figure 5.3.  (A) Electropherogram with LIF detection showing an individual Aβ (1-42) 
aggregate at 148.35 s. The dashed plot and solid plot are the parallel and perpendicular 
fluorescence emissions, respectively. (B) Anisotropy plots at varying levels of z (0, 0.5, 1.5, 3.0 
and 5.0) added to the LIF emissions. Note that all the y-axis in Figure 5.3B are the same except 
in the plot where z = 0. 
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The impact of the magnitude of z on the adjusted fluorescence anisotropy was 
investigated. Figure 5.3A shows another time segment of parallel and perpendicular fluorescence 
data from the same electropherogram shown in Figures 5.1 and 5.2. Figure 5.3B shows five plots 
of fluorescence anisotropy vs. time, which were calculated from the fluorescence data in Figure 
5.3A using several values of z (z = 0, 0.5, 1.5, 3.0 and 5.0 RFU). Consistent with Equation 5.3 
and the discussion above, larger z values result in lower fluorescence anisotropy values, and 
fluorescence anisotropy peaks become apparent in the electropherograms. 
The S/N of some of the fluorescence anisotropy peaks were analyzed as a function of the 
magnitude of z. Figure 5.4 shows a plot of the fluorescence anisotropy S/N vs. z for selected 
peaks from the same electropherogram. The S/N values are also presented in Table 5.1. 
 
Figure 5.4.  S/N of four individual Aβ aggregate anisotropy peaks plotted as a function of z. The 
anisotropy values were derived from fluorescence peaks with various S/N values. The diamonds, 
triangles, circles and squares are are anisotropy S/N values from a fluorescence peaks whose 
parallel fluorescence peaks’ S/N values were calculated to be 127, 65, 30 and 15, respectively. 
The S/N values plotted here are tabulated in Table 5.1. 
 
The peaks in Figure 5.4 were selected based on the S/N of their corresponding 
fluorescence peaks prior to any data treatment (S/N = 15, 30, 65, and 127). In general, the S/N 
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values of the anisotropy peaks initially increase as z increases before approaching a limiting 
value. For the peaks examined here, the S/N values of the anisotropy peaks plateau at a 
maximum S/N when z is approximately 10 RFU. The plots in Figure 5.4 show that the maximum 
anisotropy S/N was greater if the corresponding fluorescence peak had a greater S/N. For z = 20 
RFU, the anisotropy S/N values are 5.9, 11.0, 28.8, 48.7 and 142.7 for fluorescence peaks that 
had S/N values of 15, 30, 65, 127 and 323, respectively. The data treatment method resulted in a 
relatively large increase in fluorescence anisotropy S/N.  
Table 5.1. S/N of anisotropy peaks as a function of z (z = 0.5, 1, 1.5, 2, 3, 5, 10, 20 and 35). Data 
shown for 5 different aggregate peaks, whose fluorescence peaks S/N values varied (15, 30, 65, 
127 and 323). All data are plotted in Figure 5.4 with the exception of the data from the 
fluorescence peak with a S/N of 323. 
  z 
0.5 1 1.5 2 3 5 10 20 35 
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15 4.9 5.3 5.5 5.6 5.7 5.8 5.9 5.9 5.9  
(1.2) 
30 7.6 9.0 9.6 10.0 10.3 10.6 10.8 11.0 11.0 
(1.4) 
65 14.1 19.1 21.7 23.2 25.0 26.7 28.0 28.8 29.1 
(2.1) 
127 19.6 28.3 33.1 36.4 40.1 43.7 46.9 48.7 49.4 
(2.5) 
323 29.0 48.7 63.3 74.3 90.4 109.1 129.4 142.7 149.3 
(5.1) 
 
5.4 Conclusions 
A simple and effective data treatment method was described for visualizing fluorescence 
anisotropy peaks in a plot of fluorescence anisotropy vs. time for capillary electrophoresis 
separations of Aβ (1-42) peptide aggregates. The data treatment method revealed fluorescence 
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anisotropy peaks that were masked by the high anisotropy noise of the background signal prior to 
the data treatment. Although this method did alter the fluorescence anisotropy values in the 
peaks, true fluorescence anisotropy values could be easily calculated once peaks of interest had 
been identified and considered. While this data treatment method was applied to CE separations 
with laser-induced fluorescence anisotropy detection, it is equally applicable to other separation 
techniques using fluorescence anisotropy detection. 
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CHAPTER 6 
FLUORESCENCE ENHANCEMENT OF THIOFLAVIN T  
BY POLYSTYRENE BEADS 
 
6.1 Introduction 
Thioflavin T is a benzothiozole fluorescent dye that has been used extensively to study 
amyloid aggregation. After binding to amyloid aggregates, ThT undergoes a red shift for both the 
excitation and emission λmax and an increase in fluorescence signal relative to unbound ThT 
[64,65]. These two characteristics of ThT are often referred to in the literature as “ThT 
enhancement”. Because ThT enhancement has been observed in the presence of several amyloid 
proteins, it is believed that the β-sheet structural motif, which is common to amyloid aggregates, 
is the binding site of ThT.  
The exact cause of ThT enhancement is not well understood. Related hypotheses have 
been that ThT enhancement depends on the torsional angle between the benzylamine and 
benzylthiol rings [12,66]. The underlining idea is that when ThT is bound, the torsional angle 
between its ring structures is rigid and small, i.e. the rings are more coplanar relative to when 
ThT is unbound. This can reduce the HOMO/LUMO gap, resulting in a red shift observed in 
ThT enhancement. This is plausible, and if it is accurate, it is also plausible that ThT 
enhancement could be observed in the presence of other structures that can bind and stabilize the 
coplanar ThT. In fact, bacteria, which can grow readily under the conditions used for Aβ 
aggregation, can bind ThT and produce false positives [39].  
Thioflavin T was used to label and detect hundreds of individual Aβ (1-40) and (1-42) 
aggregates that were separated by capillary electrophoresis (CE) (see Chapter 4). This was 
accomplished by including ThT as a component in the electrophoresis buffer. While establishing 
a baseline, the buffer (with ThT in it) showed irreproducible sharp peaks that mimicked Aβ/ThT 
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peaks. These false-positive peaks could not be deconvoluted from Aβ/ThT. After filtering the 
ThT buffer through a 0.02 µm filter, the number of peaks in the buffer reduced to nearly zero and 
the few random peaks remaining were far less intense. Because filtering reduced the number of 
peaks, it is assumed that the peaks were either due to bacterial growth in the buffer or the 
accumulation of dust particles.  
Importantly, these peaks were not observed in buffer that did not include ThT even 
before filtering. This suggested that whatever was causing the peaks was not itself fluorescent, 
but it could have bound ThT and produced a fluorescent signal. Although we nearly eliminated 
the false positive peaks by filtering, we wanted to develop a better understanding of ThT 
enhancement in the presence of non-amyloid particles because of the potential they have to 
produce false-positives in amyloid studies using ThT. 
This work is a fluorescence spectroscopic study of ThT enhancement by polystyrene (PS) 
beads. Polystyrene beads are ideal analytes for this study because they are uniform in size and 
the concentrations are controllable (unlike amyloid aggregates). Moreover, many sizes of PS 
beads are commercially available. 
6.2 Experimental 
6.2.1 Chemicals 
Polystyrene (PS) beads of different sizes (1072 ± 19, 771 ± 25, 535 ± 10, 356 ± 14, 202 ± 
10, 108 ± 4.5 nm) were purchased from Polysciences (Warrington, PA). Thioflavin T (ThT) was 
purchased from Sigma (St. Louis, MO). Tris(hydroxymethyl) aminomethane (Tris) was 
purchased from Acros (Geel, Belgium) and hydrochloric acid (HCl) was purchased from Fisher 
Scientific (Pittsburgh, PA).  10.00 mM Tris buffer was prepared in ultrapure water (>18 MΩ cm) 
from a Modulab water purification system (United States Filter; Palm Desert, CA) and adjusted 
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to pH 7.80 with HCl. The solutions of PS beads were prepared by mixing required volume of 
stock solution with the 10.00 mM Tris buffer at pH 7.80 filtered twice with a 0.02 µm syringe 
filter (Fisher Scientific; Pittsburgh, PA). All stock solutions were homogenized by vortexing 
prior to use. Dilutions of bead stock solutions were performed directly in microplate well for 
plate reader studies and in cuvette for fluorometer study. 
6.2.2 Plate Reader Study 
Fluorescence of the samples was measured using a BMG Lab Technologies FLUOstar 
430 microplate reader (Offenberg, Germany). Measurements were made from the top of a black 
96 well plate (Corning 3650) (Corning incorporated; Corning, NY) with excitation wavelength 
440±12 nm and emission wavelengths 485± 12 nm. A 60 s orbital shaking of the plate was 
performed prior to the measurement to mix and homogeneous samples.  
Measurements were performed in well mode. Each measurement was the average 
intensity from 100 flashes. Three measurements were made from each well before moving on the 
next well. Each well that contained PS beads with ThT had a corresponding well with the same 
concentration of PS beads without ThT. This allowed any scattered light from PS beads to be 
subtracted from the fluorescence signal. 
6.2.3 Spectrophotometry and Spectrofluorometry 
Absorbance spectra (200 - 800 nm) of all samples and blank solutions in 10.00 mM tris 
buffer at pH 7.80 were determined with a Cary 50 UV-Vis spectrophotometer (Varian; Palo Alto, 
CA) using a 1 cm quartz cuvette. A slit width of 1 nm was used for data collection. Absorbance 
spectra were collected at room temperature, and the blank was subtracted from each spectrum.  
Excitation-emission spectra and EEMs of the samples were determined using a SPEX 
Fluorolog-3 spectrofluorometer (model FL3-22TAU3; HORIBA Jobin Yvon; Edison, NJ) 
  100 
 
equipped with a 450 W Xenon lamp and R928P photomultiplier tube (PMT) detector. Both 
excitation-emission spectra and EEMs were performed at room temperature using a 1-cm quartz 
cuvette and adjusting both excitation and emission slit widths to 5 nm. For the determination of 
EEMs the excitation wavelength was varied from 250 nm to 500 nm in 5 nm intervals, while the 
emission spectra were collected from 350 nm to 600 nm in 2 nm intervals. For the determination 
of excitation spectrum, the emission wavelength was fixed (at 435 or 490 nm) and excitation was 
scanned from 250 nm to 500 nm. Similarly, for the determination of emission spectrum, the 
excitation wavelength was fixed (at 332, 405, or 440 nm) and emission was scanned from 350 
nm to 600 nm. The scanning was at the interval of 1 nm for both excitation and emission spectra.  
For data processing, an inner-filter effect correction was performed on the data for both 
PS bead without ThT and PS bead with ThT. This was accomplished using Equation 6.1, where 
the Fc is the corrected fluorescence, Fobs is the observed fluorescence, i.e. the raw measured 
fluorescence, Abem is the absorbance measured at the emission λ and Abex is the absorbance 
measured at the excitation λ. After the inner filter correction, the scattering was subtracted from 
the fluorescence. The contour plots of EEM data and excitation-emission spectrum were plotted 
using OriginPro 7.5 (Origin Lab; Northapton, MA). 
=	 = >? (@A, 2 @AB)2 																																																						(6.1) 
6.3 Results and Discussion 
6.3.1 Effect of Bead Diameter on ThT Fluorescence 
The interaction of ThT with PS beads is thought to be dependent on the surface area of 
the PS beads similarly to the ThT interaction with the β-sheet motif of the protein aggregates. 
The concentration units, therefore, are reported here as PS bead surface area per volume of 
solution, i.e. µm2/mL. The data in Table 6.1 and Equations 6.2–6.4 demonstrate how these values 
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were determined. The 108 nm PS beads will be used to briefly explain the equations. For the 108 
nm PS beads, the surface area per bead, Ab, was calculated using Equation 6.2, where C is the 
PS bead diameter. The number of beads per volume, Nv, was determined using Equation 6.3, 
where w is the grams of polymer per mL of solution (provided by PS bead manufacturer), ρ is 
the density of the polymer (g/mL) (provided by PS bead manufacturer), V is the volume of PS 
bead solution prepared. Equation 6.4 is used to convert from number of beads per mL to total 
surface area per mL, AT. 
Table 6.1. Volume of beads needed to obtain a PS bead concentration of 1.26 × 108 µm2/mL for 
each PS bead. 
Bead Diameters, C (nm) 
Surface Area per 
Bead,  
Ab (µm
2
) 
Number of Beads 
per Volume, NV 
(N/mL)* 
Total Surface 
Area per Volume, 
AT (µm
2
/mL) 
Volume of Bead 
Solution Used 
(µL) ‡ 
108 3.67 × 10-2 3.75 × 1013 1.38 × 1012 2.3 
202 1.28 × 10-1 5.78 × 1012 7.41 × 1011 4.2 
356 3.98 × 10-1 1.09 × 1012 4.33 × 1011 7.2 
535 9.00× 10-1 3.17 × 1011 2.85 × 1011 10.9 
771 1.87 1.04 × 1011 1.94 × 1011 16.6 
1072 3.61 3.90 × 1010 1.41 × 1011 23.5 
* Based on manufacturer’s percent weights. 
‡ This was the volume used of a 100-fold dilution of the manufacturer’s stock solution to obtain 
1.26 × 10
8
 µm
2
/mL in a total of 250 µL for the plate reader study. 
 
@> = 4D *E2-
 																																																																							(6.2) 
                                                 
FG =	6H10JKELD) 																																																																							(6.3) 
 
 @M = @> 	× FG																																																																							(6.4) 
 
Figure 6.1 demonstrates the effect of PS bead diameter on ThT fluorescence for two 
different concentrations, 1.26 × 109 µm2/mL (A) and 1.26 × 108 µm2/mL (B). Six PS bead 
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diameters were tested, and first column in Table 6.1 lists the bead diameters used. 
 
Figure 6.1.  Fluorescence of 15 µM ThT in the presence of PS beads of different sizes. The 
fluorescence was measured using a plate reader and a 96-well plate (excitation: 440 nm, 
emission: 485 nm). Two graphs are for two different PS bead concentrations (1.26×109 µm2/mL 
and 1.26×108 µm2/mL). Concentrations are reported as bead surface area per mL. 
 
A maximum fluorescence is reached that appears to be related to bead diameter and 
concentration. For both concentrations, the intensity of the maximum fluorescence is 
approximately 3-fold that of the intensity of the smallest bead size tested. The bead diameter at 
which the maximum fluorescence is reached is 202 nm for 1.26 × 109 µm2/mL (Figure 6.1A) and 
535 nm for the 1.2 × 108 µm2/mL (Figure 6.1B). More smaller beads are needed to attain the 
same µm2/mL compared to larger beads. For example, 8.63 × 1010 beads/mL of the 108 nm 
beads are needed to attain a surface area per volume of 1.26 × 108 µm2/mL, while 3.46 × 109  
beads/mL of the 535 nm beads are needed to attain the same 1.26 × 108 µm2/mL. A higher 
number of beads/mL could result in the beads being packed more closely together. Also, the 
greater number of beads/mL could cause the beads to aggregate in solution. Either of these 
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possibilities could effectively reduce the available surface area of the beads for binding ThT and 
would explain the lower ThT fluorescence intensity for the smaller beads relative to larger beads. 
Larger beads will not pack so tightly, so more bead surface area is available for binding ThT. A 
related effect has been suggested to explain the decrease in ThT intensity in the presence of Aβ 
fibril formation that is followed by the initial ThT increase and plateau [39]. It is suggested that 
Aβ fibrils can stack on top of each other forming a mat-like motif, which effectively reduces the 
binding sites available for ThT binding; hence, a reduction in ThT intensity is observed [39]. 
6.3.2 Effect of Bead Concentration on ThT Fluorescence 
The data in Figure 6.1 show that the overall fluorescence intensity is approximately 1 
order of magnitude greater for the 1.26 × 109 µm2/mL concentration versus the 1.2 × 108 
µm2/mL concentration. This observation indicates that PS bead concentration has an impact on 
the ThT fluorescence intensity. Based on the results in Figure 6.1, two PS bead diameters (108 
and 535 nm) were selected to further investigate the effect of PS bead concentration on ThT 
fluorescence. The 108 and 535 nm PS beads were selected based on the fact that in Figure 6.1, 
they covered the range of minimum and maximum ThT fluorescence for both concentrations. 
The concentrations studied are listed in the caption of Figure 6.2.  
Figure 6.2 shows that the ThT intensity as a function of concentration is drastically 
different for the 535 nm PS beads (A) versus the 108 nm PS beads (B). The data for the 535 nm 
PS beads suggest that even for the highest concentration of PS beads tested, a maximum ThT 
intensity is not reached. This is in stark contrast to the data for the 108 nm PS beads, which 
indicate that a maximum ThT is reached. The data in Figure 6.2 also support the hypothesis that 
bead packing may play a role in the amount of bead surface area for ThT to bind as described in 
section 6.3.1. 
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Figure 6.2. Fluorescence of 15 µM ThT in the presence of 535 nm (●) and 108 nm (■) PS beads 
as a function of bead concentration (µm2/mL). Bead concentrations are 1.26 × 105, 1.26 × 106, 
1.26 × 107, 1.26 × 108, 6.92 × 108, 1.26 × 109, 4.08 × 109, 6.92 × 109, 9.72 × 109, 1.26 × 1010 
µm2/mL. Fluorescence measurements were performed according the procedure described in the 
experimental section. 
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6.3.3 ThT Enhancement: PS Beads Are Similar to Aβ 
All the data described in sections 6.3.1 and 6.3.2 were collected on a fluorescence plate 
reader at excitation and emission wavelengths of 440:485 nm. These wavelengths are the 
enhanced ThT maximum wavelengths described in the literature for the interaction of ThT with 
amyloid fibrils [63].  It is clear from the plate reader data that PS beads do induce ThT 
fluorescence at these wavelengths over the range of 108–1072 nm.  
Excitation/emission matrix (EEM) data were also collected to determine the enhanced 
λmax of ThT in the presence of PS beads. For this study, a spectrofluorometer was used, which 
scans the defined wavelengths of interest using monochromators. This is clearly advantageous 
over the plate reader, whose wavelengths were rigidly defined by bandpass filters. In addition to 
indicating the ex:em λmax, another advantage of EEM measurements is that it can indicate 
whether any additional interesting ex:em fluorescence wavelengths result from the interaction of 
ThT with PS beads.  
Figure 6.3 shows EEMs for unbound 15 µM ThT (A), 15 µM ThT in the presence of Aβ 
(1-40) fibrils (B), 15 µM ThT in the presence of 1.26×108 µm2/mL 535 nm PS beads (C) 15 µM 
ThT in the presence of 1.26×108 µm2/mL 108 nm PS beads (D). The Aβ (1-40) fibril sample was 
confirmed to contain fibrils in another published study [118]. After that study the Aβ sample was 
frozen at -80°C until thawed for this study. Figure 6.3A shows only a single peak at for ThT at 
ex:em 332:440 nm. In the presence of Aβ fibril, ThT enhancement is observed with a new ThT 
peak emerging at ex:em 440:490 nm (Figure 6.3B). These wavelengths are consistent with those 
reported by LeVine et. al. for Aβ-bound ThT enhancement [63]. Moreover, unbound ThT can 
also be observed in Figure 6.3B, which indicates that not all the ThT is bound to Aβ. Figures 
6.3C and 6.3D illustrate that the 535 and 108 nm PS beads exhibit ThT enhancement at ex:em 
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405:490 nm. The excitation λmax of ThT in the presence of PS beads (405 nm) is not perfectly 
aligned with that for Aβ-bound ThT (440 nm). The emission λmax for ThT in the presence of PS 
beads and Aβ are the same. The EEM data presented in Figure 6.3 clearly demonstrate that PS 
beads can be a source of interference when studying Aβ aggregates with ThT at ex:em 440:490 
nm. 
 
 
Figure 6.3.  Contour plots of EEM of 15 µM ThT (A), 15 µM ThT in the presence of Aβ fibrils 
(B), and 15 µM ThT in the presence of 1.26×108 µm2/mL 535 nm beads (C), 15 µM ThT in the 
presence of  1.26×108 µm2/mL 108 nm PS beads (D). All samples were in 10.0 mM tris buffer at 
pH 7.80. 3.00mL of sample were placed in a in a 1.0 cm quartz cuvette for measurements. Inner 
filter correction was performed before plotting the data.  
 
6.3.4 Excitation and Emission Scans of ThT as a Function of Bead Concentration 
The goal of this part of study was to evaluate the excitation-emission spectra as a 
function of PS bead concentration at selected wavelengths observed in the contour plots of EEMs 
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in Figure 6.3. The wavelengths of interested selected from the EEMs where 332 nm, 405 nm, and 
440 nm for the excitation and 435 nm and 490 nm for the emission. Emission spectra were 
collected with the excitation at 332 nm, 405 nm, and 440 nm. Similarly, excitation spectra were 
collected with the emission at 435 nm and 490 nm. Initially, the goal was to analyze a larger 
range of concentrations of both 108 nm and 535 nm beads as in microplate reader studies 
(1.26×105 µm2/mL to 1.26×1010 µm2/mL). Due to the high inner filter effect at higher 
concentrations and insignificant change in the fluorescence of ThT at lower concentrations this 
was not possible. After evaluation of several sets of experiments the range of concentrations 
studied was between 1.26×107 µm2/mL and 1.26×108 µm2/mL for the 535 nm PS beads and 
between 1.26×108 µm2/mL and 1.26×109 µm2/mL for the 108 nm PS beads.  
The study of the mixtures of PS beads and 15 µM ThT using a fluorometer showed an 
increase in fluorescence signal of ThT with the increase in concentration of beads. The data are 
illustrated in Figure 6.4. It is clear in Figure 6.4 that other than intensity the emission spectra are 
not affected by concentration, i.e. no additional emission peaks are observed as a function of PS 
bead concentration 
Figure 6.4A shows emission spectra of mixtures of 15 µM ThT and different 
concentrations of 535 nm PS beads between 1.26 ×107 µm2/mL and 1.26×108 µm2/mL with the 
excitation at 440 nm. The bead concentration was added in equal steps of 3.88×107 µm2/mL as 
discussed in the figure caption. There is an increase in the fluorescence of ThT with the addition 
of 535 nm beads. The increase in ThT fluorescence as a function of PS bead concentration is 
plotted in the inset of Figure 6.4A, where the fluorescence value is the apex, or λmax of the 
emission intensity. An exponential fit provided the highest correlation coefficient (R2 = 0.989) 
between the ThT fluorescence and PS bead concentration. A linear fit resulted in an R2 = 0.957. 
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Figure 6.4B shows emission spectra of mixtures of 15 µM ThT and different concentrations of 
108 nm diameter beads between 1.26×108 µm2/mL to 1.26×109 µm2/mL with the excitation at 
440 nm. Note that the concentration of 108 nm PS beads used for the experiment is one order of 
magnitude higher than the concentration of 535 nm PS beads. This is because initial experiments 
showed only negligible changes in ThT fluorescence with PS bead concentration. The bead 
concentration was added in equal steps of 3.88×108 µm2/mL. The inset of Figure 6.4B shows that 
the relationship of ThT fluorescence versus PS bead concentration is linear (R2 = 0.998). 
 
          (C)   Legend for Figure 6.4 (A) and (B). 
Line Style 
Concentration of PS Beads (µm
2
/mL) 
535 nm PS Bead 108 nm PS Bead 
Dash/Dot 1.26×107 1.26×108 
Dot 5.03×107 5.03×108 
Dash 8.80×107 8.80×108 
Solid 1.26×108 1.26×109 
 
Figure 6.4.  Fluorescence emission spectra of of 15 µM ThT in the presence of 535 nm PS beads 
(A) and 108 nm PS beads (B) over a 1 order magnitude range in concentrations (surface 
area/mL). Excitation was performed at 440 nm. Inner filter correction was performed before 
plotting the data. For both (A) and (B) the initial mixture of PS beads was prepared in 10 mM tris 
buffer at pH 7.8 with 15 µM ThT in a 1 cm quartz cuvette. To increase the concentration of PS 
beads in the cuvette, subsequent additions of PS beads were pipetted directly into the cuvette. 
For the 535 nm PS beads, equal steps 4.0 µL of 2.91×1010 µm2/mL was added, which equals 
3.88×107 µm2/mL step in concentration. Likewise, for the 108 nm PS beads 4.0 µL of 2.91×1011 
µm2/mL was added, which equals 3.88×108 µm2/mL step in concentration. A legend is provided 
in (C) below figures (A) and (B), which list the PS bead concentrations. The insets in (A) and (B) 
plot the intensities of the em λmax versus concentration. 
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6.4 Conclusions 
This work demonstrated that PS beads can induce Thioflavin T fluorescence 
enhancement similarly to Aβ. Polystyrene beads were used as a model system here because their 
sizes and concentrations could be carefully controlled. It was shown that the intensity of ThT 
increases with increasing PS bead diameter, and a maximum fluorescence was reached over the 
PS bead sizes studied. In general, the magnitude of the ThT intensity increased with increasing 
concentration of PS beads; however, this relationship is not necessarily linear and depends on 
both PS bead diameter and PS bead concentration range. 
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CHAPTER 7 
ANALYSIS OF Aβ (1-40) PEPTIDE AGGREGATION BY CAPILLARY 
ELECTROPHORESIS WITH LASER-INDUCED FLUORESCENCE ANISOTROPY 
DETECTION 
 
7.1 Introduction 
 
The development and progression of Alzheimer’s disease (AD) and other 
neurodegenerative diseases have been linked to aggregation of amyloidogenic peptides. Soluble 
monomeric amyloid peptides self-aggregate under physiological conditions to form aggregates 
ranging vastly in size and structure. The level of neurodegenerative toxicity has been suggested 
to be related to the size and structure of Aβ aggregates, but it is not clear what size/structure is 
most toxic. It has also been suggested that the most toxic forms of Aβ are intermediate in size 
between monomer and fully-formed fibrils [13,27,35,36]. 
Developing methods to monitor intermediate species between monomers and fully-
formed fibrils is extremely challenging. Methods that are commonly used to study monomers or 
fully-formed fibrils do not work well for studying intermediate-sized structures. For example, 
mass spectrometry has been used to study monomers, but ionizing aggregates without breaking 
apart their structures is a problem. Thioflavin T fluorescence is a powerful analytical tool for 
studying fully-formed fibrils and their rates of formation but is less effective at monitoring Aβ 
structures that are smaller than fully-formed fibrils, especially monomers. Moreover, a minimum 
size or structure of Aβ for ThT binding is not clear. Other examples include TEM imaging and 
light scattering which are effective for studying fully-formed fibrils but less effective for 
structures smaller than fully-formed fibrils.  
An underlying hurdle for Aβ analysis is that multiple methods are needed to study the 
vast sizes, structures and numbers of Aβ species present in an aggregating Aβ mixture. 
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Complicating matters further is that intermediates Aβ structures are short-lived transient and 
dynamic species. Very little is known about these structures because they are unstable relative to 
fibrils and monomers making it difficult to sample and study. 
Capillary electrophoresis (CE) has been shown to be a powerful tool for Aβ analysis 
[45,77,93,118]. Monomeric and aggregated peptides have been separated by CE-UV for both Aβ 
(1-40) and Aβ (1-42) isoforms [45,118]. Previous studies in our laboratory [128] and by Kato et 
al. [113] demonstrated that capillary electrophoresis with laser-induced fluorescence detection 
could be used study the aggregation of Aβ peptides. Both of these studies used thioflavin T in the 
separation buffer to label Aβ aggregates. In Chapter 4, it was demonstrated that CE with laser-
induced fluorescence (LIF) detection can resolve individual Aβ aggregates using Thioflavin T as 
a fluorescence probe. In that same chapter, LIF anisotropy (LIFA) was introduced to size 
characterize the individually detected Aβ aggregates; however, no anisotropy differences were 
detected for different Aβ aggregates using ThT as a fluorescence probe. Another problem was 
that the background ThT anisotropy and Aβ aggregate anisotropy were indistinguishable. It was 
hypothesized that the unpredictable binding ratio and unknown binding mechanism of ThT to Aβ 
aggregates could have been a partial cause for not observing any anisotropy differences between 
aggregates and between aggregates and the background. 
 In this work, a covalently labeled Aβ (1-40) peptide with carboxyfluorescein (FAM) was 
investigated using CE-LIFA to determine whether different forms of Aβ could be differentiated 
based on their relative fluorescence anisotropy (FA) values. By using a covalently labeled Aβ 
peptide, all forms of Aβ from monomers to fully-formed fibrils will be fluorescently labeled. 
This is distinct from the work in Chapter 4 where ThT was used to noncovalently label some of 
the Aβ structures in an unpredictable manner. In addition to using covalently labeled Aβ 
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peptides, this work is distinct from the previous work in Chapter 4 because the FAM-Aβ peptide 
is sampled and analyzed during its incubation while aggregating over several days. The goal of 
analyzing the aggregating mixture over time is to attempt to detect transient Aβ species that are 
intermediate between monomers and fully-formed aggregates. 
7.2 Experimental 
7.2.1 Chemicals 
All solutions were prepared in 18 MΩ water obtained from a Modulab water purification 
system (United States Filter Corp.; Palm Desert, CA) unless otherwise noted. Phosphate buffered 
saline (PBS), Tris (hydroxymethyl) aminomethane (Tris) and methanol (99.8%) were purchased 
from Fisher Scientific (Fair Lawn, NJ). Phosphate buffered saline contained 22.8 mM phosphate, 
274 mM  NaCl, 5.4 mM KCl and 0.1% NaN3 at pH 7.4. Tris buffer was prepared at 10.00 mM, 
and the pH was adjusted to 7.80 with HCl. This Tris buffer was used for all experiments unless 
otherwise noted. The buffer was filtered through a 0.02 µm filter (Whatman; Hillsboro, OR). 
Mesityl oxide (MO) was purchased from Alfa Aesar (Ward Hill, MA), and working solutions of 
MO were prepared in Tris buffer at a concentration of 0.2% (v/v). Coumarin 334 was purchased 
from Acros Organics (Morris Plains, NJ), and a stock solution was prepared at 1.00 µM in 
methanol. Working solutions of coumarin 334 were prepared at 100 nM in Tris buffer. 
7.2.2 Aβ Sample Preparation and Characterization 
Unlabeled Aβ (1-40) peptide was purchased from the W.M Keck Foundation 
Biotechnology Research Laboratory (Yale University, New Haven CT). Carboxyfluorescein 
labeled Aβ (1-40), i.e. FAM-Aβ (1-40), was purchased from Anaspec Inc. (Fremont, CA). Each 
Aβ peptide monomer is covalently labeled with a single carboxyfluorescein on the first aspartic 
acid (D) on the amine terminus of the peptide chain. Arctic Aβ (1-40) was purchased from 
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BioSource. Arctic Aβ (shown below) is a variant of the normal Aβ (1-40) peptide by 
replacement of the glutamic acid (E) at position 22 in the peptide chain with Glycine (G). All 
peptides were stored with desiccant at -80 °C until used.  
 V VG G  V M LG  I I AG K  N S G V D EA  F F V LK  Q H H V E YG  S D H R F EA  D-FAM
4035302520151051
 
All monomeric peptide solutions were prepared independently in PBS buffer, and the 
targeted, total concentration of Aβ used for aggregation studies was 20 to 25 µM [45,118,128]. 
After the monomeric peptide solutions were prepared, the Aβ monomer concentration of each 
solution was determined by HPLC-UV. Monomer preparation and analysis have been described 
in detail previously [45,118]. After the concentrations were determined, the FAM-Aβ peptide 
was mixed at a mass ratio of 1:4 or 1:1 with either unlabeled Aβ (1-40) or Arctic Aβ (1-40), 
respectively, to give a final total monomeric equivalent Aβ concentration between 20 and 25 µM. 
The total volume of each mixture was 1 mL. The mixed monomeric Aβ peptides were then 
incubated at 37°C and ambient pressure during the aggregation studies. 
In order to remove aliquots of sample for analysis during aggregation, the sample was 
removed from the incubator and lightly vortexed to homogenize the mixture and suspend any 
aggregates that may have settled to the bottom of the centrifuge tube. A 200 µL aliquot of the 
sample was removed from the mixture to analyze, and the remaining portion of the mixture was 
returned to incubator to continue aggregating. The 200 µL aliquot was buffer exchanged from 
PBS buffer into the Tris buffer at pH 7.80 for CE analysis [59]. To perform the buffer exchange, 
the sample was placed in a 3000 molecular weight cutoff Microcon filter cartridge and 
centrifuged at 14,000 rpm (approximately 20,000 g) at 4° C for 60 min. The retained portion of 
the sample was resuspended in Tris buffer. This process was performed until the theoretical 
volume % PBS was below 5%, which typically required 3 cycles of centrifuging. Next, the 
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Microcon filter was inverted into a clean centrifuge tube and spun at 3000 rpm for 1 min to 
collect the Aβ sample. This sample was transferred to a 200 µL thermowell polypropylene tube 
(Corning Incorporated; Corning, NY) and put on ice until CE analysis, which was performed 
approximately 2 hr after completing the buffer exchange. 
To minimize photobleaching of the fluorophore-labeled peptide during sample 
preparation and prior to CE analysis, exposure of samples to ambient light was minimized during 
the all stages of the sample handling, including incubation, sampling, buffer exchanging and 
analysis. This was accomplished by keeping the sample container wrapped in aluminum foil 
when possible and reducing the ambient light. 
7.2.3 Capillary Electrophoresis with Laser-Induced Fluorescence Anisotropy Detection 
Prior to CE-LIFA, samples were characterized by CE-UV [45,118] using a Beckman 
Coulter PACE MDQ equipped with a diode array detector. Samples were then analyzed 
immediately with a lab-constructed CE-LIFA instrument. The LIFA detector used for this work 
was described in detail previously [128] and is based on a design published by [120]. Excitation 
was carried out using a polarized diode laser with and excitation wavelength and laser power of 
445 nm and 1.63 mW, respectively. For the detection system used in this work, the 490 nm 
emission bandpass filter used previously for thioflavin T detection [128] was replaced with a 560 
nm emission bandpass filter better suited for detection of emission of the fluorescein label. The 
parallel and perpendicular fluorescence emissions were collected simultaneously by two separate 
photomultiplier tubes (PMT). The outputs of the PMTs were filtered by 500 Hz low pass RC 
filters and collected by a National Instrument PCI-6024E DAQ board at a scan rate of 1000 Hz. 
The fast data collection was necessary for detecting peaks from individual Aβ fibrils that 
typically have peak widths of 3-15 ms at FWHM [128]. The CE-LIFA data collection was 
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controlled by a program written with LabView Version 5.0, and the data were analyzed using 
Origin Pro and Microsoft Excel. 
The fluorescent neutral marker (coumarin 334) was injected prior to the Aβ sample 
injection. This injection order minimized potential interactions between Aβ and the neutral 
marker because all forms of Aβ detected migrated slower than the neutral marker. Injections 
conditions are given in the figure captions. The Aβ samples were vortexed prior to every 
injection to suspend any aggregates that could have settled to the bottom of the sample vial. The 
electrophoretic potential was applied using a Spellman CZE1000R high-voltage power supply 
(Hauppauge, NY) at 25.0 kV (417 V/cm). The electrophoretic current was 5-6 µA. 
7.2.4 Data Analysis 
The dual channels of the detection system allowed the parallel and perpendicular 
fluorescence emission relative to the polarization of the laser source to be measured 
simultaneously. The measured fluorescence intensities were used to calculate the fluorescence 
anisotropy according to Equation 7.1, where r is the fluorescence anisotropy and I║ and I┴ are the 
measured parallel and perpendicular fluorescence intensities relative to the polarization of the 
excitation source, respectively. The factor G corrects for differences in responses and 
sensitivities between the two PMTs. For this work, the voltages applied to both PMTs were 
adjusted so that G was as close to 1 as possible. This was done by using a dilute solution of 
coumarin 334 (50-100 nM), which is expected to have an FA near 0 because of its small size and 
fast rotational diffusion rate.  After adjusting the G-factor empirically to as close to 1 as possible, 
some day-to-day variability was observed in the coumarin 334 fluorescence anisotropy values. 
To correct for this, the average G-factor per day was calculated using Equation 7.2, where the 
intensities are those from coumarin 334. This G-factor was used in the Equation 7.1 to calculate 
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the fluorescence anisotropy of all the peaks in the electropherograms from that day.   
r =
.∥ − 0.1.∥ 2 20.1 																																																																								(7.1) 
	G = .∥.1 																																																																																				(7.2) 
Fast data collection (1000 Hz) was used because of the narrow peak widths due to 
individual, large Aβ aggregates, which produce peaks that are only ~ 10 ms wide [82,106,128]. 
The fast data collection causes fast random fluctuations in measured signals. These random 
fluctuations do not occur equally in both the parallel and perpendicular channels; therefore, the 
fluorescence anisotropy can be drastically different from one time point to the next based on 
these random fluctuations. To reduce the impact that the random fluctuations could have on the 
calculated FA of the narrow (~10 ms) Aβ fibril peaks, the FA was averaged over the FWHM of 
the fibrils’ fluorescence peaks. For broad peaks due to coumarin 334 and Aβ monomer and 
intermediate peaks, the FA was averaged over 100 ms at the apex of the peak. 
7.3 Results and Discussion 
Previous studies have demonstrated that CE-LIF with ThT in the separation buffer can be 
used successfully for analysis of Aβ peptide aggregation [113] and detection of individual Aβ 
aggregates [128]. Our work also explored the potential of this approach with LIFA detection 
[128,129]; however, different Aβ aggregates detected with ThT labeling did not exhibit distinct 
fluorescence anisotropy values. Another limitation of labeling with ThT is that only some larger 
Aβ aggregates will produce enhanced fluorescence [4,12,63]. In this study, the aggregation of 
Aβ (1-40) with a covalently attached fluorophore was carried out using CE-LIFA. The objective 
of this study was to determine if significant differences in FA could be measured for different 
aggregate types by CE-LIFA. The Aβ (1-40) peptide was labeled with carboxyfluorescein on the 
  117 
 
first aspartic acid (D) on the amine terminus of the peptide chain, and all forms of this peptide 
should produce a fluorescence signal. A mixture of this labeled peptide with unlabeled Aβ (1-40) 
was analyzed by CE-LIFA at different times during the aggregation process. 
7.3.1 Aggregation of Aβ (1-40) 
Figures 7.1-7.3 present CE-LIF electropherograms for an aggregating mixture of FAM-
Aβ (1-40) and unlabeled Aβ (1-40) mixed at a mass ratio of 1:4 (FAM labeled:unlabeled) at days 
0, 4 and 6 during aggregation. Only one data channel (parallel polarization) for the CE-LIFA 
experiments is plotted in Figures 7.1, 7.2A and 7.3 for clarity. Corresponding electropherograms 
for the same samples by CE-UV are shown in Appendix A (Figure A.5). The main objective of 
sampling and analyzing the aggregating Aβ sample at different days was to attempt to detect Aβ 
aggregates exhibiting distinct FA values intermediate between monomers and fully-formed 
fibrils. Figure 7.1 shows that on day 0, only the neutral marker peak at 64.0 s and a monomer 
peak at 94.7 s were observed, as expected. The CE-UV data did not indicate the presence of any 
aggregated species (Appendix A: Figure A.5A).  
 
Figure 7.1. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ 
(1-40) peptide sampled on day 0.The main peaks are the neutral marker (NM) peak coumarin 
334 at 64.0 s and the FAM-Aβ monomer peak at 94.7 s.  
  118 
 
 
 
Figure 7.2. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ 
(1-40) peptide sampled on day 4. (A) Single channel data (parallel channel). The neutral marker 
(NM)and FAM-Aβ (1-40) monomer peaks are labeled. Sharp peaks following the monomer peak 
are due to large Aβ aggregates. In (B) and (C) the perpendicular and parallel channels are plotted 
in grey and black, respectively. (B) Expanded view of a broad peak at 112 s thought to be due to 
an intermediate sized Aβ aggregate. (C) Expanded views of 3 large Aβ aggregate peaks detected 
individually. The x-axes in (C) are 100 ms for each plot. 
 
The FA value for the monomer peak shown in Figure 1 was 0.019, and the FA value for 
coumarin 334 was -0.001. The molecular weight of the labeled Aβ monomer, and coumarin 334 
are 4689.2 g/mol and 283.3 g/mol, respectively. The measured FA values are consistent with the 
relative sizes of the two molecules. Fluorescence anisotropy is capable of discerning size 
differences between different fluorescent species in solution based on their rotational diffusion 
rates. In general, larger species have smaller rotational diffusion rates and exhibit larger 
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fluorescence anisotropy values as indicated by the Perrin Equation shown in Equation 7.3, where 
D is the rotational diffusion coefficient, rₒ, is the fundamental anisotropy and τ is the fluorescence 
lifetime. The fundamental anisotropy is dependent on the angle between the absorption and 
emission transition dipoles of the fluorophore [69]. 
 
 = 	 1 2 645																																																																																	(7.3) 
 
Figure 7.2A shows an electropherogram for the same aggregating mixture sampled on 
day 4. In Figure 7.2A, the FAM-Aβ monomer peak is at 94.7 s. The day 4 electropherogram 
includes 12 narrow peaks between 100–120 s with an average FWHM = 12 ms. These peaks are 
not present in the day 0 sample and are consistent with peaks observed in our earlier studies and 
attributed to individual Aβ aggregates [128]. That work used ThT in the separation buffer for 
fluorescence detection.  
Figure 7.2B shows one of the most interesting features of this electropherogram, a 
relatively broad peak (FWHM ~ 2 s) with a migration time of 112 s that was not detected in the 
day 0 sample. The broad shape of this peak and its migration relative to the monomer peaks 
suggests that this peak could be to an aggregate peak that is small relative to the structures that 
can be detected individually as narrow peaks (FWHM =12 ms) [45,118,128]. If this peak is an 
aggregated form of Aβ (1-40), it should exhibit a FA value greater than that of the monomer 
peak. Both fluorescence channels are plotted in Figure 7.2B (parallel and perpendicular 
polarization), and the peak does exhibit fluorescence anisotropy. The average FA value for 5 
injections of this sample was 0.063 ± 0.015, while the average value for monomer was 0.018 ± 
0.001 (Table 7.1). 
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Table 7.1. Summary of fluorescence anisotropy results for Aβ mixtures.   
Aβ Samples Coumarin  Monomer Intermediate Fibril 
FAM:Unlabeled 
(n = 5) 
0.000 ± 0.007 
 
0.018 ± 0.001 
 
0.063 ± 0.015 
 
0.100 ± 0.020 
(43 peaks) 
FAM:Arctic  
(n = 3) 
0.000 ± 0.002 
 
0.020 ± 0.001 
 
0.095 ±0.002 
 
0.093 ± 0.029 
(40 peaks) 
 FAM:Unlabeled Aβ sample data are averaged from 5 injections 
 FAM:Arctic Aβ sample data are averaged from 3 injections 
 
 
Figure 7.3. CE-LIF electropherogram of a 1:4 mixture of FAM-Aβ (1-40) peptide:Unlabeled Aβ 
(1-40) peptide sampled on day 6.  
 
This intriguing peak is not present in the electropherogram for the day 6 sample (Figure 
7.3). The electropherogram has a monomer peak at 94.4 s and 13 narrow aggregate peaks 
between 100-120 s. These peaks are similar in shape to the narrow peaks in Figure 7.2A, but they 
are clearly more intense, on average. These data are consistent with the identification of the 
broad peak in Figure 7.2A as a relatively small Aβ aggregate, and the narrow peaks in Figures 
7.2A and 3 as larger aggregates detected individually. It is not surprising that a small Aβ 
aggregate would disappear as the aggregation proceeded towards larger structures. The presence 
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of large aggregates that produce narrow peaks would not be expected at day 0. These peaks 
increased in number from day 4 (9 peaks averaged from 5 injections) to day 6 (31 peaks 
averaged from 3 injections), and their intensities increased – consistent with Aβ fibrils that are 
continuing to grow in size and number. 
Figure 7.2C shows parts of the electropherogram from the day 4 sample with both 
fluorescence channels plotted. Clearly these narrow peaks exhibit significant FA. The average 
FA value for all 43 of the narrow peaks detected from 5 injections of the day 4 sample was 0.100 
± 0.020 (Table 7.1). These FA data are plotted as a histogram in Figure 7.4A to take advantage 
of the additional distribution information provided. The FA values for these narrow peaks are 
larger and distinct compared to the values for the monomer peak and peak shown in Figure 7.2B 
(Table 7.1). Figure 7.4B is a histogram of the FA of the narrow peaks detected on day 6. The 
average FA value for all 63 of the narrow peaks detected from 3 injections of the day 6 sample 
was 0.101 ± 0.023, and a Gaussian distribution is observed. 
  
Figure 7.4. Fluorescence anisotropy histograms of narrow peaks detected from the 1:4 mixture 
of FAM-Aβ (1-40) peptide:Unlabeled Aβ (1-40) peptide sampled on days 4 (A) and day 6 (B). In 
both (A) and (B), bin = 0.01. In (A), 43 peaks are represented from 5 injections. In (B), 63 peaks 
are represented from 3 injections. 
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These experiments were repeated with sampling at days 0, 2, 3 and 6. The primary aim of 
the increased number of samples taken during the early stages of aggregation was to increase the 
probability of detecting the apparently transient peak shown in Figure 7.2B. This peak was not 
observed despite the increase in sampling frequency. The CE-LIFA experiments and 
corresponding CE-UV experiments did indicate that aggregation to place to form large Aβ 
aggregates as expected (data not shown). This result is not unexpected. Other reports in the 
literature indicate the appearance of relatively stable Aβ aggregates of intermediate size indicate 
that they are short lived, found at low concentration and are not observed in all experiments [83]. 
At this point it was decided that it would be wise to change to an Aβ aggregation experiment 
known to produce higher concentrations of more stable intermediate aggregates. 
7.3.2 Aggregation of Mixtures of Aβ (1-40) and Arctic Aβ (1-40) 
Arctic Aβ is a variant of wild type Aβ where Glu22 is replaced by Gly. This single amino 
acid mutation has been shown to promote and stabilize the formation of smaller soluble Aβ 
aggregates, such as oligomers and protofibrils, which are thought to play a pathogenic role in AD 
[83,105]. Arctic Aβ has been used to study the structure of these species [83,105,130-133]. To 
further investigate whether intermediate Aβ aggregates between monomers and fully-formed 
fibrils could be analyzed be CE-LIFA, monomeric FAM-Aβ (1-40) peptide was mixed with 
monomeric Arctic Aβ (1-40) at a mass ratio of 1:1 to increase the stability of intermediate 
aggregates; thereby increasing the chance of detecting intermediate species. This Aβ mixture was 
sampled on days 1, 2, 3, and 6.  
Figure 7.5 shows LIF electropherograms from days 2, 3, and 6. The day 1 LIF 
electropherogram and CE-UV electropherograms for all 4 days are included in Appexdix A 
(Figures A.6A-E). Compared to the experiments shown in Figures 7.1-7.3, the distance from the 
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capillary inlet to the detector was increased while using from the same applied potential (417 
V/cm) in order to improve the separation resolution.  
 
 
Figure 7.5. Electropherograms of a 1:1 mixture of FAM-Aβ (1-40) peptide:Arctic Aβ peptide 
sampled on day 2 (A), day 3 (B) and day 6 (C). Peak I is hypothesized to be due to a population 
of Aβ aggregates that are intermediate in size between monomer and fully-formed fibrils (shown 
as individually detected narrow peaks). 
 
The FAM-Aβ monomer peak was detected in each electropherogram shown in Figure 7.5 
(labeled FAM Aβ Monomer) while the Arctic Aβ monomer was not detected since it was not 
labeled with a fluorophore. The CE-UV data for the day 1 and day 2 samples (Appendix A: 
Figure A.6B and A.6C) has peaks for both the Arctic Aβ monomer and FAM-Aβ monomer, at 
approximately a 1:1 ratio as expected. Intermediate aggregate peaks similar to that in Figure 7.2 
were observed for day 1, day 2 and day 6 samples. The CE-UV electropherograms also included 
  124 
 
peaks consistent with intermediate aggregates [45,118]. Significant numbers of narrow peaks 
attributed to larger individual Aβ aggregates are first apparent on day 3 (13 peaks averaged from 
3 injections) and increase on day 6 (35 peaks averaged from 3 injections). The average FA value 
for all 40 of the narrow peaks detected from 3 injections of the day 3 sample was 0.093 ± 0.029 
(Table 7.1). Figure 7.6 shows a FA histogram of the narrow peaks detected on day 3. By day 3, 
the peaks for Arctic Aβ monomer and FAM-Aβ monomer were near or below the CE-UV 
detection limits though the labeled peptide was still detectable by CE-LIF. Overall these results 
are consistent with the expected progression of Aβ aggregation. 
 
Figure 7.6. . Fluorescence anisotropy histograms of narrow peaks detected from the 1:1 mixture 
of FAM-Aβ (1-40) peptide:Arctic Aβ (1-40) peptide sampled on day 3 (A). bin = 0.01. 40 peaks 
are represented from 3 injections. 
 
7.3.3 CE-LIF Anisotropy Analysis of Aβ Peptides 
The fluorescence anisotropy data are summarized in Table 7.1. There is a clear increase 
in the fluorescence anisotropy from monomer to intermediate Aβ peaks and fibrils for both 
samples. The smaller fluorescence anisotropy for the monomer compared to the intermediate 
peaks and fibrils is understandable based on fluorescence anisotropy theory because the 
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monomer is relatively small. The anisotropy of the monomer is greater than that of the coumarin 
as expected.  
It is interesting that the monomer and fibrils, on average, are similar between the two 
samples taking into account the standard deviation, but the intermediate Aβ peaks’ anisotropy 
values are quite different. The arctic Aβ was used in this work because of it stabilizing effect on 
intermediate Aβ structures. The data suggest that fluorescence anisotropy can be used to 
differentiate between intermediates that are potentially different in size and structure.  
A relatively high standard deviation of the fibrils’ fluorescence anisotropy values is 
observed in Table 7.1 and Figures 7.4 and 7.6.. Wide variability in the fibrils’ fluorescence 
anisotropy values is understandable since individual fibrils presumably have vastly different 
sizes and shapes, which would be reflected as differences in fluorescence anisotropy. Plotting the 
fibrils’ anisotropy values versus peak migration time did not result in any discernable trend (data 
not shown). 
7.4 Conclusions 
In this work, time-course Aβ aggregation studies were investigated by capillary 
electrophoresis with laser-induced fluorescence anisotropy detection. By performing the 
aggregation with fluorescently-labeled Aβ peptides (FAM-Aβ), several forms of Aβ were 
separated and observed in a single electrophoretic run from monomers to fully-formed fibrils. 
This data demonstrated that fluorescence anisotropy can be used to differentiate Aβ peaks 
separated by capillary electrophoresis. 
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CHAPTER 8 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
8.1 Conclusions 
 
The general focus of this dissertation is the analysis of amyloid peptides by capillary 
electrophoresis (CE) combined with spectroscopic detection. In Chapter 2, a method based on 
capillary electrophoresis with UV absorbance detection was developed to quantify the 
concentration of Aβ (1-40) monomer. This method is an alternative to previously established 
HPLC-UV methods for the same purpose. The advantages of the CE-based method over the 
HPLC-based method are that the CE-method has faster analysis times, consumes less sample 
material and achieves lower mass detection limits. The CE method was determined to have a 
limit of detection of 0.5 µM (19 pg). Chapter 2 also showed that the CE-UV method could be 
used to indicate whether an Aβ sample preparation would exhibit accelerated aggregation 
kinetics. This was possible because of the ability of the CE-UV method to separate and detect 
monomeric and aggregated forms of Aβ (1-40). It is highly significant that open bore CE (i.e. no 
stationary phase) can separate Aβ aggregates. This is a nontrivial challenge faced by stationary 
phase-based separation techniques, e.g. LC and gel-based methods. 
 In Chapter 2, the original goal was to analyze Aβ (1-40) preparations of pure monomer. It 
was clear from CE results in Chapter 2 that some the preparations contained aggregated forms of 
Aβ (1-40). Although this was inadvertent, it opened to door to the experiments presented in 
Chapter 3. In Chapter 3, experiments were designed to analyze various monomeric and 
aggregated forms of Aβ (1-40) and Aβ (1-42). The CE-UV method described in Chapter 2 was 
used in Chapter 3 with the exception that the maximum data scan rate allowed by the instrument 
was used in Chapter 3 (32 Hz versus 4 Hz). The data showed that monomeric and aggregated 
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forms Aβ peptides were resolved by CE-UV for preparations of both Aβ (1-40) and Aβ (1-42) 
isoforms. By maximizing the data scan rate, additional sharp peaks were observed in aggregate 
containing samples. These sharp peaks are believed to be due to fully-formed fibrils, and the 
broad aggregate peaks are believed to be due to unresolved Aβ intermediate sized aggregates, i.e. 
oligomers or protofibrils. Aβ seeds are often used to promote aggregation through the 
elimination of the lag phase associated with the nucleation-dependent growth. Aβ seeds are 
sonicated Aβ fibrils, where the sonication process breaks up larger fibrils into smaller Aβ fibril 
fragments that can seed further fibril growth. Aβ (1-40) seeds were also prepared and analyzed 
by the CE-UV method. Comparing the CE-UV electrophoretic profiles of the Aβ (1-40) seed and 
Aβ (1-40) fibril samples, fewer sharp peaks, i.e. fibrils, were observed in the seed sample relative 
to the fibril sample.  
The observation of additional sharp peaks in aggregate containing sample shown in CE-
UV data in Chapter 3 was largely due to the increase in the data sampling rate from 4 to 32 Hz. It 
was believed that 32 Hz was still not sufficient for detecting individual Aβ fibrils. In an effort to 
detect all Aβ fibrils injected into the CE system, a CE-LIFA (laser-induced fluorescence 
anisotropy) instrument was constructed using a 1000 Hz data sampling rate. This data is 
presented in Chapter 4. Aβ peptides do not exhibit strong native fluorescence; therefore, the 
amyloid dye Thioflavin T was used for detecting Aβ fibrils. Thioflavin T was added to the 
electrophoresis buffer, and labeling the Aβ fibrils with ThT was performed on-column during 
electrophoresis. The basic CE conditions were held a similar to those in Chapters 1 and 2 as 
possible. Using the lab-constructed CE-LIFA system, individual Aβ fibrils were resolved and 
detected as individual peaks. This was shown for Aβ (1-40) and Aβ (1-42) isoforms. These 
results were validated by analyzing the same Aβ samples by bulk measurements using a 
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fluorescence plate reader, which is a more common technique used to study Aβ fibrils. The 
results from the CE and bulk plate reader experiments were consistent. 
Chapter 4 also showed that separating Aβ fibrils in the absence of ThT produced sharp 
peaks due to scattered light albeit careful optical design to eliminate elastic scattering from being 
detected. Scattered light was also observed in the plate reader study for aggregate-containing 
samples. It was clear; however, that using ThT resulted in an increase in signal intensity relative 
to not using ThT. This effect was extremely clear in the case of the Aβ (1-42) monomer sample, 
which was shown to contain aggregates. 
In Chapter 4, LIFA detection was used as a means to characterize individual Aβ fibrils. It 
was shown in plots of fluorescence anisotropy versus time that no distinction could be made 
between the fluorescence anisotropy values of the background electrophoresis buffer that 
contained ThT and the Aβ aggregates, i.e. the fluorescence anisotropy electropherograms looked 
like noise although there were clearly peaks in the corresponding fluorescence 
electropherograms. Chapter 5 presented a data treatment method designed to differentiate the 
fluorescence anisotropy values of the background signal and peaks due to Aβ fibrils. The basis of 
the data treatment method was the addition of an artificial signal that was equally applied to all 
fluorescence data points prior to calculating the fluorescence anisotropy. After the data treatment 
was applied, there were clear fluorescence anisotropy peaks that correspond in time to the 
fluorescence peaks detected for Aβ aggregates. It was found that increasing the amount of 
artificial single added to the fluorescence data increased the S/N of the fluorescence anisotropy 
peaks, but the S/N eventually plateaus as a function of added artificial signal.  
In the initial studies of using ThT in the electrophoresis buffer for the on-column labeling 
and detection of individual aggregates, several sharp peaks mimicking those of Aβ were 
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observed in the background buffer that included ThT. These peaks were hypothesized to be due 
to particulate matter in the electrophoresis buffer that were removed by filtering the buffer 
through a 0.02 µm filter. The potential of particulate matter to enhance ThT similarly to Aβ and 
produce false positives laid the groundwork for the experiments described in Chapter 6. Chapter 
6 describes a spectroscopic investigation of ThT enhancement in the presence of polystyrene 
(PS) beads. The study showed that ThT enhancement in the presence of PS beads was similar to 
that of Aβ peptides. Moreover, it is clear in Chapter 6 that ThT enhancement is dependent on 
both PS bead size and concentration.  
In Chapter 7, covalently labeled fluorescent FAM-Aβ (1-40) peptide was mixed with 
either normal unlabeled Aβ (1-40) or Arctic Aβ (1-40) to produce aggregates. The aggregating 
Aβ mixtures were sampled over time and analyze by CE-LIFA. The progression of Aβ 
aggregation was clearly observed from day-to-day CE-LIF data. Aβ monomer, intermediate 
aggregates and fully-formed fibrils were separated and detected in a single electrophoretic run 
for some of the days of aggregation. It was determined that these Aβ peaks exhibited different 
fluorescence anisotropy values.  
8.2 Future Directions 
 Our understanding of amyloid aggregation will continue to depend on developing and 
improving separation and detection methods. The lab-constructed CE-LIFA instrument used in 
Chapters 4 and 7 demonstrated, for the first time, the separation of monomers, intermediate 
aggregates and hundreds of individual fibrils. Moreover, in Chapter 7, the differences in the 
fluorescence anisotropy values for different forms of Aβ suggested that fluorescence anisotropy 
may be useful to differentiate Aβ based on size. To continue development work using 
fluorescence anisotropy as a detection method for Aβ, eliminating scattered light produced from 
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Aβ fibrils so that the fluorescence anisotropy can be calculated from a pure fluorescence signal 
will be critical. The magnitude of scattering can be seen in Chapter 4. Reducing scattered light 
could be accomplished by simply adding multiple notch filters in series.    
Eliminating scattered light would be beneficial for fluorescence anisotropy; however, an 
interesting study would be to modify to the optics of the LIFA system so that one PMT is 
monitoring light scattering and the other PMT is monitoring fluorescence, i.e. the detection 
system would not be used to calculate fluorescence anisotropy, but it would provide the 
magnitude of the scattering under the fluorescence signal for each aggregate. This could be 
accomplished by replacing the polarizing beam splitter cube with a dichroic shortpass filter, 
which is essentially a spectral beam splitter. These types of filters are commercially available, 
e.g. from Edmunds Optics. By using a dichroic shortpass filter, scattered light would pass 
through the filter and be detected by the PMT that is currently being used to detect perpendicular 
radiation. This means that the scattering PMT would be scattering at 90° relative to the incidence 
of the excitation laser radiation on the capillary. The long wavelength of the fluorescence would 
be reflected by the dichroic shortpass filter and be detected in the PMT currently being used to 
detect parallel radiation. Another necessary change would be to move the notch filter and 
fluorescence bandpass filter so that they are between the dichroic shortpass filter and the PMT 
that is detecting fluorescence. Moreover, it would be necessary to include a scattering bandpass 
filter between the dichroic shortpass filter and the PMT detecting scattering.  
Many researchers are using bulk ThT data to measure amyloid aggregation endpoints and 
kinetics. Based on the scattering data in Chapter 4, it would be interesting to perform a bulk ThT 
time-course aggregation study on Aβ but without the ThT. No data in the literature was found 
that compared bulk scattering to ThT fluorescence of Aβ aggregates in a time-course study. 
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 The time-course aggregation study of FAM-Aβ and unlabeled Aβ presented in Chapter 7 
discussed that 1:4 mixture of FAM-Aβ:unlabeled Aβ monomers does not necessarily result in 
aggregates containing a composition of 1:4 FAM-Aβ:unlabeled Aβ. It would be an interesting 
study to mix two fluorescently labeled Aβ monomers, which both could absorb radiation from 
the same excitation source but each would have a unique emission wavelength that could be 
selectively monitored. This may require custom fluorescent labeling because all the 
commercially fluorescent Aβ peptides that could be found are fluorescein-based. This means that 
the emission from the two dyes would be very similar, which makes spectrally separating the 
emissions extremely difficult or impossible. If suitable dyes become commercially available or if 
they can be synthesized in lab, changes to the emission optics similar to those described above 
with the dichroic filter would allow the independent and simultaneous detection of individual 
aggregates for selective wavelengths. Based on the fluorescence intensity detected from each 
dye, the ratio of each fluorescently-labeled Aβ incorporated into a single aggregate could be 
determined. It would be interesting to determine if a correlation exist between the ratio of the 
starting monomers and the ratio of the monomers incorporated into single aggregates.   
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APPENDIX A: SUPPLEMENTAL FIGURES 
 
 
 
Figure A.1. Aβ (1-40) monomer preparation. Same plot as Figure 2.2 except plotted in time and 
showing the entire electrophoretic run (360 s or 5 min). 
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Figure A.2.  Electropherogram of Aβ (1-40) monomer with UV absorbance detection (190 nm). 
The sample was the same as that used for Figure 4.3. The capillary (ID = 50 µm, OD = 366 µm) 
had a total length of 63.0 cm. The detection window was 53.0 cm from the inlet end. The neutral 
marker (NM) was injected for 2.0 s at 0.3 psi followed by the Aβ injection for 5.0 s at 0.5 psi. 
The separation potential was 25.0 kV (397 V/cm). The peaks at 216 s and 264 s are due to the 
neutral marker and Aβ (1-40) monomer, respectively. The small peaks near the Aβ monomer 
peak are thought to be due to Aβ synthetic impurities. 
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Figure A.3.  Electropherogram of Aβ (1-42) fibril with UV absorbance detection at 190 nm. The 
sample was the same as that used for Figure 4.6. The experimental conditions are the same as in 
Figure A.2. The peaks at 200 s and 280–360 s are due to the neutral marker and Aβ (1-42) 
aggregates, respectively. 
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Figure A.4.  Optimizing laser power for maximum S/N of a 2.5 µM FAM-Aβ (1-40) sample. 
Seven laser powers tested (values shown in embedded table). The laser power was not tunable. 
Each laser power was adjusted with neutral density filter(s). The laser power was measured with 
a power meter. The black curve is there to guide the eye.  
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Figure A.5. CE-UV electropherograms of a 1:4 mixture of FAM-Aβ (1-40) peptide: Unlableled 
Aβ (1-40) peptide sampled on day 0 (A), day 4 (B) and day 6 (C). 
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Figure A.6. (A) CE-LIF electropherogram of the FAM-Aβ (1-40) peptide:Arctic Aβ (1-40) 
peptide analyzed on day 1 of aggregation. (B-E) CE-UV electropherograms of the sample FAM-
Aβ (1-40) peptide:Arctic Aβ (1-40) peptide mixture shown in (A) analyzed on day 1 (B), day 2 
(C), day 3 (D) and day 6 (E).  
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